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ABSTRACT 
The goal of the research presented in this dissertation was to create a biomimetic 
artificial material that exhibits functions of extracellular matrix relevant for improved nerve 
regeneration. 
To identify minimal factors necessary for neurite extension In a suitable model 
system, neural adhesion peptides were photoimmobilized on highly crosslinked 
poly(ethylene glycol)-based substrates that were otherwise non-adhesive. Neurons adhered 
in two-dimensional patterns for eleven hours, but no neurites extended. In contrast, human 
fibroblasts adhered and spread on regions with photoimmobilized RGDS oligopeptide, but 
not on RDGS peptide, suggesting that specific integrin-ligand binding accounted for 
fibroblast adhesion and spreading. 
To enable neurite extension and nerve regeneration In three dimensions, and to 
address the need for specifically cell adhesive and cell degradable materials for clinical 
applications in tissue repair in general, an artificial protein was recombinantly expressed and 
purified that consisted of a repeating amino acid sequence based on fibrinogen and anti-
thrombin III. The artificial protein contained integrin-binding RGD sites, plasmin 
degradation sites, and heparin-binding sequences. Furthermore, the protein contained six 
cysteine residues as grafting sites for poly(ethylene glycol) diacrylate via Michael-type 
conjugate addition. The resulting protein-graji-poly(ethylene glycol)acrylates were 
crosslinked by photopolymerization to form hydrogels. Human fibroblasts attached to, 
invaded, and apparently proliferated in the artificial hydrogel matrices three-dimensionally. 
Fibroblast penetration was inhibited in a concentration-dependent manner by both soluble 
cyclo(RGDFV) peptide and aprotinin, a serine-protease inhibitor. Inhibition of fibroblast 
VB 
outgrowth by cyclic RGD peptide suggests that cellular integrins engaged in specific binding 
to RGD sites present in the artificial protein-graft-poly(ethylene glycol) hydrogels' protein 
core. Inhibition by aprotinin suggests that serine protease-mediated cleavage of the hydrogel 
matrix was the mode of cellular ingrowth. 
Although three-dimensional ingrowth of fibroblasts into protein-gr«ft-poly( ethylene 
glycol) hydrogels occurred, only surface neurite outgrowth was observed from chick dorsal 
root ganglia. Neurite outgrowth depended on the concentration of matrix-bound heparin, 
suggesting that heparin was necessary to immobilize neuroactive adhesion- and/or growth 
factors in the hydrogels. Toward three-dimensional neurite outgrowth in protein-graJt-
poly(ethylene glycol) hydrogels, additional heparin-binding factors can be identified or 
designed for intentional immobilization in future experiments. 
Together, the above results show that specific biological functions can be harnessed 
by protein-graJt-poly(ethylene glycol) hydrogels to serve as matrices for tissue repair and 
regeneration. In particular, the two design objectives, specific cell adhesion and 
degradability by cell-associated proteases, were fulfilled by the material. In the future, this 
and similar artificial protein-gr~ft-poly(ethylene glycol) materials with varying protein 
elements for improved wound healing might serve as biosynthetic implant materials or 
wound dressings that degrade in synchrony with the formation of a variety of target tissues. 
Vlll 
TABLE OF CONTENTS 
ACKNOWLEDGMENTS ___________________ lv 
ABSTRACT ___________________________________________________ vl 
TABLE OF CONTENTS _________________________________________ Vlll 
LIST OF FIGURES _________________________________ xlll 
LIST OF TABLES AND CHARTS. _________________ xv 
CHAPTER 1 
GENERAL INTRODUCTION .................................................................................... 1 
CHAPTER 2 
INTRODUCTION TO PERIPHERAL NERVE REGENERATION AND REPAIR .... 6 
BIOLOGICAL BACKGROUND ............................................................................ 6 
Axonal Pathfinding .............................................................................................. 6 
Wallerian Degeneration of the Distal Nerve Stump .............................................. 7 
Axonal Regeneration From the Proximal Nerve Stump ........................................ 8 
Extracellular Adhesion Molecules ....................................................................... 8 
Proteolytic Activity of the Growth Cone ............................................................ 12 
SURGICAL REPAIR OF TRANSECTED NERVES ............................................ 13 
End-to-End Repair ............................................................................................. 14 
Autologous Nerve Grafts ................................................................................... 14 
Entubulation Repair ........................................................................................... 15 
TOWARD NEW MATRICES FOR PERIPHERAL NERVE REGENERATION .. 19 
Overview of Matrices for Nerve Regeneration and Tissue Repair ...................... 21 
Natural, Acellular Matrices for Nerve Regeneration .......................................... 22 
Cell-Containing Matrices ................................................................................... 24 
Functionalized Natural, But Non-Mammalian-Derived Materials ...................... 24 
Biosynthetic and Bioartificial Materials ............................................................. 25 
Enzymatically Degradable Synthetic Materials .................................................. 27 
Methods of Matrix Formation ............................................................................ 28 
A New Class of Protease-Sensitive and Self-Forming Materials ........................ 29 
AIM OF THIS PROJECT ...................................................................................... 29 
CHAPTER 3 
SURFACE PATTERNS OF NEURAL ADHESION PEPTIDES ON A 
POL Y(ETHYLENE GL YCOL)-BASED SURFACE TOWARD TWO-DIMENSIONAL 
ARTIFICIAL NEURAL NETWORKS 
INTRODUCTION ................................................................................................. 31 
MOTIVATION FOR NEURONAL CULTURES ON PATTERNED SURFACES 32 
PREVIOUS WORK WITH PATTERNED SURFACES ........................................ 34 
Chemically Patterned Surfaces ........................................................................... 34 
Shortcomings of Chemically Patterned Substrate Materials ............................... 35 
Biospecific Patterned Surfaces ........................................................................... 36 
The Poly(Ethylene Glycol)-Containing Substrate MateriaL ............................... 37 
Modification of the Poly(Ethylene Glycol)-Containing Substrate MateriaL ....... 37 
Photopatterning ................................................................................................. 40 
MATERIALS AND METHODS ........................................................................... 41 
Synthesis of poly(ethylene-glycol) a-monoacrylate w-monomethylether. ........... 41 
Photoinitiated Formation of Highly Crosslinked Networks ................................ 42 
Automated Fmoc-based Peptide Synthesis on Solid Supports ............................ 42 
Photolabelling of Peptides ................................................................................. 43 
Surface Patterning ............................................................................................. 44 
Culture of Human Foreskin Fibroblasts ............................................................ .44 
Culture of Dissociated DRG Cells ..................................................................... 45 
RESULTS AND DISCUSSION ............................................................................ 45 
Adhesion Resistance of Unmodified Substrate Surfaces ..................................... 45 
Derivatization of Peptides with Photoactive Groups ........................................... 46 
Surface Patterns ................................................................................................. 46 
Specific Integrin-Mediated Cell Adhesion to Regions of RGD Peptide .............. 46 
Patterned DRG Cell Adhesion to Multiple Peptides .......................................... .48 
CONCLUSION ..................................................................................................... 50 
CHAPTER 4 
DESIGN, SYNTHESIS, AND CHARACTERIZATION OF PROTEIN-gru:ft-PEG 
HYDROGELS 
OVERVIEW ......................................................................................................... 51 
INTRODUCTION ................................................................................................. 52 
Design of Protein-graft-PEG Hydrogel .............................................................. 52 
Reaction Selectivity 152 ..................................................................................... 54 
MATERIALS AND METHODS ........................................................................... 55 
DNA Design ...................................................................................................... 55 
General Notes .................................................................................................... 57 
Multimerization of DNA and Cloning into pETI4b ........................................... 57 
Expression of Recombinant Protein Pentamers [A] and [B] ............................... 59 
IX 
Protein Purification ............................................................................................ 59 
Acrylation of Poly(Ethylene Glycol) .................................................................. 60 
Synthesis and Purification of Protein-graft-PEGacrylates .................................. 61 
Verification of Reaction Selectivity ................................................................... 63 
Heparin-Affinity Chromatography ..................................................................... 64 
Verification of Acrylate Presence ...................................................................... 64 
Gelation by Photopolymerization and Swelling ................................................. 65 
Rheological Measurements ................................................................................ 66 
Plasmin Degradation Assay ............................................................................... 66 
RESULTS AND DISCUSSION ............................................................................ 67 
Multimerization of DNA ................................................................................... 67 
Expression and Purification of Recombinant Protein Pentamers [A] and [B] ...... 68 
Characterization of the Recombinant Protein Pentamers .................................... 69 
Synthesis of Protein-graft-PEGacrylates ............................................................ 72 
Selectivity of Protein PEGylation ...................................................................... 76 
Purification of Protein-gr~!t-PEGacrylates ......................................................... 79 
Heparin Affinity of Protein[A]-gr~ft-PEGacrylate ............................................. 80 
Confirmation of Acrylate Presence .................................................................... 81 
Gelation by Photopolymerization and Characterization of Protein-gmp-PEG 
Hydrogels ....................................................................................................... 82 
Plasmin Degradability ....................................................................................... 84 
CONCLUSION ..................................................................................................... 84 
CHAPTERS 
INTERACTIONS OF hFFs WITH RECOMBINANT PROTEIN PENTAMERS AND 
PROTEIN[A]-graft-PEG HYDROGELS 
INTRODUCTION ................................................................................................. 86 
hFF-Fibrin Clusters as a Model for Tissue Regeneration .................................... 86 
MATERIALS AND METHODS ........................................................................... 87 
General Notes .................................................................................................... 87 
Nickel-Affinity Surface Coating and Cell Adhesion Experiments ...................... 87 
Embedding and Culture of hFF-Fibrin Clusters Inside 
Protein-graft-PEG Hydrogels .......................................................................... 88 
RESULTS AND DISCUSSION ............................................................................ 90 
Cell Adhesive Properties of Recombinant Protein Pentamers [A] and [B] .......... 90 
hFF Outgrowth Into Hydrogel Matrix ................................................................ 93 
Inhibition of Three-Dimensional hFF Outgrowth by Heparin and solRGD 
in Protein-gr«!t-PEG Hydrogels ...................................................................... 98 
Competitive Inhibition of hFF Outgrowth by Cyclic RGDFV Peptide .............. 101 
Inhibition of hFF Outgrowth by Aprotinin, a Serine-Protease Inhibitor ............ 102 
CONCLUSION ................................................................................................... 103 
x 
CHAPTER 6 
EFFECT OF HEPARIN ON CHICK NEURITE OUTGROWTH ON 
PROTEIN-grajf-PEG HYDROGELS 
INTRODUCTION ............................................................................................... 105 
BACKGROUND ................................................................................................. 107 
DRG Assay ..................................................................................................... 107 
PC 12 Cells ....................................................................................................... 107 
MATERIALS AND METHODS ......................................................................... 108 
Peptide Synthesis ............................................................................................. 108 
Heparin-Affinity Chromatography with Heparin-Binding Adhesion Peptide .... 109 
Rheological Characterization of Protein-graft-PEG(6000) Hydrogels 
Containing Heparin ....................................................................................... 110 
Preparation of Neural Culture Medium (NCM) ................................................ III 
Dissection of Chick Dorsal Root Ganglia (DRGs) ........................................... 112 
Dissection of Mouse DRGs .............................................................................. 112 
Embedding and Culture of Whole DRGs Inside Protein-gr«ft-PEG Hydrogels. 112 
Embedding and Culture of DRG-Fibrin Clusters Inside 
Protein-groft-PEG Hydrogels ........................................................................ 116 
Embedding and Culture of Dissociated DRG Cell-Fibrin Clusters 
Inside Protein-gr«ft-PEG Hydrogels ............................................................. 116 
Embedding and Culture of PC 12 Cell-Fibrin Clusters Inside 
Protein-gr«ft-PEG Hydrogels ........................................................................ 117 
Culture of DRGs on Laminin-Coated Surfaces with Subsequent 
In Situ Formation of Protein-graft-PEG Hydrogels in Contact with DRGs .... 118 
Culture of DRGs on Protein-gr«ft-PEG Hydrogels .......................................... 119 
Verification of Chick Neurite Outgrowth by Immunostaining with 
Anti-Growth-Associated Protein-43 (GAP-43) Monoclonal Antibody .......... 121 
RESULTS AND DISCUSSION .......................................................................... 122 
Heparin Affinity of hep.bind.-YIGSR Peptide ................................................. 122 
Increase of the Mechanical Strength of Protein-gr«ft-PEG Hydrogels 
Due to Heparin ............................................................................................. 124 
Fibroblast or Glial Cell Outgrowth, but Lack of Neurite Outgrowth, from 
Whole DRGs Inside Protein-graft-PEG Hydrogels ....................................... 125 
Lack of Neurite Outgrowth from PO Mouse DRGs in 
Protein-graft-PEG Hydrogels ........................................................................ 127 
Lack of Outgrowth from DRG-Fibrin Clusters Inside 
Protein-graft-PEG Hydrogels ........................................................................ 129 
Lack of Neurite Outgrowth from Dissociated DRG Cell-Fibrin Clusters 
Inside Protein-grajf-PEG Hydrogels ............................................................. 130 
Lack of Neurite Extension by PC12 Cells Embedded in Fibrin and Placed 
Inside Protein-gr«ft-PEG Hydrogels ............................................................. 131 
Arrest of Neurite Outgrowth after In Situ Formation of 
Protein-gr«ft-PEG Hydrogels ........................................................................ 132 
Surface Neurite Outgrowth upon Protein-groft-PEG Hydrogels ....................... 133 
Heparin-Dependence of Neurite Outgrowth upon Protein-gr«ft-PEG Hydrogels 134 
Xl 
XJ1 
Dependence of Neurite Outgrowth on Crosslink Density of Protein-graft-PEG 
Hydrogels ........................................................................................................ 137 
CONCLUSION ................................................................................................... 138 
FUTURE WORK ................................................................................................ 139 
CHAPTER 7 
SUMMARY, CONCLUSIONS, AND OUTLOOK 
MATERIAL DEVELOPMENT ........................................................................... 140 
Protein Solubility and Oxidation State ............................................................. 140 
Modification of Proteins by Michael-Type Conjugate Addition ....................... 141 
Purification by Ni++-Affinity Chromatography ................................................. 141 
In situ Photogelation ........................................................................................ 142 
MATERIAL PROPERTIES ................................................................................ 143 
Physical Properties .......................................................................................... 143 
Biofunctional Features ..................................................................................... 144 
MATERIAL IMPROVEMENTS AND FUTURE APPLICATIONS ................... 145 
Material Improvements .................................................................................... 145 
Biological Considerations ................................................................................ 146 
Versatility of Protein-gr«ft-PEG Hydrogels ..................................................... 148 
REFERENCES .......................................................................................................... 149 
LIST OF FIGURES 
Figure 2.1 A-D: Spontaneous Regeneration of Peripheral Nerves after Axotomy ............................................. 7 
Figure 2.2: Nerve Regeneration Through a Nerve Guide Tube ......................................................................... 16 
Figure 3.1: Constituent Molecules of Polymer Networks .................................................................................. 38 
Figure 3.2: Non-Adhesive Nature of Network Surface Due to PEGMA ........................................................... 38 
Figure 3.3: Cacking During Formation of Highly Crosslinked Polymer Networks .......................................... 39 
Figure 3.4: Molecular Structure of SANPAH ..................................................................................................... 40 
Figure 3.5: The Substrate Material's Resistance to Cell Adhesion ................................................................... 46 
Figure 3.6: hFF Patterns Due to Adhesion to Regions Containing RGD-Peptide ............................................. 47 
Figure 3.7: Exactness of Cellular Adhesion to Regions of RGD-Peptide ......................................................... 47 
Figure 3.8: Cell Adhesion and Spreading Requires Integrin Binding to RGD-Peptide .................................... 47 
Figure 3.9: Cellular Adhesion Conforming to Concentration Patterns .............................................................. 48 
Figure 3.10: Patterned Adhesion of Dissociated Chick DRG Cells ................................................................... 49 
Figure 4. I: 1.5% Agarose Gel Illustrating DNA Multimerization ..................................................................... 67 
Figure 4.2.a: Bacterial Expression and Purification of Recombinant Protein Pentamer [A J ............................ 68 
Figure 4.2.b: Western Blot of Recombinant Protein Pentamer [AJ ................................................................... 69 
Figure 4.3.a: SDS-PAGE Gel Showing the PEGacrylation of Recombinant Protein Pentamer r AI ................ 72 
Figure 4.3.b: PEGylation of Protein Pentamer [A] with PEGs of Increasing Molecular Weight... .................. 75 
Figure 4.3.c: Reaction Selectivity of Michael-type Conjugate Addition ........................................................... 77 
Figure 4.4: NiH-affinity Purification of Protein[AI-graft-PEGacrylate ............................................................. 79 
Figure 4.5: Heparin-Agarose Affinity Chromatography With Protein[AH~raft-PEGacrylate ......................... 80 
Figure 4.7: Gelation of ProteinIAl-grafr-PEGacrylate ....................................................................................... 82 
Figure 5. I: hFF Adhesion to Protein Pentamers ................................................................................................. 91 
Figure 5.2: Competitive Inhibition of hFF Adhesion to Recombinant Rrotein Pentamer [AJ .......................... 92 
Figure 5.3: Adhesion Inhibition by Heparin ....................................................................................................... 93 
Figure 5.5: Three-Dimensional hFF Outgrowth ................................................................................................. 93 
Figure 5.6: hFF Morphology and Proliferative Penetration Inside Protein-graft-PEG Hydrogels ................... 94 
Figure 5.7: Three-Dimensional Migration of Individual Cells .......................................................................... 95 
Figure 5.8: hFFs Forming Three-Dimensional Intercellular Connections ......................................................... 95 
Figure 5.9: Apparent Cell Divisions Inside Protein-graft-PEG Hydrogels ....................................................... 96 
Figure 5. 10: Dense hFF Sphere Formation ......................................................................................................... 97 
Figure 5.13: Inhibition of hFF Outgrowth by Heparin and solRGD Peptide .................................................... 99 
Figure 5.14: Inhibition of hFF Outgrowth by Cyclic RGDFV ......................................................................... lOl 
Figure 5.15: Inhibition of hFF Outgrowth by Aprotinin .................................................................................. 102 
Figure 6.1: "Heparin Bridge" Immobilization Scheme .................................................................................... 106 
Figure 6.2 a.b; c.d: Heparin-Agarose Affinity Chromatography With hep.bind.-YIGSR Peptide ................. 123 
Figure 6.3: Physical Intermolecular Crosslinking by Heparin ........................................................................ 124 
Figure 6.4: Lack of Three-Dimensional Neurite Outgrowth from Embryonal Chick DRGs .......................... 126 
Figure 6.5: Occasional Three-Dimensional Fibroblast or Glial Cell Outgrowth 
from Embryonal Chick DRGs ................................................................................................................. 126 
Figure 6.6: Late Three-Dimensional Fibroblast or Glial Cell Outgrowth from Embryonal Chick DRGs ..... 127 
Figure 6.7: Three-Dimensional Fibroblast or Glial Cell Outgrowth from Embryonal Chick DRGs 
at Low Gel Density .................................................................................................................................. 127 
Figure 6.8 a: Lack of Three-Dimensional Neurite Outgrowth from PO Mouse DRGs ................................... 128 
Figure 6.9: Surface Neurite Outgrowth from PO Mouse DRGs ....................................................................... 128 
Figure 6.10: Lack of Three-Dimensional Neurite Outgrowth from Embryonal 
Chick DRG-Fibrin Clusters ..................................................................................................................... 129 
Figure 6.11: Lack of Three-Dimensional Neurite Outgrowth from 
Embryonal Chick DRG Cell-Fibrin Clusters .......................................................................................... 130 
Figure 6.12: Fibroblast or Glial Cell Spreading Inside Embryonal Chick DRG Cell-Fibrin Clusters ........... 131 
Figure 6.13: Lack of Neurite Outgrowth from PC 12-Fibrin Clusters Inside Protein-graft-PEG Hydrogels. 131 
Figure 6.14: Arrest of Neurite Outgrowth After Hydrogel Formation in Contact 
X III 
XIV 
with Chick Embryonic DRGs .................................................................................................................. 132 
Figure 6.15: Anti-GAP-43 Immunostaining of Axonal (a and b) and Non-Axonal (c and d) Outgrowth ..... 133 
Figure 6.16: Anti-GAP-43 Immunostaining of Axonal Outgrowth Upon Laminin-Coated TCPS ................ 134 
Figure 6.17: Heparin-Dependence of Axonal Outgrowth On the Surface of Protein-f,'ratt-PEG Hydrogels. 135 
Figure 6.17: Effect of Hydrogel Crosslink Density on DRG Neurite Outgrowth ........................................... 137 
xv 
LIST OF TABLES AND CHARTS 
Table 2.1: Examples of the Most Common Nerve Guidance Channel Materials 
(hascd 011 Fine et aI., 20(0)65 ................................................................................................................... 17 
Table 2.2: Classes of Materials for Peripheral Nerve and Other Tissue Repair.. .............................................. 21 
Table 4.1: Amino Acid Analysis of ProteinIAJ-g-raft-PEG and Protein I B I-graft-PEG ................................... 70 
Table 4.2: Charge Analysis of ProteinIAI-graft-PEG and Protein[B]-g-raft-PEG ........................................... 73 
Table 6.1: Culture Conditions for DRGs Half-Embedded in Protein-graft-PEG(3400) Hydrogels ............... 119 
Table 6.2: Culture Conditions of DRGs Half-Embedded in Protein-graft-PEG(6000) Hydrogels ................ 120 
Chart 4.1: Fibrinogen- and ATlII-based Recombinant Protein Pentamer IAI and 
Non-Functional Control Pentamer [B] ...................................................................................................... 53 
Chart 4.1: Fibrinogen- and ATllI-based Recombinant Protein Pentamer lAJ and Control Pentamer [B] ....... 53 
Chart 4.2: Recombinant Gene Assembly ........................................................................................................... 56 
Chart 4.3: DNA Multimerization ........................................................................................................................ 56 
CHAPTER 1 
General Introduction 
In the United States alone, more than 200.000 nerve repair procedures are estimated 
to be performed annually. I Despite major advances in the understanding of nerve 
regeneration and developments in surgical techniques, complete recovery of sensory and 
motor function after nerve injury is rare. 2 In attempts to repair peripheral nerve injuries 
where the two severed nerve endings cannot be re-attached directly. the best clinical results 
are achieved when the nerve gap is bridged with a nerve autograft, considered the "gold 
standard" for peripheral nerve repair. However, to avoid the use of such an autograft, 
which causes discomfort and loss of function elsewhere in the patient's body, nerve guide 
tubes are under intense investigation to be used as implant devices that can provide a 
defined path as well as physical and immunologic protection for the regenerating nerve until 
it reaches its target. the severed distal nerve ending. From there on, the remains of the 
degenerated distal nerve provide sufficient information for the regenerating axons to reach 
their target organs. Although even empty or saline-filled nerve guide tubes can support 
regeneration over short distances (e.g., up to a critical injury size of 10 mm in rat sciatic 
nerve3 and up to 6 mm in mice4), various synthetic and natural materials, including cell-
loaded materials, have been tested experimentally to serve as matrices for nerve 
regeneration inside nerve guide tubes. Most of these materials are either deficient in their 
ability to significantly improve nerve regeneration beyond critical injury sizes; or various 
biological and physical concerns prevent their clinical use altogether, such as poor 
mechanical properties. a severe inflammatory response. poor nutrient supply, or potential 
epidemiological hazards inherent to human or animal derived substances, unless they are 
autologous.56 
These deficiencies often apply to materials for tissue regeneration in general. and so 
far no "ideal" material for tissue repair is available for clinical use. Clearly, different 
material requirements must be fulfilled to promote regeneration of the different types of 
2 
tissue in the body, including target tissues such as cartilage, bone, skin, tissues of the 
peripheral and central nervous system, etc., but a better understanding and progress in the 
design of materials for the repair of one type of tissue will also benefit the design of 
biomaterials for other tissues. It is in this spirit that this doctoral research was conducted, 
and although Chapter 2 lists material requirements specifically for peripheral nerve 
regeneration, the basic principles also apply to other types of tissue. Accordingly, the 
materials intended for peripheral nerve repair, which will be described in Chapters 4, 5, 
and 6, also hold promise for the repair of tissues other than peripheral nerve. 
The specific aim of this doctoral research project was to develop a synthetic 
alternative to human and animal derived matrices for nerve repair. However, given the 
promising improvements of peripheral nerve regeneration with modified or native natural 
materials, notably fibrin and modified fibrin-based matrices, the material developed and 
presented in this work was highly inspired by substances found in nature. In particular, 
cell-adhesiveness and cell-controlled degradability are two principal characteristics of 
natural extracellular matrices that are crucial for wound healing. Accordingly, our design 
of a material for nerve repair was aimed at achieving (a) specific, three-dimensional cellular 
adhesion by cell types involved in nerve regeneration as well as (b) cell-associated matrix 
degradation in spatial and temporal synchrony with cellular outgrowth and/or proliferation. 
Since specific cellular adhesion and migration in the material were to be achieved by 
means of a limited number of biological signals that could possibly be incorporated, 
initially all efforts were directed at identifying and optimizing a combination of minimal 
adhesion peptides to promote neurite extension on an otherwise cell-nonadhesive surface 
and thereby gaining control over neuronal behavior at the level of individual neurons. Like 
the eventual three-dimensional matrix intended for nerve regeneration inside nerve guide 
tubes, the surface was that of a highly cross-linked poly(ethylene glycol) (PEG) containing 
material, in which the high PEG content assured low protein adsorption and zero cell 
adhesion. unless cellular adhesion sites were covalently immobilized on the surface. 
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Chapter 3 describes this work involving the photo-immobilization of cellular adhesion 
peptides and the patterned adhesion and spreading of human fibroblast that was achieved. 
However, Chapter 3 also describes the limited success with a neuronal cell type that was 
cultured on this patterned substrate material: Neuronal adhesion was sustained for only up 
to eleven hours, and neurites did not extend upon the surfaces. 
Although neuritic extensions, let alone neural circuits, were never achieved on the 
PEG surfaces described in Chapter 3, the results with mere fibroblasts on surfaces were 
still promising. A three-dimensional material that would support specific fibroblast 
attachment and penetration still holds great potential as a matrix for nerve regeneration, 
because initial ingrowth of fibroblasts and Schwann cells is known to precede and promote 
the subsequent invasion ofaxons during nerve regeneration (Chapter 2). This is likely due 
to, both, trophic factors as well as extracellular matrix molecules that fibroblasts and 
Schwann cells secrete. 
Extrapolating from two-dimensional cell adhesion to the intended three-dimensional 
neuronal cultures, subject to the biological "boundary conditions" reviewed in Chapter 2, 
gave rise to the design and development of a three-dimensional matrix for nerve 
regeneration that is described in Chapter 4. The material, a non-toxic protein-grajt-PEG 
hydrogel, could be formed in direct contact with cells by photo-crosslinking PEGylated 
artificial protein precursors under physiological conditions. The ability to rapidly cross-
link a solution of protein-grajt-PEGacrylate precursor molecules by light and in sitl! was 
important so as to allow curing of the material around the severed nerve endings during 
surgery. In fact, the entire Chapter 4 is dedicated to the unique chemistry chosen to 
synthesize the protein-gn4t-PEGacrylate precursors, their crosslinking, and to the physical 
characterization of the resulting hydrogels. 
Chapter 5 is dedicated to the biological properties and in \'itro performance of the 
protein-gr«ft-PEG matrices in contact with human cells. In a model system, in which 
fibroblast clusters were embedded inside protein-gr«ft-PEG hydrogels, invasion by the 
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fibroblasts into this biosynthetic, highly crosslinked matrix was observed. This suggested 
that the material was indeed a successful representative for a truly new class of materials 
that are specifically biofunctional and cell-responsive. In particular, it was shown that 
cellular penetration of the protein-gr~ft-PEG matrices was due to specific interaction with 
integrin-binding cell adhesion motifs that had been incorporated into the protein backbone 
of the hydrogels, and that cellular invasion required cell-associated proteolytic degradation 
in synchrony with cellular outgrowth and apparent proliferation inside the material. 
While none of the neuronal cell types tested in vitro produced neuritic extensions 
inside the protein-gr«ft-PEG matrices, perhaps due to poor viability or insufficient neuronal 
protease activity, axons extended abundantly upon the protein-graft-PEG hydrogels in 
studies with two-dimensional cultures, as elaborated in Chapter 6. Amazingly, this neurite 
outgrowth from chick dorsal root ganglia was independent of the presence of exogenous 
extracellular matrix proteins fibronectin and laminin, but depended vitally on the presence 
of heparin bound to the heparin-binding sites of the protein-gr«ft-PEG matrix. 
Since the protein-gr«ft-PEG material described in this doctoral thesis fulfilled some 
essential requirements toward functioning as a matrix for nerve regeneration, such as 
suitable physical properties, apparent lack of cytotoxicity, cell adhesivity, proteolytic 
degradability, and ease of handling, the hope is that possible future experiments will prove 
the material's successful performance in supporting improved nerve repair in l'il'O. 
Toward this end, it might prove conducive or even necessary to pre-seed the matrix with 
suitable supporting cells, such as autologous Schwann cells. Such and other continuing 
experiments are envisioned and discussed in Chapter 7. 
Beyond the context of nerve regeneration and repair, Chapter 7 also briefly touches 
upon the role that the general class of biosynthetic PEG-based materials might play in the 
future of wound healing and tissue repair. Among this class of materials the particular 
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Axonal pathfinding during development or the regeneration of nerves in v/\'o IS 
governed by complex interactions of a neuron's growth cone with its environment. Cell-
cell interactions, cell-extracellular matrix interactions, gradients of inhibitory or 
neuroinductive molecules and growth factors, as well as electrical stimuli all provide 
possible cues for the growth cone's complicated task of establishing the correct connections 
among neurons in the brain or between neurons and their target organs in the periphery of 
the body. In culture, however, a cell adhesive substrate and the presence of sufficient 
growth factors in the culture medium alone can support outgrowth of neurites and the 
fonnation of synapses. Within dense three-dimensional substrates, neuronal outgrowth 
also requires proteolytic activity, unless the substrate material is porous or fibrillar and, 
thus, effectively allows for unobstructed two-dimensional outgrowth within the pores or 
along the material's fibers. However, such conditions do not exist at the site of a nerve 
injury, where a dense fibrin clot and even scar tissue may fonn, nor within the remains of a 
distal nerve piece where, after axotomy and Wallerian degeneration, Schwann cells shape 
and populate a dense extracellular matrix surrounded by basal lamina or endoneurial tubes.2 
An infOlmative review of the molecular and cellular events ensuing after nerve crush or 
axotomy, i.e., the complete severance of an axon, and of early approaches to enhance 
peripheral nerve regeneration via nerve guide tubes, can be found in the reviews by Seckel, 
1990,2 and Fawcett and Keynes, 1990.7 The following overview is based on their work. 
7 
Wallerian Degeneration of the Distal Nerve Stump 
In the distal nerve stump, myelin, which surrounds nerves in the healthy peripheral 




















Figure 2.1 A·D: Spontaneous Regeneration of Periphcral Nerves after Axotomy 
Schematic of a single myelinated neuron rcgenerating aftcr axotomy. An actualncrve consists of thousands 
of such axons. bundled into fascicles and sun"Ounded by basal lamina and endoneurium. (from Seckel. 
1990)2 
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Schwann cells proliferate and, together with invading macrophages, remove the myelin 
debris by phagocytosis. During this process, the basal lamina tubes and endoneurium, 
which are connective tissues that ensheathe the myelinated nerve fibers, persist. Schwann 
cells align longitudinally within the confines of the basal lamina and form continuous 
columns of cells called endoneurial tubes or bands of Bilngner.8910 At later stages, 
Schwann cells also deposit collagen along both surfaces of the basal lamina tube, while the 
basal lamina itself consists of collagens, laminins, fibronectin, heparan sulphates, 
proteoglycans, and enactin.1l12 
Axonal Regeneration From the Proximal Nerve Stump 
In the peripheral nervous system, axons that survive rapid traumatic degeneration 
near the tip of the proximal nerve stump (Figure 2.I.B) have the capacity to re-sprout 
spontaneously after axotomy (C). In fact, the injury leads to a dedifferentiation of the 
injured neurons toward a more plastic or embryonic state that permits growth.B 1415 This 
may be due to the loss of certain trophic factors from the periphery that usually maintain the 
differentiated, mature state of a functional neuron. 16 
Extracellular Adhesion Molecules 
Besides the necessity of certain neurotrophic factors to sustain neuronal survival 
(not directly subject of this thesis, but reviewed elsewhere ),'71819 supporting cells and 
regenerating growth cones require adhesion molecules that provide adhesion sites for 
mechanical attachment, signalling for vital second messenger pathways toward proper gene 
expression and differentiation state, and directional cues for continued outgrowth. 
Adhesion molecules can be divided into cell-cell adhesion molecules (cell adhesion 
molecules) and cell-matrix adhesion molecules (extracellular matrix adhesion molecules). 
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Cell Adhesion Molecules 
Since the aim of this research project was to design a matrix that would support 
ingrowth of both neuronal and supporting cells, and since those supporting cells were 
expected to provide the cell-cell interactions necessary for sustained neurite outgrowth, the 
main objective of the matrix was to provide equivalents of the necessary extracellular matrix 
molecules that are required for cellular adhesion during nerve regeneration. Therefore, the 
focus of the following section will be on extracellular matrix molecules, particularly those 
that function in neuron-matrix adhesion. For an overview of cellular adhesion molecules 
such as neural cell adhesion molecule (N-CAM), neuroglia CAM (NgCAM or L1), the 
fasciclins, N-cadherin, etc., the reader is referred to introductions by Jesse!, 1991,20 and 
Nicholls et al., 1992,21 or to studies by Daniloff et al., 1986,22 and Martini and Schachner, 
1988,23 that focus on neural adhesion molecules expressed, e.g., by Schwann cells, in 
response to injury and ensuing repair. 
Extracellular Matrix Adhesion Molecules and Their Cellular Receptors 
The extracellular matrix (ECM) is a complex set of collagens, noncollagenous 
glycoproteins, glycosaminoglycans and proteoglycans. ECM adhesion molecules among 
these constituents play important and defining roles in the development and regeneration of 
neurons after injury. During peripheral nerve regeneration, especially those adhesion 
molecules that are contained in the basal lamina tubes, which persist or are maintained even 
after Wallerian degeneration, provide crucial ligands and directional cues for growth cone 
attachment and outgrowth. Ligands for cell surface-associated integrin receptors (reviewed 
specifically in the context of the peripheral nervous system by Previtali et al., 200 I ),24 and 
the integrin-binding RGD motif in particular,25 are the most prominent and abundant factors 
in the ECM that enable neuronal attachment and extension. The RGD domains in 
laminin,26 fibronectin,26 collagen type I and IV,27 and thrombospondin28 have all been 
directly implicated in neurite outgrowth. 
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Especially laminin, a large (900 kDa), three-chain (A, B I, B2), cross-shaped 
glycoprotein found in basement membranes, functions as a very potent substrate for neurite 
outgrowth in vitro. Laminin contains a number of additional, non-integrin binding sites. 
Although some uncertainty remains regarding the relative significance of its domains in 
mediating attachment and/or outgrowth, and about the specificity of some of the 
corresponding laminin receptors,29 it seems clear that at least the following sites in laminin 
are functionally relevant for neuronal cell and growth cone adhesion: a domain in the B 1 
chain containing the amino acid sequence YIGSR;JOJI a nearby heparin-binding and cell 
adhesion-promoting site in the globular region of the B I chain with amino acid sequence 
R YVVLPRPVCFEKGMNYTVR;J2 and a site at the end of the long arm in the A chain 
containing the amino acid sequence IKV A V.JJJ4J5 
As far as the corresponding cellular receptors for laminin's adhesion domains are 
concerned, a 67 kDa non-integrin receptor has been identified in peripheral neurons that 
seems to mediate specific binding to the YIGSR-containing active site of laminin.J637 
Similarly, an IKV A V -specific 110 kDa receptor for neurite outgrowth has been known for 
several yearsJII and been localized in the hippocampus among other regions of the brain,394o 
suggesting that interactions between laminin and this receptor play a role in controlling 
axonal guidance during development, or in repair during regeneration.4o 
It is remarkable that, instead of requiring the entire laminin molecule or its local 
three-dimensional context, neuronal cell-surface receptors also interact specifically with 
some short synthetic oligopeptides that are functional elements of the above-mentioned 
domains. Such interactions may not have the full signalling or binding capacity that the 
native corresponding protein domain has, but short oligopeptides can -to an extent- fulfill 
the function of the entire domain that they are derived from and, thus, mimic the domain's 
role as a ligand, for instance. For example, neurons adhere and extend upon defined 
regions of oligopeptides containing the isolated YIGSR motif,J031412942 as demonstrated, 
for example, with synthetic, photo-immobilized CDPGYIGSR peptide by Clemence et al., 
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1995.43 and others. Likewise. an immobilized synthetic RGD peptide based on the RGD-
site of the laminin A chain was active in cell attachment. spreading. migration and neurite 
outgrowth. 26 
One further laminin-derived peptide sequence that is important for neurite 
outgrowth. at least in hippocampal cells. is RDIAEIIKDI.44 This peptide was potent not 
only in eliciting neurite outgrowth, but also necessary to induce a mature neuronal 
phenotype of embryonic hippocampal neurons in culture. 
Regarding the role of many other extracellular adhesion proteins such as agrin, the 
tenascins and the thrombospondins, the reader can find comprehensive lists and summaries 
in the reviews by Reichardt and Tomaselli, 1991,45 Martini, 1993.46 Venstrom and 
Reichardt, 1993,27 and others. 
Proteoglycans represent another important class of adhesion molecules that require 
mentioning especially in the context of the project presented in this thesis. Proteoglycans 
are macromolecules composed of glycosaminoglycan chains covalently bound to a protein 
core. An unusually large number of proteoglycans is expressed in the nervous system, and 
they are expressed by both neurons and gJiaP Their functions include roles both as 
receptors and components of neuronal extracellular matrix that can actively promote neurite 
outgrowth. An important feature in the context of the materials presented in this doctoral 
thesis is that proteoglycans' glycosaminoglycan side chains (such as highly negatively 
charged heparin) provide binding sites for adhesion molecules -such as laminin474/L and 
growth factors. 495o and thus act as indirect modulators of cellular adhesion and growth 
factor action. One directly neurite-promoting heparan sulfate proteoglycan, that is basal 
lamina-associated, is perlecan,51 and its receptors even include imegrins.52 
Some proteoglycans. such as certain chondroitin sulfate proteoglycans,5354 can also 
inhibit neural cell migration and neurite outgrowth, especially at high concentrations.55 As 
a consequence. some approaches to nerve repair have involved nerve grafts that were 
stripped of chondroitin sulfate proteoglycan by incubation with appropriate matrix 
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metalloproteinases prior to implantation.56 Proteoglycans may inhibit cell migration and 
neurite outgrowth by binding to the cell surface, thereby sterically hindering other cell 
adhesion receptors, or by binding matrix proteins and thereby masking cell attachment 
sites. 27.57 
As far as the results of the research presented in this thesis are concerned, the 
balance between enough and too much of the glycosaminoglycan heparin turned out to be 
of significant importance (Chapters 5 and 6). 
Proteolytic Activity of the Growth Cone 
In addition to matrix interactions and chemotaxis, extending axons reqUIre 
proteases, in particular plasmin, to penetrate first the cellular debris and initial fibrin clot 
that they encounter at the site of the injury and, then, to invade and penetrate the remains of 
the distal nerve piece, when the distal stump is reached. In accordance with numerous ill 
\'itro studies, Siconolfi and Seeds, 2001,58 have recently shown that the induction of the 
plasminogen activator system accompanies peripheral nerve regeneration in vivo after 
sciatic nerve crush in mice. The plasminogen activators (PAs), tissue plasminogen 
activator (tPA) and urokinase plasminogen activator (uPA), two serine proteases, convert 
inactive plasminogen to its proteolytically active form, plasmin, which is also a serine 
protease. Mice lacking tPA, uPA, or plasminogen genes showed delayed functional nerve 
recovery after sciatic nerve crush.59 
Plasmin has broad activity by virtue of its ability to cleave many, but not all, peptide 
bonds carboxy-terminal to basic residues lysine and arginine. In pal1icular, in fibrinogen's 
a-chain, plasmin cleaves between residues ArgI1l4_Asp lO:i, Argllll-Val lll , and Lys206_ 
Met207 .60 Of these cleavage sites, Arg11l4-Asp11l5 and Argllll-Val ill were chosen to be part 
of recombinant protein pentamer rA] (Chart 4.1, Chapter 4) in order to confer specific 
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degradability by plasmin to proteinIAJ-graft-PEG hydrogels, the subject material of this 
thesis. 
Although plasminogen's most prominent role is in fibrinolysis in the blood, where 
it has a circulating concentration of 211M, plasminogen IS also present in the 
extracellular/extravascular space of most tissues. However, m tissues, plasminogen 
activation to plasmin is highly localized to cellular surfaces or to the surface of neuritic 
growth cones, because uP A, the relevant PA in cell migration and matrix remodelling, 
binds to a well characterized receptor (uPAR) on cell surfaces. 61 Plasminogen activation 
and plasminolysis are, thus, limited to the immediate cellular proximity62 and the direction 
of neurite outgrowth. Potent and abundant serine protease inhibitors such as a2-plasmin 
inhibitor and a2-macroglobulin constantly curb plasminolysis and prevent plasmin activity 
altogether when it diffuses away from the cell surface or neuritic growth cone. Another 
serine protease inhibitor, and therefore inhibitor of plasmin, is aprotinin. Aprotinin, also 
known as pancreatic trypsin inhibitor, is a small protein (6.5 kDa) that has high structural 
complementarity with its target enzymes and engages them in strong electrostatic 
interactions, thus blocking their proteolytic activity. In the context of this thesis project 
aprotinin was used to establish a negative control (Chapter 5) for the plasmin degradability 
of the proteinf A l-graft-PEG materials presented in Chapter 4. 
SURGICAL REPAIR OF TRANSECTED NERVES 
Sprouting axons have to be able to reach the distal stump m order for nerve 
regeneration and eventual reinnervation of the target organ to occur. Therefore, the 
proximal and distal stumps should ideally be in direct contact, and must not be separated by 
an insurmountable distance nor be obstructed by ingrowth of scar tissue or poor alignment 
of the nerve's microstructure. Otherwise, possible consequences include a backward 
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change in direction of the axonal sprouts, axonal branching into surrounding tissue, or the 
fonnation of a neuroma,63.64 which clinically are all catastrophic results. 
To overcome nerve gaps due to large injuries, and evade obstruction by scar tissue 
between the two nerve stumps, surgical intervention is usually necessary after peripheral 
nerve lesions. Fine el al., 2000,65 provide an up-to-date summary of the materials as well 
as clinical and experimental advances in peripheral nerve repair, upon which the following 
overview is largely based. 
End-to-End Repair 
When axotomy results from a "clean cut" and the nerve endings merely retract, it is 
often possible to reconnect the severed nerve fascicles directly using microsurgical 
techniques. Presently the most commonly used suture material in end-to-end repair is fine 
monofilament nylon.65 Similarly, fibrin glue materials have been used for many years in 
experimental nerve repair. 66 One experimental system even uses poly(ethylene glycol) to 
fuse axons of transected nerves in earthworms.6768 
These procedures cannot be performed when injury leads to a large nerve gap or 
when a large segment of the nerve is crushed. Also, after a complete transection it is 
always difficult to achieve good surgical reconstruction of the fonner microstructure and to 
avoid mismatching individual nerve fiber connections. Since many neurons are "forced" to 
regenerate along endoneurial tubes that lead to inappropriate targets, nerve reattachment 
might not even necessarily be the best option toward optimal functional recovery. 
Autologous Nerve Grafts 
Nerve auto grafts are employed when nerve retraction or nerve tissue loss preclude 
direct end-to-end repair. Autologous grafts typically originate from the patient's sural 
nerve (a nerve in the lower leg) or other sensory nerves. Since autografts continue to 
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provide the best clinical results, as a natural biomaterial they are considered the "gold 
standard" in peripheral nerve repair, and the associated functional losses elsewhere in the 
body are often regarded as acceptable. Nevertheless, major advances in the understanding 
of nerve regeneration, in surgical techniques, and in material design are producing ever 
improving alternatives to autologous nerve grafts. 
Entubulation Repair 
To circumvent the use of a nerve autograft while still providing the necessary 
guidance for axonal outgrowth toward the distal stump, both severed nerve endings can be 
placed into the openings of a tubular nerve guide (or nerve guidance channel). This also 
entails the advantage that regenerating axons are free to find their own entry points into the 
distal nerve stump as opposed to being poorly aligned with mismatched fibers or tissue 
during surgical end-to-end repair. For a brief history and some trends using this procedure 
see Suematsu, 1989.69 
Even empty or mere saline-filled tubes support regeneration according to the following four 
stages70 (Figure 2.2): 
I. Day 1: Clotting molecules, mostly fibrinogen, enter the tube. 
2. Week I: An acellular fibrin matrix forms. 
3. Week 2: Cells that will become perineural-like supporting cells migrate In first, 
followed by Schwann cells and endothelial cells. 
4. Originating only from the proximal stump, axons grow in at a rate of 1 - 2 mm per day 
with myelination following after a five-day lag. 
Eventually, axons enter the distal stump and, ideally, at long last reinnervate the appropriate 
target organs. 
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Figure 2.2: Nerve Regeneration Through a Nerve Guide Tube 







Schematic drawings of the stages during nerve regeneration through a nerve guidance channel. Shown are 
the proximal (1') and distal (D) nerve endings inside a nerve guidance tube. and the ensuing events toward 
regeneration (on day I. days 2-6. days 7-14. and days \5-2\). (from Seckel. \990)2 
The use of a nerve guide tube offers the advantage that the space between the nerve stumps 
is largely protected from scar tissue ingrowth and the properties of the tube itself, such as 
roughness,7172 permeability73 and overall dimensions,74 can influence axonal regeneration 
and organization. 
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After initial failures with a variety of poorly biocompatible materials such as 
magnesium, rubber, gelatin, bone and parchment paper, some of which were used as early 
as the late nineteenth century, advances with polymeric materials have led to the 
experimental and clinical use of a variety of materials as nerve guide tubes (Table 2.1). 
Table 2.1: Examples of the Most Common Nerve Guidance Channel Materials (hased 011 




Ethylene vinyl acetate copolymer (EV i\) 
Poly( tetrafluoroethylene) (PTFE) 
Polyethylene (PE) 
Silicone elastomers (SE) 
Poly(vinyl chloride) (PVC) 
Microporous 
Gortex. expanded poly(tetrafluoroethylene) (e~PTFE) 
Millipore (cellulose filter) 
Semipermeable 
Poly(acrylonitrile) (PAN) 




Poly(glycolic acid) (PGA) 







Acellular muscle 75 
Artery 
Collagen 




As an example for the effect of a nerve guide's physical properties, Aebischer et al .. 
1990,71 and Valentini and Aebischer. 1993,72 noted that use of tubes with highly porous. 
rough walls resulted in isolated fasicles of nerves dispersed within a loose connective tissue 
stroma. In contrast, smooth-walled, impermeable PTFE tubes led to a discrete cable 
delineated by an epineurium and located within the center of the guidance channel. In tubes 
containing alternating sections of smooth and rough luminal surface texture, an immediate 
change from single-cable to numerous fascicle morphology occurred at the interface of the 
smooth and rough segments. 
Considering the fact that sciatic nerve regeneration through empty or saline-filled 
tubes is limited to maximal gap sizes of 10 mm in the rat and 6 mm in mice, entubulation 
repair offers the additional advantage that the nerve guidance channel can be filled with 
neurotrophic and neurite-promoting factors that accelerate and extend axonal outgrowth 
beyond those length limits. Support matrices inside the nerve guidance channels are 
necessary to load. provide, or anchor these factors. Suitable matrices might also include 
materials pre-seeded with cells that fast-forward regeneration to the cellular phase (Figure 
2.2). Therefore, intense research efforts have aimed to develop nerve guide matrices for 
accelerated axonal outgrowth through nerve guidance channels toward the repair of ever 
larger nerve injuries. Furthermore, improved functional recovery is a major concern that 
can be addressed by providing directional structure to a nerve regeneration matrix, the idea 
being that the fasciculation found in a nerve can best be preserved or reinstated during 
axonal extension if the matrix has an intrinsic axial alignment or mlcro-
compartmentalization. 
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TOWARD NEW MATRICES FOR PERIPHERAL NERVE 
REGENERA TION 
In light of the known biological mechanisms and stages of nerve regeneration, the 
proposed approach to embed the matrix in a nerve guidance channel, and under the 
constraints of some general considerations relating to implant materials, a material for nerve 
regeneration should fulfill the following requirements: 
I.) A stable matrix should homogeneously fill the entire lumen of the nerve guide tube to 
avoid uneven axonal outgrowth that might lead to poor structural regeneration of the new 
nerve. Furthermore, the material should be of sufficient mechanical strength and integrity 
to support axonal ingrowth and extension over a period of several weeks. Covalently 
crosslinked materials might therefore be of advantage. 
2.) The matrix should contain or otherwise present the necessary neuronal adhesion sites as 
well as growth and trophic factors that guarantee the fastest possible ingrowth and optimal 
conditions for survival of supporting cells and neuronal processes. Although the primary 
objective is axonal outgrowth through the material, adhesion-, growth-, and guidance 
signals perhaps cannot, and do not have to be, exclusively aimed at neurite outgrowth. In 
fact, much like during spontaneous regeneration through empty nerve guides, it appears to 
be desirable that supporting cells grow into the material first to facilitate and promote 
subsequent neurite outgrowth. As a minimum requirement, supporting cells should be able 
to follow axonal extensions to guarantee myelin formation and the assembly of new 
endoneurial and basal lamina tubes that make up functional nerve cables. 
3.) Unless a highly porous material is chosen, the matrix material itself must be penetrable 
by cells and axons. When the regenerated nerve piece is fully restored, the artificial matrix 
is no longer needed and should be resorbed. Taken these two requirements together, an 
ideal matrix seems to be one that allows cells to penetrate by their own cellular enzymatic 
activity, so that matrix degradation will occur in perfect synchrony with cellular or axonal 
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outgrowth. Such a matrix must therefore contain cleavage sites that can be cleaved by 
neuronal proteases. Since the relevant mode of cell migration and matrix penetration by 
neuronal cells is plasminolysis (see above), the matrix for nerve regeneration in this project 
was designed to contain plasmin cleavage sites that allow complete degradation and 
solubilization of the matrix's crosslinked backbone when cleaved by plasmin (Chapters 4 
and 5). 
4.) In order to place any matrix into a nerve guidance channel and to embed the nerve 
endings inside the channel's openings during the entubulation surgery, it is desirable to 
start with a liquid precursor that can rapidly be transformed into the final, solid matrix 
material. For embedding of the nerve endings in the channel openings, the transformation 
even has to occur in sitll, i.e., under physiological conditions, and neither excessive heat 
nor toxic by-products must be generated. Also, the transformation reaction should not lead 
to reactions or modifications of the surrounding tissue, although the transformation may 
have to occur in direct contact. Eventually, the material should fill out any given space 
completely and create a snug closure, so no other extracellular matrix or fibrin clot 
deposition can occur that could lead to deviating neurite outgrowth or undesirable ingrowth 
of non-neuronal cells. Also, good closure at the tube opening favors better alignment of 
the regenerating axons.76 
5.) Like any implant material, the matrix constituents and degradation products must be 
non-toxic and non-immunogenic. 
6.) The matrix should either be homogeneous or patterned longitudinally to help 
regenerating axons grow in better alignment, because tight and organized axonal alignment 
is associated with better structural and functional recovery of nerve. 7 This consideration is 
an argument against materials that are porous on the micron scale (see material requirement 
3.), in which the presence of large amorphous pores and channels might lead to deviations 
and "scrambling" ofaxons, events that slow outgrowth and are counterproductive to 
fasciculation and good functional recovery. 
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Overview of Matrices for Nerve Regeneration and Tissue Repair 
Table 2.2: Classes of Materials for Peripheral Nerve and Other Tissue Repair 
Material 
Category Al!.1.!!.!.u: Problems 






seeded wi EeM with 
cells cells Navarro 
naturaL non- agarose. e.g., 
mammalian alginate, Aebischer. slow, 
etc. Navarro uncontrolled il 
modified 
hiosynthetic ii ) PLLA matrices e.g .. hydrolysis 
Hem, 
biosyntheticii) modified PEG Elbert, limited bioI. 
Hubbell information 
limited bioI. 
hiosynthetic ii ) cross-linked Sperinde, (unclear! ) enzymatically information, 
PEG Is Griffith cross-linked 
modified thermo-
biosynthctic ii ) p(NIP AAm-co- Stile, (unclear!) reversible limited bioI. 
Mc) 
artificial McGrath, (cventual 
bioartificial iii ) recomhinant TirrelL 
ins ('f at. 
cnzyme- vcry limited 
peptide-PEG West. amI. of bioI. 
hydrogcls Hubbell information 
slow gelation, 
peptide-PEG Prall, rclatively lml. 




ii) Meant to say that the material is entirely synthetic, but with biologically active parts or functions. 
iii) Meant to say that thc material is biologically produced but artificial in nature. 
Note: - Brackets denote a prediction or judgment not necessarily examined or stated by the authors. 
- Shaded boxes highlight desirable features in the context of peripheral nerve repair. 
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The above table summarizes the classes of materials that are described and analyzed 
In more detail in the subsequent sections. Given the prolific efforts of many research 
groups to create new, and improve old, biomaterials for tissue repair and regeneration, note 
that the list is certainly not complete. Instead, the intention was to categorize and judge the 
materials in terms of their usefulness as matrices for improved peripheral nerve 
regeneration. Also, some overlaps exist, as materials might belong to several categories at 
the same time. 
Natural, Acellular Matrices for Nerve Regeneration 
In order to accelerate regeneration and to increase the distance over which regeneration 
can occur, the following natural substances have been tested as pre-filling materials for 
nerve guidance channels mostly in rat models involving sciatic nerve transection: 
longitudinally oriented fibrin gels78 
fibronectin in the form of fibronectin/fibrinogen composite cables7980 
matrigel, a gel containing collagen type IV and other ECM components (for collagen 
type IV, see: Extracellular Matrix Adhesion Molecules and Their Cellular 
Receptors, above)81S2 
viscous laminin gels8182 
glycosaminoglycans8182 
muscle basal lamina (essentially acellular muscle)8.l848S86 
Blends or combinations of some of these materials have been used with great success such 
as the impressive peripheral nerve regeneration across an SO-mm gap in a dog model, 
where the sciatic nerve was bridged simply by a polyglycolic acid (PGA)-collagen tube 
filled with lam in in-coated collagen fibers.87 
23 
However, inappropriate physiochemical properties of the materials listed above 
(such as, for example, the highly negative charge of proteoglycans) may interfere with the 
regeneration process.65 Another general problem with the use of these materials is their 
poor mechanical strength (except for muscle basal lamina grafts). A merely viscous, but 
not crosslinked gel, such as laminin gel or glycosaminoglycan solutions, might have an 
initial conducive effect on the speed of regeneration, but the material usually does not last 
or retain its structural integrity long enough to support regeneration through long nerve 
guidance channels. Liquid fillings, therefore, seem flawed in terms of providing the 
necessary mechanical support that is desirable for good alignment and structural 
regeneration of a nerve. To take advantage of fibrin's relatively good mechanical properties 
and add to its limited neuroinductive and neurotrophic features, Schense ef al., 2000,88 
covalently incorporated bioactive peptides into fibrin matrices and, as a result, significantly 
enhanced neurite extension in rat models. This approach was also used by Sakiyama-
Elbert and Hubbell, 2000,8990 and Sakiyama-Elbert ef al., 2001,91 to immobilize heparin 
and heparin-binding growth factor, or to incorporate growth factor directly within fibrin 
matrices. This design prevented the loss of the exogenous growth factor by diffusion. 
Despite the advances with natural matrices toward improved nerve regeneration, 
serious problems generally exist with the intended use of human- or animal-derived 
materials for implantation. If ECM-derived materials have to be purified from the patient's 
own tissue or blood first, crucial hours or even days might be lost before the entubulation 
surgery can be performed. On the other hand, taking tissue- or blood-derived substances 
from a donor or animal entails greater risks of inflammation, immunological reactions, and 
disease transmission.56 A pre-filled, shelved, and ready-to-use nerve guide is desirable 
that is reliably free of viral and prionic agents. 
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Cell-Containing Matrices 
Another important approach toward improved nerve regeneration IS to pre-seed 
matrices (usually consisting of ECM molecules such as collagen, fibronectin and laminin) 
with autologous support cells, above all Schwann cells.9293 The intention of this approach 
is to provide neurotrophins94 and neural adhesion molecules2223 that Schwann cells 
express, and by which they promote neurite extension naturally. Although significant 
improvement in the number and degree of myelination of regenerated neurons has been 
made by this approach compared to acellular guides, Schwann cells require actual nerve 
injury to dedifferentiate and upregulate the expression of neurotrophins and adhesion 
molecules.95 Therefore, and due to the harvesting and ill vitro expansion procedure, the 
differentiation state of re-implanted Schwann cells may be very different from the 
differentiation state desirable in the context of nerve regeneration. In addition, harvesting, 
purifying and expanding Schwann cells in culture costs valuable time and requires the 
sacrifice of a nerve piece elsewhere in the body. 
Functionalized Natural, But Non-Mammalian-Derived Materials 
In order to circumvent the use of human- and animal-derived materials, intense 
research has focused on the functionalization of other naturally occurring gels and 
polyelectrolytes such as agarose and alginate. The aim of such efforts is to modify these 
materials in ways so that they mimic ECM and. thus. promote rapid and functional nerve 
regeneration. The goal of avoiding the use of whole ECM adhesion molecules completely 
is realized by using bioactive oligopeptides derived from ECM adhesion molecules that 
confer adhesive and neuroinductive properties in a highly specific and controlled fashion. 
For instance. agarose gels9697 covalently functionalized with laminin-derived peptide 
CDPGYIGSR, but not non-sense peptide CDPGRGSYI, significantly increased the 
number of myelinated axons inside an agarose-filled nerve guidance channel in a rat model 
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for nerve regeneration.9899 For other recent experimental work on alginate gels as a matrix 
for nerve regeneration, see Sufan et al., 200 1,100 and Kataoka et al., 2001.101 
Biosynthetic and Bioartificial Materials 
Another class of materials, the use of which avoids human- or animal-derived 
materials. are biosynthetic materials, that is, entirely synthetic materials upon which 
biologic activity is conferred by immobilizing synthetic, but biologically active molecules 
such as synthetic adhesion peptides, sugars, antibiotics, bacterially expressed gene 
products, etc. Examples of biosynthetic materials include the following: 
PLLA-based: poly(lactic acid-eo-lysine) matrices grafted with RGD peptide, that 
promote bovine aortic endothelial cell adhesion and spreading lO2lOJIO-t 
PEG-based: ill situ forming poly(ethylene glycol) gels grafted with adhesion-peptides, 
that promote attachment and spreading of targeted cell types (such as human dermal 
fibroblast and human umbilical vein endothelial cell),IOSI06 and that exhibit reduced acid 
formation during hydrolysis compared to PLLA-based matrices 
p(NIP AAm-(' 0-AAc )-based: thermo-reversible poly(N -isopropy lacry lamide-eo-acry I ic 
acid) hydrogels can be delivered to the body in a minimally invasive manner, and can 
be modified to contain biomimetic peptides; 107 these hydro gels support spreading and 
proliferation of osteogenic cells. 108 
Since the amount of biological information that can be incorporated in these non-biological 
systems is limited despite the extensive use of biomimetic peptides, Tirrell and co-workers 
have developed a growing number of "bioartificial" matrices from artificial, 
recombinantly expressed proteins. 109 Such protein materials consisting of well-defined 
bacterial expression products do not come with the risk of viral or prionic contamination, 
and thus represent an attractive and versatile alternative to animal-derived matrices. In fact, 
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by combining functional domains of known enzymes and proteins, the amount of 
biological functions that artificial proteins and the resulting protein-materials can fulfill is 
limited only by the repertoire that Nature herself has at her disposal. Moreover, by 
including even non-natural amino acids in bacterial expression systems,11O non-natural 
features can also be added, such as aryl bromide functionality, for instance, useful for 
derivatization of brominated proteins via metal-catalyzed coupling reactions. III Other 
material features that have been achieved in the resulting "protein designer materials" 
include the following: temperature- or pH-tuned self-assembly,1I2 precisely pre-determined 
supramolecular structures,II3114115 cell adhesivity targeted to specific cell types.1I6117 
introduction of reactive terminal alkene functionality,IIS etc. Promise with these 
bioartificial materials in the context of nerve regeneration lies in the fact that strongly 
neuroinductive and neuroadhesive ECM analogues can be envisioned that contain optimal 
and precisely defined concentrations and types of neuroactive domains. 
In the case of matrices that are not actively and specifically degraded, such as 
peptide-grafted PLLA foams, which simply hydrolyse, it remains unclear what the 
temporal fate of the matrix material will be during and after regeneration, as matrix 
degradation does not necessarily occur in synchrony with cellular invasion and neurite 
outgrowth. Even in the case of highly porous matrices, the material might locally obstruct 
and retard axonal outgrowth because of inhomogeneities. Furthermore, if degradation, 
phagocytosis, dissolution, or other forms of removal do not occur rapidly enough, some 
matrix material might be compressed into dense regions that remain void of axonal 
ingrowth forever. On the other hand. matrices that disappear too fast by whatever form of 
resorption serve no purpose at all. as the extending axons find no support for continued 
outgrowth altogether. 
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Enzymatically Degradable Synthetic Materials 
In order to create non-mammalian-derived materials that do not suffer from 
undefined and, therefore, uncontrolled degradation or lack thereof, synthetic materials can 
be rendered degradable in response to specific proteases. Toward this end, researchers 
have incorporated protease-sensitive oligopeptides into side groups and core chains of 
polymeric matrices. The origins of this approach appear to coincide approximately with the 
advent of facilitated Fmoc-based peptide synthesis. 119 
Pioneers in this field were Kopecek and co-workers, 1980,120 who prepared 
copolymers of N-(2-hydroxypropyl)methacrylamide, in which synthetic polymer chains 
were joined by crosslinks containing oligopeptide sequences degradable by papain, a thiol 
protease derived from papaya. While Kopecek proceeded to develop polymer-based drug 
delivery systems that respond to the ambient presence of proteases, such as lysosomal 
enzymes,121 other groups used peptide sequences to attach therapeutic agents that are 
released only in the presence of bacteria or cells that secrete specific proteases, which can 
cleave the particular peptide sequences used. 122 123 
The next step toward synthetic materials that are, as a whole, degradable by local 
protease activity during cellular migration, was to place enzymatic degradation sites at the 
crosslink sites of fully crosslinked materials. This was achieved by West and Hubbell, 
1999,124 who synthesized telechelic block copolymers of protease-sensitive oligopeptides 
(APGL for collagenase, VRN for plasmin) and PEG so that the resulting hydrogels 
(following terminal acrylation and photo-polymerization) were specifically degradable by 
plasmin or collagenase. two enzymes relevant for cell migration and ECM remodeling. 
Limitations of this system included the laborious addition of single amino acids, the 
inability to reliably purify polydisperse amino-acid-derived PEG, and the limited amount of 
biological information that could be incorporated by a synthetic method involving the 
stepwise addition of single amino-acids. 
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Methods of Matrix Formation 
Another important concern regarding materials in tissue engineering is the method of 
implantation. It is often desirable to inject or spread a liquid precursor at the site of a 
wound and transform it to a solid, gel-like state ill situ. As mentioned among the list of 
material requirements for a nerve guide matrix, this feature would be useful when filling a 
nerve guidance channel and embedding the nerve endings in the tube openings during 
surgery. Examples of materials that allow for an ill situ transformation include the 
following: 
fibrinogen, which forms fibrin (see above) after cleavage by thrombin, followed by 
covalent crosslinking with inherent factor XIIIa 
Healy and co-workers' thermo-reversible poly(NIPAAm-co-AAc )-based gelsl07108 
(see above) 
PEG gels developed by Sperinde and Griffith, 1997,125 that result from a 
transglutaminase cross-linking reaction of glutaminamide-functionalized PEG and 
poly(lysine-pheny lalanine). 
In contrast to these physical or enzymatic gelation processes, Hubbell and co-workers 
(e.g., West and Hubbell, 1999,124 above) have developed photo-chemical crosslinking 
schemes that enable a rapid liquid-to-solid transformation of their PEG acrylate systems 
relatively independent of pH in a physiological range, and with gelation times on the order 
of seconds. This is a very useful transformation speed for the anticipated surgical use of 
their matrices. 
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A New Class of Protease-Sensitive and Self-Forming Materials 
In continuation of West and Hubbe II' s work, Pratt and HubbelJl26127 produced self-
forming hydrogels by mixing multithiol-containing oligopeptides with acrylate-terminated 
PEG chains under physiological conditions. The oJigopeptides represented protease-
sensitive amino-acid sequences, which were cleavable by cell-associated enzymes and, 
thus, permitted penetration of cells into these hydrogels in model systems both in l'itro and 
in l'il'o. Furthermore, cellular infiltration depended on the presence of RGD adhesion 
sequences that were incorporated by reacting a small fraction of the PEG diacrylate chains 
with monothiol-containing RGD peptides prior to hydrogel formation. The resulting 
hydrogels thus represented matrices that were both specifically degradable and specifically 
adhesive to target cells. 
Some concerns remain regarding the relatively slow gelation kinetics (on the scale 
of tens of minutes) of these materials as well as the strong pH-dependence of the 
crosslinking reaction, as acidic conditions -such as present at the site of a wound- further 
slow the kinetics. A more serious potential problem, however, is the required solubility of 
all hydrogel precursors, in particular the oligopeptides' solubility, since many peptides of 
potential interest (such as hydrophobic IKV A V) are likely to precipitate even more readily 
in the presence of PEG. Furthermore, despite the possibility to confer biological activity 
via tethered adhesion- and other peptides. the amount of biological information that can be 
incorporated in purely synthetic materials remains limited, especially in the context of nerve 
regeneration. where many more, and perhaps larger adhesive, trophic and neuroinductive 
factors are likely to be necessary. 
AIM OF THIS PROJECT 
In light of the above considerations, the aim of the doctoral research project presented in 
this thesis was to develop homogeneous matrices for tissue repair. specifically peripheral 
nerve, that 
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present a basic set of relevant cell adhesion sites as well as sites for the immobilization 
of additional cell-type specific adhesion sites and trophic factors. The integrin-binding 
~ ~ 
RGD motif was chosen as a permanent element of the matrices, and a heparin-binding 
site was incorporated to immobilize heparin and, in tum, heparin-binding neuroactive 
agents such as neural growth and adhesion factors. 
are degradable by cell-associated enzymatic activity. To match the relevant mode of 
axonal outgrowth during nerve regeneration, plasmin-degradation sites were 
incorporated in the matrix. 
are non-animal derived. Instead, the protein backbone of the matrices was bacterially 
expressed, then purified; and the bulk of the material consisted of poly(ethylene glycol) 
that was grafted to the protein backbone by Michael-type conjugate addition. 
have sufficient mechanical strength to support cellular ingrowth. Therefore, the 
material was to be covalently crosslinked at a high crosslink density. 
can rapidly fonn ill sitl! from a liquid precursor, so as to act as a glue or sealant for the 
nerve guide openings, and to be potentially injectable. Light-induced radical 
polymerization of terminal acrylate groups was chosen to crosslink the precursor. 
consist of constituents and degradation products that are non-toxic and non-
immunogenic. The core protein sequence was therefore based on human protein 
sequences, and poly(ethylene glycol) was chosen as the bulk constituent because of its 
well-established immunocompatibility.l28 
are transparent to enable microscopic analysis of anticipated three-dimensional cell 
cultures. The high water content of PEG matrices and their anticipated homogeneous 
sub-micron architecture were expected to ensure this feature. 
Chapter 4 will describe the design and creation of matrices with these intended features in 




SURF ACE PATTERNS OF NEURAL ADHESION PEPTIDES ON A 
POLY(ETHYLENE GLYCOL)-BASED SURFACE TOWARD TWO-
DIMENSIONAL ARTIFICIAL NEURAL NETWORKS 
INTRODUCTION 
As a prelude to the work in three dimensions to be described in Chapters 4, 5, and 
6, the aim of the work presented in this chapter was to photo-immobilize multiple cell 
adhesion peptides in a patterned fashion on an otherwise protein- and cell-adhesion 
resistant surface in order to effect localized adhesion, directed neurite outgrowth, and 
controlled synapse formation among groups of individual neurons in two dimensions. The 
envisioned neural circuits were intended to provide in vitro models of neuronal behavior 
including development, nerve regeneration, and learning, and to allow for applications such 
as biosensors and bioelectric devices. 
The adhesion-resistant culture substrate was a highly crosslinked polymer network 
of trimethylolpropane triacrylate (TMPTA) and pentaerythritol tetraacrylate (PET A) 
copolymerized with poly(ethylene glycol) a-monoacrylate w-monoethylether (PEGMA). 
Due to the high content of pending PEG chains, the advantage of this substrate material 
compared to many other surfaces was its persistent resistance to protein adhesion, therefore 
ensuring the preservation of a defined and controllable surface. In an initial test of 
principle, UV light-induced functionalization of this substrate was achieved with 
photolabel-derivatized RGDSG peptide in simple patterns, to which human fibroblasts 
adhered RGD-specifically. To achieve the adhesion of dissociated cells from the dorsal 
root ganglia (DRG) of embryonic chicks, which include sensory cells that belong to the 
class of pseudo-unipolar neurons whose axons have a central and a peripheral branch. 129 
regions on the substrate material had to be derivatized with a combination of five peptides 
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based on the receptor-binding domains of laminin and N-cadherin as well as a heparin-
binding domain of anti-thrombin III. 
In summary, this work was aimed at (a) providing an example of precise control of 
cellular function via surface-immobilized bioactive peptides. (b) providing further insight 
into the function of the adhesion ligands LRGDN, YIGSR, IKYAY, HAY, and 
KAF([3A)KLAARLYRK in controlling neuron and neurite morphology, and (c) enabling 
the formation of designed neuronal circuits for neurobiological investigation. Toward these 
goals, this study was -to my knowledge- the first attempt to employ multiple bioactive 
peptides simultaneously to create a patterned surface with highly defined biological signals 
on an otherwise non-adhesive culture substrate. 
The results of this work foreshadowed some of the results with fibroblast cultures 
in three-dimensional systems that will be presented in Chapters 4 and 5, and yielded 
valuable clues for effecting and understanding the neurite outgrowth on the materials 
described in Chapter 6. 
MOTIVATION FOR NEURONAL CULTURES ON PATTERNED 
SURFACES 
The computational, cognitive, adaptive. and creative capacity of the brain is 
unparalleled even by the most advanced computers of our age. Accordingly, a further 
understanding of the cellular and molecular mechanisms underlying the development, 
information processing, and plasticity, i.e., learning, of the brain would continue to 
promote the design of advanced computational methods and devices. 13o·13I Moreover. 
devices that already incorporate neuronal components as computational units are under 
investigation (e.g., by Curtis et al .• 1994; IJ2 Kovacs et al., 1994; 133 etc.). While brain slice 
preparations have revolutionized the study of synaptic transmission, neuronal integration 
and long-term potentiation,l3o the operation of the nervous system is only understood to a 
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limited extent at the level of single cells. We know little about the importance of (I) cell 
connection patterns, (2) synapse position and type, (3) cell shape (including arborization) 
and signal propagation, summation, etc., in one cell, or alternatively, (4) the differentiated 
state of the cell or (5) the previous electrical history of the cell.132 Insights of this kind are 
difficult to obtain because of the complexity and relative inaccessibility of individual cells in 
the living brain. In addition, studies involving individual cells in l'ivo are sometimes hard 
to reproduce, as many factors influencing neuronal performance remain uncontrolled, if not 
completely unknown. 
Control of the organization of neurons in defined and reproducible networks in 
culture promise the potential for new systems of study and for major technical 
innovation. 130 Toward the goal of culturing neurons in preCIse, reproducible and 
meaningful networks, the following requirements have to be met: 
A. Long-term viability of neurons in culture. 
B. Well defined and invariable culture substrates that can be patterned. 
C. Directed growth of neural processes along defined pathways. 
D. Controlled neuronal polarity by orienting the growth of the axon and dendrites. 
£. Formation of functional synapses between patterned neurons. 
F. Retention of differentiation state and transmitter phenotype of patterned 
neurons. 
(hased on Cotman et al., 1994; IJO modified) 
The pnmary focus of the research described in this chapter was to contribute to an 
improvement and understanding of the issues pertaining to requirements A - C, which 
might lead to progress and insights regarding D, E and F. That is, insights about the 
establishment of neuronal polarity, synapse formation, and determinants of neuronal 
differentiation in j'itro will be gained by studying the growth and behavior of neurons in 
culture as a function of precisely controlled surface chemistry and geometry. For instance, 
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questions for which answers were sought in this chapter include the following: Which 
peptides, if any, can support neuronal attachment and which can promote neurite extension 
on an otherwise non-adhesive substrate? Can combinations of different adhesion peptides 
on such a surface mimic the extracellular matrix and, thus, improve viability and determine 
the differentiation state and morphology of neurons in culture? 
If eventually even only simple neuronal circuits could be constructed reliably and 
reproducibly, and could be maintained for prolonged periods of time in contact with electric 
devices that measure electric activity of the neurons, these circuits would constitute a source 
for new applications in bio-sensing and bio-computing. Also, knowledge of the minimal 
requirements for neuronal cultures would provide improved design criteria for three-
dimensional, biosynthetic materials that support neurite extension and. thus. nerve 
regeneration (Chapters 4, 5, and 6). 
PREVIOUS WORK WITH PATTERNED SURFACES 
Chemically Patterned Surfaces 
The patterning of surfaces lies at the heart of any effort to guide neural growth in 
two dimensions. The idea is to outline regions and "paths" for cell attachment and neurite 
extension on surfaces that are otherwise adhesion resistant or non-permissive of neural 
growth. Ground-breaking progress in chemical patterning of surfaces has been made by 
Whitesides and co-workers (e.g., Kumar. 1994).134 Based on stamping or contact 
printing, self-assembled mono layers (SAMs) of alkanethiolates can be adsorbed on a gold 
surface in a patterned fashion on scales as small as 0.2 f.lm. An elastomeric stamp bearing 
the desired pattern is used to transfer alkanethiols with desirable functional end groups to 
the surface of an evaporation-deposited gold film. A pattern consisting of chemically 
differentiated regions can thus be created at submicron-scale resolution. The limits on the 
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resolution of these patterns arise only from the maximum resolution of the pattern that has 
to be generated on the PDMS film by a sequence of photolithographic and polymer casting 
techniques. 
Other approaches to patterning SAMs have included photochemical methods that 
were applied directly to the surface. Stenger et aI., 1992,135 for example, generated 
covalently attached monolayers of trimethoxy alkyl silane on glass that were further 
derivatized in a patterned fashion by localized activation with UV irradiation through a 
photomask followed by the appropriate solution chemistry on the activated end groups. 
An abundance of other patterning techniques has since been developed, including, 
for example, microfluidic systems, patterns involving concentration gradients of functional 
groups, and selective patterning controlled by ambient conditions such as pH. 
Shortcomings of Chemically Patterned Substrate Materials 
The abundance of surface patterning techniques presently available has given rise to 
impressive short-tenn control over the organization of various cell types on culture 
substrates by virtue of surface chemistry and geometry,l36.137 but most of the culture 
substrates used do not pennit long-tenn control over the properties of the surface, as 
protein adsorption, desorption, denaturation, and proteolysis remain unpredictable 
variables. For instance, even when human or bovine serum albumin is pre-adsorbed on 
certain regions of a surface to render those regions resistant to cell adhesion by blocking 
them from other, adhesion-promoting, proteins such as fibronectin or laminin, unwanted 
cell adhesion and neurite outgrowth have been observed depending on albumin's surface 
confonnation.1J1! In addition, over time proteolysis and/or desorption of albumin from the 
surface allows for adsorption of adhesion proteins that are naturally present in serum 
containing media. 
The problem of unwanted cell adhesion and uncontrolled neurite outgrowth even 
arises in protein free media, because cells that are cultured for long periods of time start to 
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release their own extracellular matrix proteins, which will adsorb to the culture substrate 
and then promote uncontrolled adhesion and spreading. Meaningful results of experiments 
involving neurons in culture are thus limited to the first few hours after cell seeding, when 
protein deposition and non-specific adhesion to blocked surfaces are probably still 
insignificant. While inhibitors of protein synthesis and secretion have been used to control 
the protein environment in cell cultures, such additions introduce new complications by 
depriving cells from potentially vital and experimentally crucial factors. 
Biospecific Patterned Surfaces 
Recent attempts of surface patterning and functionalization have been aimed at 
obtaining better defined culture substrates by employing short adhesion peptides based on 
extracellular-matrix proteins such as laminin, collagen, fibronectin and others (see Chapter 
2). Since short adhesion peptides are often less prone to proteolytic degradation and 
denaturation on surfaces, their use circumvents some of the complications resulting from 
using whole proteins to define surface properties. However, the problem of surface 
changes due to uncontrolled protein adsorption remains. Nevertheless, the advantage of 
employing individual adhesion- and outgrowth-promoting peptides is that the specific 
response to a particular isolated peptide can be tested. The effect of individual neuronal 
adhesion peptides, for example, has been described for several cell types on the YIGSR-
containing oligopeptide GYIGSRY by Massia and Hubbell, 1993;42 for NG 108-15 
neuroblastoma x glioma cells in response to surface-immobilized oligopeptide 
CDPGYIGSR by Clemence, et al., 1995;43 and for embryonic hippocampal neurons on 
oligopeptides RDIAEIIKDI and CDPGYIGSR by Matsuzawa et al., 1996.44 
To establish the specific and exclusive effect of isolated bioactive peptides on the 
long-term growth and development of neurons in culture, and to enable the creation of a 
biologically well defined and patterned culture substrate free of interfering proteins for long 
periods of time, a substrate is required that does not permit any protein adsorption. Such a 
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substrate with the desired protein adsorption-resistant properties was developed by 
Drumheller and Hubbell1390140o141 and was used in this study. 
The Poly(Ethylene Glycol)-Containing Substrate Material 
Besides resistance to protein adhesion, the substrate material must be mechanically 
robust and stable. non-toxic for cell culture purposes, and preferably translucent to allow 
microscopic analysis ill situ. These requirements were met by glassy, translucent, highly 
crosslinked polymer networks formed by copolymerization of trimethylolpropane 
triacrylate (TMPTA) copolymerized with poly(ethylene glycol) diacrylate (PEGDA). The 
PEG-based surface of these films was electroneutral and had a low interface energy with 
water. The hydrated high-molecular PEG chains at the water interface likely exhibited high 
segmental mobility and thus were thought to render the surface highly protein-repellent and 
cell non-adhesive.14H43 Other important qualities of this substrate material consisted in its 
mechanical strength. small amount of swelling in both organic solvents and water (as a 
result of the high degree of crosslinking), and the films' optical properties: Since the films 
were completely translucent, light microscopy of ceII cultures on the films was possible. 
Modification of the Poly(Ethylene Glycol)-Containing Substrate Material 
When the original protocol based on TMPT A and PEGDA, as reported by 
DrumheIIer and Hubbell, 1994,139 gave rise in my hands to films of insufficient cell 
adhesion resistance. further experiments indicated that only films made with poly(ethylene 
glycol) a-monoacrylate co-monomethylether (PEGMA, Figure 3.1) exhibited a similar 
resistance to cell adhesion as previously reported by Drumheller and Hubbell.139 These 
results suggest that the degree of acrylation in what Drumheller and Hubbell believed to be 
poly(ethylene glycol) diacrylate might actually have been significantly lower, such that a 
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fraction of the polymer used had actually been poly(ethylene glycol) monoacrylate, giving 




Figure 3.1: Constituent Molecules of Polymer Networks 
Poly(ethylene glycol) cx-monoacrylate w-mol1omethylether (pEGMA). mol. wt. 50()O. trimelhylolpropane 
lriacrylatc (TMPTA). penlaerythritnl tetraacrylate (PET A). 
Entropic considerations support this conclusion, in that polymer chains linked at only one 
end (as is the case with PEGMA) can achieve a much larger number of molecular 
configurations compared to a polymer linked at both ends (as would have been the case 
with PEGDA) (Figure 3.2). 
Figure 3.2: Non-Adhcsive Naturc of Network Surface Due to PECiMA 
Schcmatic of substrate surfacc resulting from use of PEGMA (left) vcrsus PEeiDA (right!, 
The larger number of attainable molecular configurations translates into a more favorable 
entropic state in the absence of adsorbed proteins as compared to the presence of adsorbed 
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proteins, which would limit chain mobility. In addition, PEG chains linked at only one end 
may generate more steric hindrance to protein adhesion, because such PEG chains reach 
out farther into the hydrous phase and "dangle" more freely (also Figure 3.2). Cell 
adhesion to the PEG-based substrate was thus prevented by obstructing the adsorption of 
adhesion-mediating proteins. 
Another improvement of the substrate material was achieved with respect to its 
mechanical properties. Initially, the combination of TMPTA and PEGMA (instead of an 
unknown mixture of PEGMA and PEGDA) produced films that were very prone to 
cracking during the photoinitiated polymerization step. Cracking during polymerization can 
be explained by tensile forces between polymerizing domains that arose when the Van der 
Waals distance between polymerizing molecules suddenly shrank to the distance of 
covalent bonds that were formed. Domains in which polymerization was occurring thus 
started to contract, while interstitial regions with fewer crosslinking became prone to 
cracking (Figure 3.3). 
\ 
CRACKING 
Figure 3.3: Cacking During Formation of Highly Crosslinked Polymer Networks 
Schematic illustration of suggested reason for cracking in films made with TMI'TA and PI:-:CJMA (not 
shown) only: As domains of polymerization contract. mcchanical failure results in regions of lillie or 110 
crossiinking. (TMPTA is represcnted schematically.) 
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Mechanical failure can only be prevented when the degree of crosslinking is large enough 
throughout the material, so that tensile forces due to the volume change of reaction can be 
withstood. This was achieved by the addition of pentaerythritol tetraacrylate (PET A), 
which by virtue of its four acrylate end groups evidently seemed to increase the density of 
covalent bonds formed such that despite shrinking, the films cracked substantially less, 
while completely retaining their adhesion-resistant character. 
Photopatterning 
Very convenient choices of bifunctional photocrosslinkers for the immobilization of 
biomolecules on polymeric surfaces are benzophenones and certain arylazides, some of 
which can be UV photoactivated at wavelengths above 320 nm. Biological activities of 
photo-immobilized biomolecules are, in general, not affected by the conditions used for 
light activation. 144·43 Inspired by the work of Huebsch et aI., 1996,145 the photocrosslinker 
N-succinimidyl-6-[4'azido-2'-nitrophenylaminolhexanoate (SANPAH) (Figure 3.4), 
which forms a reactive nitrene upon irradiation, seemed particularly convenient for the 
functionalization of the substrate films. SANPAH can easily be radiolabeled with 12'1 for 
future experiments to determine the surface concentrations of 12'I-SANPAH-immobilized 
peptides on substrate surfaces. 
N02 N'~N~o_~ 
° SANPAH 
Figure 3.4: Molecular Structure or SANPAH 
SANPAH can be attached to the N-terminus of any peptide via the formation of an amide 
bond that replaces the succinimidyl ester shown in Figure 3.4. Because of the strong 
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resistance to cellular adhesion of the substrate material,139 a larger molar amount of 
adhesion peptides had to be immobilized per unit area to elicit cell adhesion and spreading 
than is necessary on other substrates such as silanated glass. 146 The problem that arises 
from this fact is that during the immobilization reaction a very large concentration of 
photolahelled peptide was required at the surface of the substrate material, so that a 
sufficient number of peptides would be covalently bound to promote a biological response. 
This difficulty was overcome by applying a solution of photolabelled peptide onto the films 
in defined regions, and allowing the peptide to dry upon the substrate, followed by short 
irradiation to avoid high temperatures. 
MATERIALS AND METHODS 
Synthesis of poly(ethylene-glycol) <x-monoacrylate ro-monomethylether 
Poly(ethylene glycol) a-monoacrylate ro-monomethylether (PEGMA), mol. wt. 
5000, was prepared from PEG monomethylether, mol. wt. 5,000 (Fluka, Switzerland, Mil 
ca. 5000 according to supplier). PEG was dried by azeotropic distillation in benzene for I 
hr using a distillation column. After cooling to less than 50°C under argon, triethylamine 
(2.2 eg., Aldrich) was added. Addition of acryloyl chloride in two half-portions (4.0 eg. 
total, Aldrich) separated by 10 min initiated the reaction. The reaction continued with 
stirring overnight in the dark at room temperature under argon. The resulting pale yellow 
solution was filtered and the reaction product precipitated by dropwise addition of the 
solution to diethyl ether in an ice bath. After recovery by filtration, the precipitate was 
washed with diethyl ether and dried in vacuo. lH NMR spectrometry in DCCI, resulted in 
the following characteristic peaks: 3.6 ppm (94.38 H, PEG), 4.3 ppm (t, 1.93 H, -CH2-
CH 2-O-CO-CH=CH 2), 5.8 ppm (dd, 1.00 H, CH:=CH-COO-), 6.1 ppm, 6.4 ppm (dd, 
2.08 H, CH 2=CH-COO-). Quantitative acrylation was evident from comparison of the 
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peak at 3.6 ppm to the acrylate-associated peak at 5.8 ppm and applying the Mn reported by 
the supplier. 
Photo initiated Formation of Highly Crosslinked Networks 
As explained above, the adhesion-resistant substrate material for this study were 
films of a highly crosslinked network of trimethylolpropane triacrylate (TMPT A, Aldrich) 
and pentaerythritol tetraacrylate (PETA, Aldrich) copolymerized with PEGMA (Figure 3.1) 
in the presence of photoinitiator benzil dimethyl ketal (BDMK, Aldrich), which was based 
on earlier materials by Drumheller and Hubbe11.139.141 
Briefly, 0.8 g PEGMA were dissolved in 1.8 mL TMPTA and 0.2 mL PETA by heating 
the mixture to 100°C. After addition of 26 f-lL BDMK solution (300 mg/mL in TMPT A). 
the homogeneous mixture was filled into a circular space formed by a PTFE gasket (I-mm 
thickness, ~14-mm diameter; Small Parts) clamped between two clean glass coverslips 
(Corning). After re-heating to 100°C in a pre-warmed oven with a glass window 
(Bioblock). a IOO-W medium-pressure mercury vapor UV light source (Blak-Ray, UVP) 
was shone through the oven window for I min, thus exposing the coverslip assembly to a 
flux of 10 mW/cmc perpendicular to the opening in the PTFE gasket. The resulting 
polymer films were gently removed from the assembly and postcured under UV irradiation 
for I min. 
Automated Fmoc-based Peptide Synthesis on Solid Supports 
Oligopeptides RGDSG, RDGSG. KAF(~A)KLAARLYRKA, GGGYIGSR. 
GGGIKV A V. and HAV were synthesized on solid polystyrene support with a "Pioneer" 
peptide synthesizer (Applied Biosystems. USA) by automated solid phase peptide 
synthesis using 0.4 g peptide amide resin (NovaSyn TGR, Novabiochem-Calbiochem AG. 
Switzerland) per peptide. Synthesis occurred by standard 9-fluorenyl-methyloxycarbonyl 
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(Fmoc) chemistry,119 using solvents from Applied Biosystems (Warrington, England) and 
all other reagents from Novabiochem-Calbiochem. The N-terrninal Fmoc group was 
removed by a final de-protection cycle to free the N-terrninal amine for further reaction. 
After synthesis, the peptide resin was washed with MeOH and dried in a vacuum chamber 
overnight. 
Photolabelling of Peptides 
Under exclusion of light, peptide resins from different syntheses were separately 
placed in N,N-dimethyl forrnamide (DMF) containing a two-fold excess of the photolabel 
SANPAH and activator N-hydroxybenzotrizole (HOBt) per theoretical peptide, based on 
the protocol by Huebsch et a1.40 , 1996. After reacting for 2 h, the resin was recovered by 
vacuum filtration through fritted glass funnels and washed with 10 resin volumes of DMF, 
then 5 volumes of MeOH, and dried. Peptides were cleaved from the resin and deprotected 
for 4 h by shaking the resin in 10 mL of a solution containing 8.8 mL trif\uoroacetic acid 
(TFA. Fluka, Switzerland), 0.5 mL phenol (Aldrich), 0.2 mL triisopropylsilane (Aldrich), 
and 0.5 mL water. Precipitation of the orange photolabel1ed peptides occurred when the 
filtration flow-through was added drop-wise to chil1ed diethyl ether (~40 mL). The deep 
orange precipitate was recovered by vacuum filtration (0.2 11m pore-sized PTFE membrane 
filters, Gelman Sciences) and washed with three ~5 mL portions of diethyl ether. The final 
filtrate was dried in a vacuum chamber overnight and then sealed under argon for 
temporary storage at -20°C. 
Photolabelled peptides RGDSG and RDGSG were purified by preparative C 1X 
chromatography (Prep Nova-Pak 19 x 300 mm column; Waters, USA) using a BioCAD 
700E chromatograph (PerSeptive Biosystems). Separation of peptides from impurities was 
achieved by applying a gradient of acetonitrile in 0.1 % TFA. The resulting eluate fractions 
were freeze-dried and analyzed by matrix-assisted laser desorption ionization-time of flight 
(MALDI-TOF) mass spectroscopy using the "Voyager Elite 122" spectrograph (Applied 
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Biosystems, USA) and, as MALDI matrix, alpha-cyano-4-hydroxycinnamic acid (Aldrich). 
Before storage at -20°C, verified and identical peptide fractions were combined, dried in a 
vacuum chamber overnight and finally sealed under argon for storage. 
Surface Patterning 
20 mM solutions of photolabelled peptides in DMF were prepared for direct 
application to the substrate films. On the surface of at least two films per experiment, 
circular ~3-mm areas were covered with 1-2 ilL of separate solutions of photo labelled 
adhesion peptides and allowed to dry in the dark. After exposure to a 100-W medium-
pressure mercury vapor UV light source (Blak-Ray, UVP) for 10-20 s, all films were 
rinsed with DMF three times, followed by extraction in DMF over night. The DMF was 
then gradually exchanged by deionized water, and the DMF extracted by deionized water 
over 6-8 h with frequent exchanges of fresh deionized water. 
Culture of Human Foreskin Fibroblasts 
After pre-incubation of the films in fibroblast culture medium for I h, fibroblasts 
were seeded at confluence onto the peptide-treated surface of the substrate films inside 24-
well tissue culture well plates (I mL medium with cells per well). Well established 
techniques147 were used for cultures of neonatal human foreskin fibroblast (hFFs, 
Clonetics(Cambrex) via BioWhittaker Europe. Belgium) of passage numbers up to 14. 
hFFs were cultured in Dulbecco's Modified Eagle Medium (DMEM, with 1000 mg/L 
glucose. 1\0 mg/L sodium pyruvate. 862 mg/L L-alanyl-L-glutamine) supplemented with 
IOo/c (1'/,,) heat-inactivated fetal bovine serum and I X antibiotic-antimycotic (all Life 
Technologies, Scotland). 
After 5 h, the films were rinsed with DMEM, the cells fixed with formalin (10%, Sigma), 
and stained with hematoxilin (Sigma). Microscopy and image processing were performed 
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usmg a Zeiss inverted confocal light mIcroscope (Axiovert 135, Zeiss, Gennany) in 
conjunction with a Hamamatsu Color Chilled 3CCD Camera (Hamamatsu, Japan) and 
LeicaQWin image processing software (Leica Imaging Systems Ltd., 1997). 
Culture of Dissociated DRG Cells 
Day 8 chick embryos were taken from Lewis Brown chicken eggs. DRGs were 
dissected according to standard protocols described elsewhere l -l7 and then kept in a small 
petri dish with supplemented DMEM/F12 medium (DMEM/F12 medium with 1 % (1'/1') 
insulin-transferrin-selenium supplement (lOOX), 1% (l'lv) ABAM (lOOX), 0.5% (I'll') 
chick embryo extract, 60A ultrafiItrate, all Gibco; 100 ng/mL nerve growth factor, Sigma) 
at 37°C for up to 30 min until dissociation. DRGs were dissociated by incubation at 37 CC 
with trypsin-EDT A for 5 min followed by gentle trituration with a I mL plastic pipette tip. 
The dissociated DRG cells were centrifuged (700 g, 3 min, room temp.), resuspended to 
50000 cells per mL, and seeded onto the peptide-treated surface of pre-incubated polymer 
films inside 24-well tissue culture well plates (I mL medium with cells per well). After 5 
h, the medium was gently replaced with fresh, pre-wanned DMEM/F12 medium. 
Microscopy and image recording were done in situ in approximately three-hourly intervals. 
RESULTS AND DISCUSSION 
Adhesion Resistance of Unmodified Substrate Surfaces 
Despite the "adhesive challenge" presented to the PEG-containing polymer films by 
seeding hFFs at confluence and culturing on the surface for 5 h. the substrate material was 
completely resistant to cell adhesion (Figure 3.5). 
46 
Figure 3.5: The Substrate Material's Resistance to Cell Adhesion 
Photograph of an untreated substrate film after hFF culture for 5 h followed by rinsing with DMEM. fixing 
and staining. No cells adhered anywhere on the surface. (Scale bar = I mm) 
Derivatization of Peptides with Photoactive Groups 
Analysis of SANPAH-labelled peptides RGDSG and RDGSG (mol. mass both 
765.6) after UV exposure in water (to convert the nitrene groups [-N,l to amines [-NH,l so 
as to avoid unknown degradation or reaction products from the nitrene group during 
analysis) yielded dominant peaks at molecular mass = 740.6 for both peptides. This is in 
perfect agreement with the expected molecular mass for these species. 
Surface Patterns 
Even after photo-immobilization of SANPAH-labelled peptides and subsequent 
extraction with DMF and deionized water, an orange-purple stain was visible in the same 
region where the peptide had been placed. Also, despite UV exposure and solvent 
exchanges. the films remained glassy and clear, mostly free of cracks, and appeared not to 
swell at all, based on visual inspection. 
Specific Integrin-Mediated Cell Adhesion to Regions of RGD Peptide 
Figures 3.6 and 3.7 show fixed and stained fibroblasts after 5 h in culture on 
RGDSG-grafted substrate material. The cells adhered and spread exclusively on peptide-
treated regions. Surfaces that had been treated with control inactive peptide RDGSG, 
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shown in Figure 3.8, remained completely non-adhesive, similar to untreated films (Figure 
3.5). 
3.6 3.7 
Figure 3.6: hFF Patterns Due to Adhesion to Regions Containing RGD-Peptide 
hFFs cultured on a peptide-grafted substrate film for 5 h: Cells only adhered and spread in regions with 
immobilized adhesion peptide RGDSG; other regions remained completely cell non-adhesive. 
(Scale bar = I mm) 
Figure 3.7: Exactness of Cellular Adhesion to Regions of RGD-Peptide 
Close-up microscope image of stained fibroblasts cultured a locally bioactivated substrate film for 5 h. 
Cells adhered and spread precisely to regions with immobilized adhesion peptide RGDSG; other regions 
remained completely non-adhesive to cells. (Note the well-defined border between cell adhesive and cell 
non-adhesive surface regions.) (Scale bar = 100 ~m) 
.". 
1 
Figure 3.8: Cell Adhesion and Spreading Requires Integrin Binding to RGD-Peptide 
Substrate film grafted with control peptide RDGS(i. Cells did not adhere anywhere on the surface. 
Fixing with formalin apparently caused some protein precipitation and deposition onto the surface. 
(Scale bar = 100 ~m) 
These results strongly suggest that hFF adhesion was enabled by specific integrin-mediated 
binding to the RGDSG-peptide, which contains the tetrapeptide RGDS known to support 
fibroblast attachment and to inhibit fibronectin binding to platelets if present in solution. 14S 
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If the presence of adhesion peptide RGDSG had merely modified the surface in a 
biologically unspecific way, e.g., by changing the surface charge, the presence of 
RDGSG, which is very similar to RGDSG, would have been expected to elicit cell 
adhesion also. Instead, only RGDSG promoted cell attachment and spreading. The fact 
that the presence of the control peptide did not support cell adhesion strongly suggests that 
the observed hFF adhesion to the RGDSG-grafted surface was indeed integrin-mediated 
and, thus, biologically specific. 
Figure 3.9 illustrates another striking detail: In the region depicted. the droplet of 
peptide solution that had been applied to the film to deposit RGDSG peptide. left behind 
"striata" of peptide (in terms of surface concentration) in the process of drying. Assuming 
that the amount of peptide grafting was proportional to the local concentration of 
photo labelled peptide. the resulting "striated concentration pattern" of adhesion peptide 
gave rise to fibroblast adhesion that conformed intimately to the striata of photo-
immobilized. peptide. 
Figure 3.9: Cellular Adhesion Conforming to Concentration Patterns 
hFFs cultured for 5 h that adhered in a "striated'" fashion. conforming to the local differences in sUlt~lce 
concentration of photo-immohilil:ed adhesion peptide RCJ[)SG. (Scale har = 500J.lm) 
Patterned DRG Cell Adhesion to Multiple Peptides 
Cells from dissociated embryonic chick DRGs. presumably mostly pseudo-unipolar 
sensory neurons, attached to surface regIOns grafted with a combination of peptides 
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RGDSG, GGGYIGSR, KAF(~A)KLAARL YRKA, HA V, and GGGIKV A V (Figure 
3.10), but not to regions without peptides nor regions with any of these peptides alone 
(images not shown). 
Figure 3.10: Patterned Adhesion of Dissociated Chick DRG Cells 
Dissociated chick DRC; cells seeded onto a regionally peptide-grafted substrate film. After:1 h the cells only 
adhered to regions containing immobilized adhesion peptides RGDSG. GGGYIGSR. 
KAF(pA)KLAARL YRKA. GGGlKYAY. and HA Y; other regions only supported a minimal amount of 
adhesion in clusters of cells. (Scale bar = 100 llm.) 
Many paired combinations of receptor ligands RGDSG, GGGYIGSR, HAV, and 
GGGIKV A V also did not support cell adhesion, suggesting that the heparin-binding site 
KAF(~A)KLAARL YRKA was a necessary contributor. A possible reason for this is that a 
surface-bound heparin-binding site can function as an adhesion site for cell-surface 
proteoglycans and. thus. contribute to cell adhesion to the surface. Furthermore, heparin-
binding sites can bind heparin from the culture medium which, in tum, can help immobilize 
heparin-binding growth factors and extracellular matrix (ECM) proteins on this otherwise 
protein-resistant substrate material. Relevant growth factors and ECM proteins are 
conducive to the adhesion of neural cells to any substrate. 
Adhesion by dissociated DRG cells to peptide-grafted regions only persisted for 
about 6 hours, after which no cells remained attached. No neuritic extensions were 
observed at any time. Possible reasons for the lack of continued attachment and lack of 
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neurite outgrowth include an insufficient concentration of peptides immobilized. a 
suboptimal combination or ratio of adhesion ligands. insufficient overall Iigand- and 
signalling capacity of the peptides immobilized. loss of adhesion peptides due to hydrolysis 
of peptide-grafted PEG chains, and surface rearrangements that reduce binding to tethered 
adhesion peptides. 
CONCLUSION 
Surfaces otherwise resistant to protein- and cell adhesion can be grafted with 
specific cell-receptor ligands to effect highly localized surface attachment and spreading. 
This principle was demonstrated for the PEG-containing substrate material by hFFs. which 
attached via specific integrin-binding to surface regions photo-grafted with RGD peptide. 
While the creation of highly defined and functional neural circuits for 
neurobiological investigation was the ultimate. but unaccomplished goal of this part of the 
project, it was also an important, more direct aim of the work in this chapter to investigate 
the function of the receptor-ligands RGD, YIGSR. IKVA V and HA V and of the heparin-
binding peptide KAF(~A)KLAARL YRKA. Although neurite extension on the PEG-
containing films was not supported even by regions grafted with the combination of all five 
of these adhesion ligands. the conducive effect that the heparin-binding peptide had led to 
its inclusion in the protein backbone of the protein-gr«!t-PEG gels described in Chapters 4. 
5. and 6. 
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CHAPTER 4 
DESIGN, SYNTHESIS, AND CHARACTERIZATION OF PROTEIN-
graft-PEG HYDROGELS 
OVERVIEW 
To address the need for bioactive materials toward clinical applications In wound 
healing and tissue regeneration, an artificial protein was created by recombinant DNA 
methods and modified by grafting of poly(ethylene glycol) diacrylate. Subsequent 
photopolymerization of the acrylate-containing precursors yielded protein-graft-
poly(ethylene glycol) hydrogels. The artificial protein contained repeating amino acid 
sequences based on fibrinogen and anti-thrombin III, comprising an RGD integrin-binding 
motif, two plasmin degradation sites, and a heparin-binding site. Two-dimensional 
adhesion studies (Chapter 5) showed that the artificial protein had specific integrin-binding 
capability based on the RGD motif contained in its fibrinogen-based sequence. 
Furthermore, heparin bound strongly to the protein's anti-thrombin III-based region. 
Protein-grajt-poly(ethylene glycol) hydrogels were transparent and plasmin degradable, 
had Young's moduli up to 3.5 kPa, and -as will be described in Chapter 5- supported 
three-dimensional outgrowth of human fibroblasts. Cell attachment in three dimensions 
resulted from specific cell-surface integrin binding to the material's RGD sequence. 
Hydrogel penetration by cells involved serine-protease mediated matrix degradation in 
temporal and spatial synchrony with cellular outgrowth. Protein-gJ'(~ft-poly(ethylene 
glycol) hydrogels represent a new and versatile class of biomimetic hybrid materials that 




Design of Protein-graft-PEG Hydrogel 
Advances in tissue repair call for implant materials that permit cell specific 
adhesion, that degrade in spatial and temporal synchrony with cellular infiltration and 
proliferation, and that do not elicit an immune response.14915U Such materials should also 
display sufficient mechanical stability to be useful in surgical applications. Fibrin, formed 
as a result of injury, is the initial, naturally occurring wound healing matrix. As such, 
fibrin serves as a useful therapeutic material itself. but also presents a model for semI-
synthetic and synthetic analogs, which can potentially be more specifically tailored to 
various applications and can be produced without the complexities associated with human 
blood products. 
Toward the use of bio-functional materials in wound healing and tissue 
regeneration, the goal of this study was to obtain a biosynthetic material that could mimic 
the natural extracellular matrix in two important features: cell attachment and specific 
proteolytic remodeling. Genetic engineering techniques were employed to design and 
produce a specific bio-functional component inspired by fibrin that would confer these 
properties. As mentioned in Chapter 2, where surface-immobilization of a heparin-binding 
sequence contributed to neural cell adhesion. heparin-binding sites can bind heparin and, 
thus, help immobilize growth factors and ECM proteins that are conducive to the adhesion 
of neural cells to a given substrate. Therefore, as a third feature, we sought to incorporate 
affinity for heparin into the biosynthetic material, thus providing for immobilization of 
heparin and, in turn, for heparin-binding growth factors as well as potentially other 
designed exogenous agents that possess affinity for heparin.!!99U An amino acid sequence 
based on a heparin-binding domain of the protein anti-thrombin III (ATIII) was 
incorporated to accomplish this. lSI Grafting PEG chains with terminal acrylate groups to 
this recombinant protein then enabled the fOImation of a three-dimensional protein-gmft-
polymer matrix that can be cured ill sitll. 
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Specifically. the recombinantly ex pressed. repeating 26 ammo acid sequence of 
human fibrinogen (ex chain. residues L'!4_I"'J)60 that is at the core of the multifunctional 
protein constituent (Chart 4.1. ¥~q~~) contains an RGD cell adhesion site (underlined) and 
two adjacent plasmin degradation sites (indicated by up arrows t). 
Chart 4.1: Fibrinogen- and ATIII-based Recombinant Protein Pentamer [AI and Non-
Functional Control Pentamer [B J 
~1<;SSHHHHHHSSGLVPR .!.GSHM (:::HG{ 
~1<;SSHHHHHHSSGLVPR .!.(;SHVI ( :::HG AKIAARLYRKAS)5 2H<; [B 1 
Chart 4.1: hbrinogen- and ATIII-hased Recomhinant Protein Pentamer 1 A] and C 'ontrol Pentamer] B I 
In IA]. the R(lD cell adhesion site is underlined and the two adjacent plasmin degradation sites are indicated 
hy up ,mows (t). In [13 I. the non-functional R(JG domain is underlined and the loss of plasmin 
degradahility is indicated~y the symhol *' In hoth constructs. the amino acid se4uence hased on human 
fihrinogen is shown ~: cysteine residues are 01:nHRITIecl: and the thromhin-cleavahle (.!.) hexa-histidine 
tag is spelled out fully as HHHHHH. 
Amino acid codes: alanine (A). arginine (Rl. asparagine (N). aspartic acid (D). cysteine (C). glutamic acid 
(E). glutamine (Q). glycine (C.). histidine (H). isoleucine (I). leucine (Ll. lysine (K). methionine (M). 
phenylalanine (F). proline I Pl. serine (S). threonine (T). tryptophan (W). tyrosine I Y). valine (V). 
The RGD motif was included to enable integrin-mediated cell attachment.25 while the 
plasmin sites enabled cell-controlled degradation via cell-associated plasmin activity that 
represents one of the relevant modes of matrix penetration during wound healing.62 
Furthermore. a 14 amino acid heparin-binding seyuence (cllrsil'c) derived from anti-
thrombin III (ATIII; residues K 121_A 1'4)151 was recombinantly fused with the fibrinogen 
seyuence in order to provide the heparin binding sites. Finally. repeating constructs of the 
above-described cassette. with multiplicity five (recombinant protein pentamers). were 
designed to contain six intermittent cysteine residues (Gl.:.:::jl2l~;'i) that allowed for grafting 
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of PEG chains with tenninal acrylate groups at the cysteines' thiol groups. thereby 
rendering the protein pentamer covalently photo-crosslinkable to form an elastic hydrogel. 
A thrombin-cleavable (.I.) hexa-histidine tag (HHHHHH) exists near the protein construct's N-
tenninus in order to facilitate purification of recombinant protein pentamers. their mutant 
variants. as well as their derivatives. Two different recombinant protein pentamers were 
designed: One all-active construct with functional RGD and plasmin degradation sites 
(Chart 4.1. protein pentamer lAD; and an analogous recombinant protein pentamer (Chart 
4.\. protein pentamer [B]) containing non-functional RGG domains (underlined) and ten 
point mutations resulting in arginine-to-glycine substitutions that led to loss of plasmin 
degradability (indicated by the symbol *). 
Chapter 5 will describe that human cells interact specifically with the artificial matrix 
described above. The observed cellular responses, namely three-dimensional cell 
attachment and proteolytic penetration. are promising of controlled and improved wound 
healing and tissue regeneration by use of this biosynthetic biomaterial. 
Reaction Selectivity lS2 
Hydrogels as wound sealants or for drug delivery have been cross-linked usmg 
relatively non-specific chemical reactions. These reactions. if allowed to occur ill situ. may 
lead to the covalent modification of proteins of surrounding tissue. For example. materials 
made from poly(ethylene glycol) (PEG) have been fonned in the presence of proteins via 
nucleophilic substitution reactions between activated PEG-carboxylic acids and PEG-
nucleophiles. ISJ In this case. the activated PEG also reacts with the proteins to be released 
as therapeutic agents. Therefore, this uncontrolled coupling of the polymer to the protein is 
undesirable. Other hydrogels have been cross-linked using large doses of y-radiation, 
ultraviolet light. or high temperatures. often for 30 minutes or more. which may damage 
protein drugs IS-I 155 156157 or adjacent tissues. More selective reactions using long 
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wavelength ultraviolet light irradiation and shorter irradiation times have also been 
described. IS!! 
The matrices that will be presented in this work consist of proteins grafted with 
PEG diacrylate by reaction of the terminal PEG-acrylates with protein-thiols. The reaction 
is rapid at physiological conditions. and reaction between PEG-acrylates and other chemical 
groups on proteins. notably the proteins' amine terminus and primary amines of Iysines. is 
slow.IS2106 IS9 The exclusive character of the reaction between acrylates and thiols will be 
referred to as reaction selectivity. 
To verify the reaction selectivity between acrylates and thiols. the model protein 
albumin was reacted with PEG diacrylate and other electrophiles under various conditions. 
Part of this chapter will be devoted to these model reactions and their analysis. 
MATERIALS AND METHODS 
DNA Design 
Recombinant DNA techniques were used to obtain protein pentamers [Al and [Bl. 
First. the DNA encoding the monomeric constituents of protein pentamers [AI and [B I was 
assembled from DNA fragments I a l and I b l (Chart 2). We optimized the DNA sequences 
of fragments I a l and I b l to match the codon preferences for E. co/i 160 while taking into 
account the required restriction enzyme sequences for gene manipulation. In order to 
obtain both protein pentamer variants IAI and [B I. oligonucleotides for I a l and I b l were 
synthesized with mixed bases at positions 34 and 54 in I a l. and mixed bases at position 16 
in I b l (Chart 2). The pairs of DNA fragments I a l and I b l encoding the desired 
monomeric constituents of recombinant protein pentamers [AI and [B I (base:; D ,K,K = A, r~, r~ 
for [AI and Cd D,K,K =, =, for [B]) were identified by DNA sequence analysis and 
then ligated at restriction site BsaAI to produce the complete DNA segment \ c l (Chart 3). 
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Chart 4.2: Recombinant Gene Assembly 
DNA fragments ta) (four possible variants; coding and anti-coding oligonucleotides) 
BsaAI 
A~. 'TTCCA'J' ATe TGel' A :( ;C='GG':'C Tee CTCC TCDC'·'TC ';'( :'1"1' :TC C~ AA:_ AACKCTCft.CAACACC.;'I'AfI.~ A."4'l'AP.,C 75 
TSLCA 
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DNA fragments tb) (two possible variants; coding and anti-coding oligonucleotides) 
BsaAI 
P •. AT":'CC:' _'C'['AC;'.A~K' 'r''T''""''T' -':TCAAGf".:C'1 ;~CCTTCr-'CC'l'Ar:::'CGA':'AAACCTTTCCCTAAA( ':'C:~: ~'GCTr-':CTC l'GT-
-:~.' '::~",;L 
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Chart 4.3: DNA Multimerization 





-: :Ar-':CTCC( 'I"·':-':~CCT.6,'I':-':C,~ TA/\AC::;C' 'T,":'CGC'l'A.A,ACTCG:-='l'CCTCGTC :'C_~,["Zi.CCC' 'A,A.ACC""' j1,C;~: 1':~ccp.ccc'1 ':'AAG 162 
',AACACC .A,'I';·,Cl":'P,';'T '·'~~C.A,A,AGCCP..'~ '["I'GACCC;P.,r_:C;ACCil...( ,A.( .l\"'GC;C AT]" 'eCA' ',::( .,A.c~CC'~'G(_: :AAT~C:-":TAC 
DsaI-digested segment {c)_for multimerization 
Dsa! !~;3d;:'. 
,., ,::r';:;CG'l'(;: '. ':_;0(:' "['C']'C""J'C ';'C C']' A.4CAACKC'I'Gf\CAA~: A;": C'':''ACAP>.CKC'1'G1'T,]'C 'j'C;AP>.-
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The described design strategy allowed for the efficient assembly of the target DNA and its 
variant encoding the three simultaneous amino acid substitutions RGQ -7 RGG, NR -7 
NG and, again, NR -7 NG. The resulting DNA segments lc l were multimerized in 
correct coding orientation by ligation at the non-palindromic 3' DNA overhangs resulting 
from DsaI restriction enzyme digestion (Chart 3).109 
General Notes 
Bacterial strains used were E. coli strains DH5a-F' (Life Technologies, Scotland) 
and JM I 09 (Promega, USA) for cloning, and BL21 (DE3)pLysS (Novagen, USA) for 
protein expression. In all DNA constructs, appropriate pairs of terminal restriction sites 
were used: EcoRI and BamHI for simple DNA manipulations with vector pUC I 8 (Life 
Technologies, USA) and NdeI and BamHI for gene expression with vector pETI4b 
(Novagen, USA). The restriction enzymes were purchased from Roche Diagnostics 
GmbH, Germany. Standard molecular biological methods as described elsewhere 1(,1 162 
were employed for DNA manipulations, bacterial cultures, agarose gel- and polyacrylamide 
gel electrophoresis (PAGE), and Western blotting. 
Multimerization of DNA and Cloning into pETl4b 
Coding and anti-coding strands, as supplied (Microsynth GmbH, Switzerland), for 
DNA fragments I a l and I b l constituting the monomeric target DNA segment I c l (Charts 
4.2 and 4.3) were purified by 6c,1 polyacrylamide gel electrophoresis under denaturing 
conditions (TBE buffer: 89 mM Tris base. 89 mM boric acid, and 2 mM EDT A; with 7M 
urea). Bands of purified oligonucleotides were cut out of the polyacrylamide gel and eluted 
over night into DNA elution buffer (0.5 M NH~OAc), followed by DNA precipitation the 
next day. For each of oligonucleotides I a l and I b l, 2 Ilg each of the coding and anti-
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coding strands were annealed in 30 III TE buffer (10 mM Tris. I mM EDT A. pH 7.4) by 
heating to <)0 °C and cooling to room temperature overnight. The resulting double-stranded 
DNA fragments 1 a) and 1 b) were phosphorylated with alkaline phosphatase (Roche). 
ligated into EcoRLBamHI-cut pUC 18 vectors and transformed into DH5a-F'. Plasmid 
DNA was amplified in 6 ml E. Coli cultures followed by isolation via mini preparations 
(Wizard Plus Minipreps, Prom ega. USA). Insert-containing pUC 181 b) was cut with 
BsaAI (New England Biolabs Inc., USA) and BamHI. The resulting fragments 1 b) were 
ligated into BsaAI- and BamHI-digested pUC 181 a) using T4 DNA ligase (New England 
Biolabs). In this step, fragments 1 b) and insert-containing vectors pUC 181 a) were 
matched appropriately to form the correct desired DNA segments 1 c) (Chart 4.3). 
To muItimerize the DNA segments 1 c) encoding the monomeric forms of 
recombinant protein pentamers [AI and IBI (Chart I), the following steps were performed: 
Midi preparations (Whizard Plus Midipreps. Prom ega. USA) of the vectors pUC 181 c) 
were digested with non-palindromic restriction enzyme BstDSI (Hybaid-AGS, Germany). 
an isoschizomer of Dsai. DsaI-digested segments (c) were separated from host vector 
pUC 18 by Ilo/r polyacrylamide gel electrophoresis in TBE buffer. Bands of 138 base 
pairs. corresponding to DsaI-digested segments (c). were cut out from the gel. and the 
segments eluted into DNA elution buffer overnight followed by precipitation using Pellet 
PaintT\1 Co-Precipitant (Novagen) for improved precipitation of small DNA fragments. 
ligation. i.e.. multimerization. of DsaI-digested segments 1 c) at (>.3-0.4 Ilg/Ill was 
allowed to proceed at 16°C for only 15 min. The ligation products were run on a 1.5o/r 
agarose gel to separate the different DNA multimers. Bands of 690 base pairs. 
corresponding to DNA pentamers of DsaI-digested segments 1 c). were cut out, and the 
DNA extracted using the QiaEx gel extraction kit (Qiagen AG, Switzerland). DNA 
pentamers were then ligated back into de-phosphorylated BstDSI-cut vector pUC 18. 
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amplified in E. coli followed by mini preparation. and cut out with restriction enzymes 
NdeI and BamHI for ligation into the multiple cloning site of expression vector pET 14b. 
which also encodes the N-terminal thrombin-cleavable hexa-histidine tag. resulting in 
pET 14b[ A 1 and pET 14b[ B I. All DNA sequences were confirmed by DNA sequencing 
(Microsynth. Switzerland). 
Expression of Recombinant Protein Pentamers [A] and [B] 
E. coli strain BL21 (DE3 )pLysS (Novagen. USA) was transformed with either 
pET 14b[ A I or pET 14b[ B I encoding recombinant protein pentamers 1 A I and 1 B I. and the 
resulting BL21(DE3)pLysSpET[AI and BL2I(DE3)pLysSpET[B] grew ovemight in 2X 
Yeast-Tryptone broth (10 gIL yeast extract. 16 gIL tryptone. AppliChem. Germany; and 5 
gIL NaCI) supplemented with 50 Ilg/mL ampicillin (AppliChem) and 34 llg/mL 
chloramphenicol (AppliChem). Shaking-flask cultures of I L (same medium and 
supplements) were inoculated I :50 from the pre-cultures and grew to an optical absorbance 
range of 0.6 - 1.0 A measured at 600 nm (OD(,()(). whereupon protein expression was 
induced by addition of I M ~-isopropyl thiogalactoside (IPTG. Novagen. Switzerland) to 
a final concentration of I mM. Expression proceeded for 3-4 h. after which cells were 
harvested by centrifugation (5000 g. 15 min. 4°C). Expression of recombinant protein 
pentamers [AI and [B] was monitored by 15!Jc polyacrylamide SDS-PAGE. 
Protein Purification 
The hexa-histidine tagged target protein. I.e .. protein pentamers [AI or [B]. was 
recovered from bacterial cell pellets (3-4 g wet per liter culture) and Ni++ -affinity purified 
(Figure 4.2.a) according to protocols from the pET System Manual. 162 The eluate fractions 
after NiH-affinity purification were monitored by 15% polyacrylamide SDS-PAGE for 
content of target protein. Fractions with target protein were combined and dialysed against 
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PBS (0.2 gIL KCI .0.2 gIL KH"P04 , 2.16 gIL NacHP04·7Hp, 8 gIL NaCI. pH 7.4) 
with 8 M urea. Arimedes Biotechnology GmbH, Germany, expressed and purified one 
5.5 g batch of recombinant protein pentamer [AJ and resuspended it in 100 mM TRIS, pH 
6.3.300 mM imidazole, 4 mM /3-mercaptoethanol. and 8 M urea at 7.0 mg/mL. This batch 
was also dialysed, in fractions, against PBS with 8 M urea to final concentrations of /3-
mercaptoethanol no greater than 4 nM. The protein concentration after dialysis was 
estimated by a combination of the Bio-Rad Protein Assay according to Bradford (Bio-Rad 
Laboratories, USA). and by comparing to known amounts of bovine serum albumin (Bio-
Rad) in Coomassie Blue-stained 10% or 15% polyacrylamide gels. Ellman's test for free 
thiols (Pierce. USA) was performed according to supplier's instructions. Furthermore, 
protein pentamer IB I was analyzed by matrix-assisted laser desorption ionization (MALDI) 
mass spectroscopy using the Voyager Elite 122 (Applied Biosystems) and matrix alpha-
cyano-4-hydroxycinnamic acid (Aldrich). Finally, Western blots were prepared from 10% 
polyacrylamide gels containing 1.0 Ilg recombinant protein pentamers IAI or rB] per lane, 
using the QIAexpress anti-penta· His antibody (Qiagen) for detection of the hexa- and 
penta-histidine epitopes found in the recombinant protein pentamers, followed by 
incubation with a secondary horse-radish peroxidase-conjugated antibody (goat anti-
mao use IgG; Sigma). The immunoreactive bands were visualized on X-ray film by 
enhanced chemiluminescence (ECL) detection (Amersham Pharmacia Biotech Europe 
GmbH). 
Acrylation of Poly(Ethylene Glycol) 
Poly(ethylene glycol) a,w-diacrylate (PEG diacrylate), mol. wt. 6000, was 
prepared from PEG, mol. wt. 6000 (60 g. 10 mmol, Fluka. Switzerland. Mn = 60(0). 
PEG was dried by azeotropic distillation in 600 mL toluene for 1 hr using a Dean-Stark 
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trap. After cooling to less than 50 DC under argon, triethylamine (12.3 mL, 4.4 eg., 
Aldrich, Germany) was added. Addition of acryloyl chloride in two half-portions 
separated by 10 min (6.74 mL total, 4.0 eg., Aldrich) initiated the reaction. The reaction 
continued with stirring overnight in the dark at room temperature under argon. The 
resulting pale yellow solution was filtered through a neutral alumina bed. Sodium 
carbonate was added to the toluene solution and stirred for 2 hr. The sodium carbonate 
was removed by filtration, and the toluene was removed by rotary evaporation. The 
reaction product was re-dissolved in a minimal volume of dichloromethane and precipitated 
by dropwise addition to diethyl ether in an ice bath. After recovery by filtration, the 
precipitate was washed with diethyl ether and dried in \·([CI/O. The yield was 4X.7 g, and 
IH NMR spectrometry (200 MHz) in DMSO resulted in the following peaks: 3.5 ppm 
(264.74 H. PEG), 4.2 ppm (t, 2.51 H, -CHc-CH 2-O-CO-CH=CH), 5.9 ppm (dd, I.on 
H, CHc=CH-COO-), 6.1 ppm, 6.4 ppm (dd, 2.17 H. CHc=CH-COO-). Quantitative 
acrylation was evident from comparison of the peak at 3.5 ppm to the acrylate-associated 
peak at 5.9 ppm and applying the Mn reported by the supplier. PEG diacrylate, mol. wt. 
3400, prepared similarly from PEG, mol. wt. 3400 (Aldrich), was also acrylated 
quantitatively. Likewise, PEG a-monoacrylate w-monomethyl ether, mol. wt. 5000, was 
prepared from PEG monomethyl ether, mol. wt. 5000 (Fluka, Switzerland), following 
similar protocols for synthesis and purification as for PEG diacrylate, mol. wt. 6000. 
Synthesis and Purification of Protein-graft-PEGacrylates 
In the following, the term "PEGacrylation" refers to the grafting of PEG diacrylate 
to protein thiols by Michael-type conjugate addition, producing a protein with pendant PEG 
chains that terminate in acrylate groups. The term "PEGylation" alone refers to the grafting 
of any functionalized PEG to protein thiols, producing a protein with pendant PEG chains 
of unspecified terminal functional groups. 
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PEGacrylation: 10.0 molar equivalents of PEG diacrylate (mol. wt. 3400 or 6(00) 
per protein thioL pre-dissolved at 250-300 mg/mL PBS with 8 M urea. pH 7.4. reacted 
with 7 mg/mL recombinant protein pentamers [AI and [B I by Michael-type conjugate 
addition in PBS with 8 M urea at pH 7.4 for I hr after previous reduction of protein 
disulfide bonds with 2.0 molar equivalents of tris(2-carboxyethyl) phosphine 
hydrochloride (TCEP· HC\. Pierce. USA 15 min. 25°C. shaking) per mole of theoretical 
disulfide bonds. Reaction progress was monitored by 10% polyacrylamide SDS-PAGE 
under reducing conditions (Figure 4.3a). 
The reaction products. i.e .. PEGacrylated recombinant protein pentamers [A 1 or I B J 
(presumably proteinl AJ-grafr-hexaPEGacrylate or protein I B l-grafr-hexaPEGacrylate). 
were purified from excess PEG diacrylate by Ni++-affinity chromatography: Briefly. after 
raising the pH to 7.9 by addition of I N NaOH. the solution of reaction products was 
applied to beds of His·Bind'" resin with sufficient binding capacity for the PEGacrylated 
target protein. 12-15 consecutive column volumes of wash buffer (17 mM N aH -,PO.j' 183 
mM Na-,HPO.j. 286 mM NaCI. adjusted to pH 7.9 with NaOH) removed unreacted PEG. 
and the PEGacrylated target protein eluted with four consecutive volumes of elution buffer 
(17 mM NaH2PO.j' 183 mM Na2HPO.j' 286 mM NaCL I M imidazole. adjusted to pH 7.9 
with NaOH). Again, \0% polyacrylamide SDS-PAGE allowed monitoring of the 
purification fractions. The wash fractions were freeze dried for verification of complete 
elution ofunreacted PEG diacrylate. Only eluate fractions containing PEGacrylated protein 
pentamer were dialysed I: 10' in Spectra/Por® dialysis tubing with a molecular weight cut-
off of 6-8 kDa (Spectrum Laboratories Inc., USA, MWCO 6-8,0(0) at 4 °C against ddHp 
containing O.I'1c (1'i1') glacial acetic acid (Aldrich). FinalIy. the dialysate was lyophilized 
after addition of -lOCk (Ill/Ill) anhydrous D( + )-glucose (AppliChem) to improve solubility 
upon re-dissolution. For confirmation of the PEGaerylated recombinant protein pentamers' 
identities. amino acid analyses were performed on an HP AminoQuant II (Agilent 
Technologies, Palo Alto, USA). One sample of proteinIAI-grqfr-PEGacrylate was 
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analyzed that originated from protein pentamer IAI expressed by Arimedes Biotechnology 
GmbH, and four samples of protein[B l-graft-PEGacrylate were analyzed that originated 
from different I L protein expressions. but the same clone. 
PEG diacrylate. mol. wt. 575 (Aldrich). PEG a-monoacrylate ro-monomethylether. 
mol. wt. 5000. and PEG a.ro-divinylsulfone, mol. wt. 3400 (Shearwater Polymers Inc., 
USA), were reacted with 7 mg/mL recombinant protein pentamer IA] by Michael-type 
conjugate addition under similar conditions and in identical stoichiometric ratios per protein 
thiol as described for PEG diacrylates, mol. wt. 3400 and 6000. 
Verification of Reaction Selectivity 
SDS-PAGE was used to demonstrate that model protein albumin remained 
unmodified by PEG-thiol and PEG-acrylate during hydrogel formation. Bovine serum 
albumin (BSA. Sigma) was dissolved in 50 mM HEPES buffered saline. pH 7.4, at a 
concentration of 1.5 mg/mL. To reduce disulfide bonds in albumin before reacting with the 
PEG derivatives, I () ilL of tris(2-carboxyethyl)phosphine hydrochloride (11.1 mg/mL in 
DI water, Pierce Chemicals) were added to 500 ilL of the albumin solution. The following 
PEG derivatives were added to aliquots of the albumin solution in specified stoichiometric 
ratios: PEG-dithiol mol. wt. 3400, PEG-monoacrylate, monoNHS ester mol. wt. 3400 
(Shearwater Polymers), or PEG-diacrylate mol. wt. 3400. In addition, acrylic acid 
(anhydrous, Aldrich) was added to selected albumin solutions in order to quench free thiol 
groups on PEG-dithiol and prevent thiol exchange with albumin during SDS-PAGE sample 
preparation. Proteins were analyzed by SOS-PAGE using 100/, acrylamide gels. For 
sample preparation, 10 ilL of any given reaction mixture were combined with 6 ilL DI 
water and 4 ilL 5x SDS-PAGE running buffer containing 1M dithiothreitol (OTT) unless 
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otherwise noted. The samples were then boiled for about 3 mm. Molecular weight 
markers (Bio-Rad, Hercules, CA. USA) were 3 L 45, 66.2, 97, 116, and 200 kDa. 
Heparin-Affinity Chromatography 
0.5 g heparin-agarose beads (bead size 50-150 /lm, 5-7 mg heparin per milliliter 
resulting gel; AppliChem A 1481, Germany) were pre-swollen in PBS, pH 7.4, for I h at 
room temperature, poured into a chromatography column, and allowed to settle to yield a 
bed of heparin-agarose gel of approximately I mL. I mg of protein I A I-gratt-
PEG(6000)acrylate in I mL PBS with and without 28.3 mg/mL heparin from porcine 
intestinal mucosa (MW 16,000 - 18,000, 181 USP units/mg, Sigma H-9399, Germany) 
was applied to the heparin-agarose gel and allowed to bind for 15 min at room temperature 
and zero column flow. The column was then drained, and chromatography was performed 
with seventeen consecutive I mL washes of PBS containing increasing amounts of NaCI, 
starting with the original 137 mM up to 2 M in steps of I 10 mM NaCI. The flow-through 
fractions were collected separately and analyzed by 15'lr polyacrylamide SDS-PAGE for 
the presence of proteinIAl-graft-PEG(6000)acrylate. 
Verification of Acrylate Presence 
To verify presence of the acrylate termini of both proteinIAI-graft-
PEG(6000)acrylate and proteinIAI-graft-PEG(3400)acrylate, 80 IlL of each PEGacrylated 
recombinant protein pentamer (1.25 mg/mL in PBS, pH 7.4) were combined with 20 IlL 
0.3 M triethanolamine, pH 8.(), containing 20.0 molar equivalents per theoretical acrylate 
group of oligopeptide didansyl-KRDGPDGIWGDDRCG-coNII, (kindly provided by Dror 
Seliktar, Institute for Biomedical Engineering, ETH and UNI Zurich, Switzerland). After 
allowing Michael-type conjugate addition of the peptide thiols to protein-gnift-
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PEGacrylates for 15 min under shaking at 37°C, a 16 ilL sample was quenched with 4 f.1L 
DIT-containing SDS-PAGE sample buffer (0.2X M Tris·HCI. 307< (\'il') glycerol. Irk 
(11'11') SDS, 0.5M dithiothreitol (DTT), 0.00127< (11'/\') bromphenol blue; pH 6.8). After 
heating the sample for 5 min at 95-100 0C, SDS-PAGE was performed using 107< 
polyacrylamide gels. To visualize unreacted didansyl-oligopeptide as well as dansylated 
protein-g/'{dt-PEGacrylate species by virtue of their fluorescence, gels were first placed 
atop a MacroVue UVis-20 gel viewer (Hoefer Pharmacia Biotech, USA) and photographed 
through a UV filter with a digital camera. To visualize any protein species by direct 
staining, the SDS-PAGE gels were subsequently stained in Coomassie Blue G-250 
staining solution (0.0257< (11'/1') Coomassie Blue G-250, 107< (l'il') acetic acid) and 
de stained in de staining solution (lOCk (\-11') acetic acid, 2W'k (1'11'i ethanol). 
Gelation by Photopolymerization and Swelling 
57<, 7.57<, 107<, 12.57<, and 157< (11'+\') solutions of PEGacrylated protein 
pentamers IAI and \07< and 157< (11'+\') solutions of PEGacrylated protein pentamer IBI in 
serum-containing DMEM (e.g .. to obtain a lOCk (11'+\') solution, I mg protein-graft-PEG 
was combined with \0 ilL DMEM) containing 0.1 mM eosin Y (Aldrich, Germany), 13.2 
llL/mL triethanolamine, and 3.5 llL/mL l-vinyl-2-pyrrolidinone (Aldrich, USA), were 
photopolymerized by irradiation at A = 4XO - 520 nm and 75 mW/cm2 for 15-30 s from a 
portable Cermax Xenon Fiber Optic Light Source CXE300 (lLC Technology Inc., USA). 
Swelling of proteinIAI-gmff-PEG(6000) hydrogels was measured by weighing the gels 
before and after swelling in PBS, pH 7.4, for 16 h. 
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Rheological Measurements 
A Bohlin Instruments CVO 120 High Resolution rheometer (Bohlin Instruments, 
United Kingdom) was used in combination with a portable Cermax Xenon Fiber Optic 
Light Source to characterize the light-induced liquid-to-solid transition (photogelation) of 
protein-f,'raft-PEGacrylate solutions in a parallel disc geometry. The light source was 
installed underneath a glass plate serving as the fixed bottom surface, while a circular 
parallel plate with radius 10.0 mm was rotating in oscillatory mode atop 30 f.lL of a 10% 
(11'+1') protein[AJ-graft-PEG(3400)acrylate or -PEG(6000)acrylate solution throughout the 
measurement, imposing a target shear strain of 0.05 at a frequency of I Hz and with an 
initial shear stress of I Pa. The distance between the bottom glass surface and the parallel 
disc was 95 f.lm. After allowing the phase angle of the solution to stabilize for 1-2 min, the 
light source was switched on at designated time = 0 and allowed to irradiate the sample for 
the entire duration of the rheological measurement. For each protein-f,'r«ft-PEG two 
measurements were performed on two samples that were prepared identically (n=2), but 
due to material constraints the measurements have not been repeated independently. 
Plasmin Degradation Assay 
\0% (11'+1') protein[A]-gr~ft-PEG(60()0) hydrogels were tested for degradability by 
plasmin by placing a pre-swollen -5 mg pieces of protein-f,'rajf-PEG hydrogel into a 200 
f.lL solution of 2 U/ml plasmin from porcine blood (Sigma P-X644, Germany) in PBS, pH 
7.4. Degradation of the gel by plasmin was allowed to proceed for 3 hr at 37°C. In 
parallel, pieces of hydrogel, similar in size, were placed in 200 f.lL PBS, pH 7.4, without 
plasmin, and incubated at 37°C for 3 hr. 
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RESULTS AND DISCUSSION 
Multimerization of DNA 
As verified by DNA sequencing, the DNA segments 1 c I (Chart 4.3) encoding the 
monomeric sequences of recombinant protein pentamers [A I and [B I 
assembled correctly from matching DNA fragments 1 a I and 1 b I (Chart 
4.2). The products of the subsequent multimerization of DsaI-digested 
segments 1 c I for recombinant protein pentamer [B] can be seen in lane 1 of 
the agarose gel shown in Figure 4.1. 
Figure 4.1: 1.'i'1r Agarose Gel Illustrating DNA Muitimerization 
Lane I: Products of the multimerization of Dsal-digcsted DNA segment I c I (13X bp) for 
n;comhinant protein pentamer 1131. Multimers Ic I, of Dsal-digested DNA segment Icl 
(Chart .') can he observed as stained DNA hands that run at multiples of 13X bp. including 
the un-multimerized segment at 13X bp. The DNA pentamer I c I, (6<j() bp) encoding 
recombinant protein pentamer 1131 is highlighted with an arrow (-t). Lane 2: 50 hp DNA 
molecular weight ladder. 
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In particular, multimers 1 c I \ can be observed as DNA bands that run at multiples of 13X 
bp. The DNA pentamer 1 c I) (690 bp) encoding recombinant protein pentamer [B I is 
highlighted with an arrow (-) (Figure 4.1). DNA sequencing of the DNA pentamers 1 c I, 
cloned into pET 14b confinned proper gene sequence and orientation. 
In summary, using techniques previously established by McGrath, et al.}09 DsaI-
digested segments {c I were multimerized through head to tail polymerization to form the 
pentameric DNA that encodes protein pentamers rAI and IB]. Codons encoding cysteine 
residues were present in the monomeric DNA units to introduce equispaced thiols (Chart 
4.1, for subsequent modifications,163J().J165 such as the PEGacrylation of 
protein pentamers I A I and I B I described in this work. 
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Expression and Purification of Recombinant Protein Pentamers [A] and [B] 
:2 s 6 7 9 I () II 
Figure 4.2.a: Bactcrial I~xprcssion and Purification of Recomhinant Protein Pentamer 1 Al 
Coomassie-stained IS'7r polyacrylamide SDS-PACiE gel documenting the hacterial overexpression ,md 
Ni++-aITinity purification of recomhinant protein pentamer [AJ. Lane I: protein molecular weight marker 
n.s. 6.1. 14.4. 16.9. 19.7/20.4 .. ~I kDa). Lane 2: Soluhle hacterial proteins. Lane -': Insoluble hacterial 
proteins containing recomhinant protein pentamer 1 A]. soluhilil:ed with 6 M guanidine HCI: he fore now 
ovcr the Ni++-column. Lane 4: Flow-through after flow over the Ni++-column. Lane S: Washes. Lanes 6-
II: Consecutive eluate fractions containing purified recombinant protein pentamer IAI. 
As illustrated in the protein purification profile for recombinant protein pentamer 
[AI (Figure 4.2a). the recombinant protein was expressed successfully (Jane 3) using the 
pET expression system and readily purified (lanes 6 - II) by Ni++-affinity chromatography 
(40 mg/L and 10 mg/L. pentamer [A[ and [B] respectively, from shaking flask bacterial 
cultures; 127 mg/L of recombinant protein pentamer [AI from commercial fermentation). 
The presence of the recombinant protein pentamer band at 31 kDa in lane 3 (Figure 4.2.a). 
which represents all insoluble bacterial proteins. indicates that recombinant protein 
pentamer [AI was deposited into bacterial inclusion bodies during protein expression.' 
Expression and purification of recombinant protein pentamer [B I (not shown) was achieved 
similarly. in agreement with results previously achieved for several artificial periodic 
I Smaller recomhinant protein multimers such as thc monomer ami dimer. not shown. wcre not expressed 
etlicicntly. This was onc of the reasons for focusing exclusively on protein pentamer species in suhsequent 
experiments. 
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proteins. 166 114 115 112167 117 Bacterial expressIon III conjunction with affinity purification 
was a convenient and straightforward method for producing recombinant protein pentamers 
[AI and fBI. 
Characterization of the Recombinant Protein Pentamers 
Recombinant protein pentamers fAI (mol. mass 28529) and IBI (mol. mass 27247) 
both exhibited in SDS-PAGE an apparent molecular mass of about 31 kDa (I B I not 
shown). MALDI mass spectroscopy of protein pentamer [B I revealed a dominant peak 
centered at molecular mass 27498." In Western blots, recombinant protein pentamers [AI 
(Figure 4.2.b) and [BI (not shown) were detectable by immunoreactivity of an anti-
penta· His antibody with the protein pentamers' hexa-histidine tags. 
a) b) 
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Figure 4.2.b: Western Blot of Recombinant Protein Pentamer [AJ 
I.ane I in a): Coomassie-stained protein molecular weight marker (I 'J.7/:20.4 kDa I/ililll). 31.0 kDa (fiJilll i. 
45.0 kDa. 66.2 kDa). 
Lane:2 in a): Coomassie-stained recombinant protein pentamer [AJ. 
l.ane:2 in h): Signal in the Western hlot or recombinant protein pentamer [1\1. translClTed rrom the 1()(1r 
polyacrylamide SDS-PACiE gel shown in a). reacted with anti-penta· I lis antibody and visualized . 
. ' MAl.DI was not perrolllled on protein pentamer [A[ because its identity was confirmed by amino acid 
analysis of protein] A J-grall-PEC iacrylate (Table 4.1 ). 
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Amino acid analysis confinned the expected amino acid composition of PEGacrylated 
protein pentamer IA] (Table 4.1), whereas the amino acid composition detennined 
experimentally for PEGacrylated protein pentamer I B 1 deviated significantly in glutamic 
acid and proline content, as well as in threonine, serine, isoleucine, valine and lysine 
content. The numbers of protein pentamer I B I's other residues agreed with their theoretical 
abundance. 
Table 4.1: Amino Acid Analysis of ProteinIAh:rati-PEG and Protein[Bl-rrati-PEG 
Amino Experimental Theoretical values Average Theoretical values 
Acid values for for protein[A]- experimental for protein[B]-
protein[A]-graft- graft-PEG values for graft-PEG 
PEG protein[B ]-graft-
PEG ± stnd. error 
(n=4) 
Asx ti 43.6 40 31.9± 1.1 35 
Glx ti X.6 5 20.5± 1.7 5 
Ser 25.0 30 16.9±1.2 30 
His 11.9 13 9.0±0.4 13 
Gly 1t).7 19 29.X±1.9 34 
Thr 6.3 5 10.3±0.5 5 
Ala 30.7 30 26.8±0.7 30 
Arg 35.1 36 19.X±0.9 26 
Tyr 10.3 10 7.7±0.3 10 
Val X.3 6 13.5±0.X 6 
Met 0.0 2 O.7±O.7 2 
Phe 10.9 10 10.0±0.2 10 
lie 6.4 5 IO.3±O.5 5 
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Leu 22.1 21 22.6±O.3 21 
Lys 13.0 IS 13.6±O.2 IS 
Pro 1.9 I X.6±O.S I 
Cys"! -- 6 -- 6 
Trp (not detected) 0 (not detected) 0 
Note: I) As a result 01 aCid-hased hydrolysIs pnor to ammo aCid detection. asparagine and glutamine 
n:sidues were converted into aspartic acid and glutamic acid. respectively. Therefore. the number of those 
residues detected reflects the number of original asparagine and aspartic acid residues. or glutamine and 
glutamic acid residUl:s. in the protein comhined. ii) Cysteine residues arc not quantifiahle hy the analysis 
method used. 
Amino acid codes: alanine (Ala). arginine (Arg). asparagine and/or aspartic acid (Asx). cysteine (Cys). 
glutamic acid and/or glutamine ((lIx). glycine (Gly). histidine (His). isoleucine (lie). leucine (Leu). lysine 
(Lys). methionine (Met). phenylalanine (Phe). proline (Pro). serine (Sen. threonine (Thr). tryptophan (Trp). 
tyrosine (Tyr). valine (Val). 
In light of the fact that protein pentamer [B ['s encoding DNA was correct and that SDS-
PAGE as well as MALDI mass spectroscopy of the purified sample revealed a dominant 
protein band of the molecular mass expected for protein pentamer [B I. a likely explanation 
for the deviation of the experimental amounts of the amino acids mentioned above is the 
presence of bacterial impurities, which seem to have altered the numbers of the discrepant 
amino acids. 
Ellman's test for free thiols revealed that unmodified protein pentamers [A I and [B J 
contained at most 30Ck free thiols after affinity purification and dialysis against PBS with X 
M urea. Prior to PEGacrylation. recombinant protein pentamers rAJ and [8 I were 
insoluble in aqueous buffers with less than 6 M urea. Once precipitated or lyophilized. 
recombinant protein pentamers [AI and [B I did not re-dissolve in a variety of solvents. 
neither aqueous (O.I9( acetic acid. SO'lc ethanol. 0.1 % SDS) nor organic (acetonitrile. 
methanol. ethanol. N.N-dimethylformamide. tetrahydrofuran. dimethylsulfoxide). unless S 
mM reducing agent (such as DTI or ~-mercaptoethanol) and at least 6 M urea were 
present. 
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Synthesis of Protein-graft-PEGacrylates 
Figure 4.3.a illustrates the Michael-type conjugate addition of recombinant protein 
pentamer [Aj's six thiols to PEG diacrylate, mol. wt. 6000, as monitored by 10% 
polyacrylamide SDS-PAGE under reducing conditions. The reaction of PEG diacrylate, 
mol.wt. 6000, with recombinant protein pentamer [BJ was less successful and, in 10% 
polyacrylamide SDS-PAGE, produced a smear of products from apparent molecular weight 
31 kDa (unreacted protein pentamer) to species larger than 200 kDa. 
~ .....•.•.....•....•...l
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Figure 4.3.a: SDS-PAGE Gel Showing the PEGaerylation of Recombinant Protein Pentamer [A[ 
Coomassie-stained IWIr polyacrylamide SDS-PAGE gel showing the PEGaerylation by Michael-type 
conjugate addition of recombinant protein pentamer r A]. Lanes I and 9: Protein molecular weight marker 
n 1.0.45.0. 66.2, 97.4 kDa). Lane 2: Recombinant protein pentamer [A]. Lane 3: Recombinant protein 
pentamer rAJ after incubation with TCEP. Lane 4: Intermediate reaction products, after the reaction was 
quenched by addition of DTI-containing SDS-PAGE sample buffer shortly after combining the reagents. 
Lanes 5-X: Reaction products after 15,30.45. and 60 min. Lane 10: Reaction products after 1.5 hr without 
previous reduction of disulfide bonds by TCEP. 
The difference in reactivity between protein pentamers lAJ and [B] may be due to 
differences in protein structure resulting from the lower net positive charge of protein 
pentamer lB J as well as its lower total number of charged residues (Table 4.2). Because of 
its lower net positive charge and lower total number of charged residues, recombinant 
protein pentamer lB 1 may be less unfolded than [A], even in the presence of X M urea, a 
chaotropic agent, and, thus, its thiol groups be less accessible for reduction by TCEP 
and/or reaction with PEG diacrylate than recombinant protein pentamer lArs thiols are. 
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Table 4.2: Charge Analysis of Protein[Ah!rafi-PEG and ProteinIBh:rati-PEG 
Protein pentamer Protein pentamer 
[A] rB] 
Theoretical isoelectric point 
(pi) 10.43 10. I I 
Total number of negatively 
charged residues (Asp + Glu) 25 20 
Total number of positively 
charged residues (Arg + Lys) 51 41 
Total number of charged 
residues 76 61 
Expected net charge 
at pH 7.4 +26 +21 
relerenee: l:xPASy I'rolParam 1001 1611 
As far as the PEGacrylation of protein pentamer [AI is concemed. Lane 4 of Figure 
4.3.a shows that when the reaction was quenched by addition of OTT-containing SOS-
PAGE sample buffer seconds after combining the reagents. distinct intermediate reaction 
products can be observed. These compounds appear to be incompletely PEGacrylated 
protein pentamers. whereas the final reaction product, expected to be fully PEGacrylated 
proteinlA l-gra/t-hexaPEGacrylate (mo\. mass 64.5 kOa). ran in SOS-PAGE at an apparent 
molecular weight of approximately 100 kOa (Figure 4.3.a. lane 4, top protein band). (The 
high apparent molecular weight of PEGylated proteins is not surprising, as uncharged PEG 
chains do not contribute to the proteins' mobility during SOS-PAGE, and even impede 
migration by steric hindrance.) The PEGacrylation of recombinant protein pentamer did 
not go to completion unless TCEP was previously used to break disulfide bonds and thus 
free the protein thiols for reaction with PEG diacrylate (Figure 4.3.a. Lane 10). This is in 
accordance with the observation from Ellman's assay that after purification and dialysis 
only about 30';'c of recombinant protein thiols remained reduced. i.e .. capable of conjugate 
addition to acrylates. TCEP was chosen as a reducing agent, because, in contrast to OTT 
or l3-mercaptoethanol, it does not engage in thiol exchange but is irreversibly consumed in 
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the process of reducing disulfide-bound thiols. When sufficient TCEP is added, the final 
reaction product (lanes 5-8), presumably protein [A]-grqft-hexaPEGacrylate, clearly does 
not run as one distinct band in 10% polyacrylamide SOS-PAGE. A probable explanation 
for the occurrence of additional bands is that the OTT present in the SOS-PAGE sample 
buffer, whose two thiol groups can also react with acrylate groups by conjugate addition, 
may have crosslinked some protein-grajt-PEGacrylate molecules, leading to the high-
molecular-mass protein band or bands near the very top of the SOS-PAGE separating gel. 
Thus, these bands likely represent an artifact due to sample preparation. The actual 
PEGacrylation reaction reaches completion after 15 min (lane 5), as no further change in 
the reaction products is detectable even after another 45 min (lane 8). It was difficult to 
verify that the reaction product is fully PEGacrylated protein-grqft-hexaPEGacrylate or a 
protein-grqfr-multiPEGacrylate with fewer than six pending PEG acrylate chains. Other 
predominant products might include protein-graft-multiPEGacrylate species with fewer 
than six pending PEG acrylate chains, as steric hindrance by grafted PEG chains may set a 
limit to the number of protein thiols that can be PEGacrylated. Nevertheless, proteins 
PEGacrylated to different degrees may coexist as final products, because the attainable 
degree of PEGacrylation of a given protein pentamer molecule might even depend on the 
order in which its six thiols react with PEG diacrylate, or, in fact, on the extent to which 
some thiols forgo conjugate addition altogether because they engage in intramolecular 
disulfide bond formation before encountering an acrylate functional group. The exact 
nature of the (different) protein[A]-grqft-multiPEGacrylate product species is not so 
relevant as far as the biological characterization of the eventual protein[A]-grafr-PEG 
hydrogels was concerned, as the only two crosslinked matrix components were always 
proteinlA] and PEG. 
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Figure 4.3.b provides further examples of protein PEGylation reactions by 
Michael-type conjugate addition of protein thiols to PEG acrylate or vinylsulfone functional 
groups. 
! ( 
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Figure 4.3.b: PEGylation of Prott:in Pt:ntamcr [A I with PEGs of incrt:asing Mokcular Weight 
Coomassie-stained IWIr polyacrylamidt: SDS-PA(;E gel illustrating tht: PE(;ylation of rt:comhinant prott:in 
pt:ntamcr [A I with a st:rit:s of PEGs of incrt:asing molecular wt:ight. Lant: I: unreactt:d protein pt:ntamcr 
IAI. Lane~: IA] rt:acted with PEG a.w-diacrylatt:. mol. wI. 575. Lant: 3: IAI reactt:d with PEC; a.w-
diacrylate. mol. wI. 3400. Lant: 4: [AI reacted with PEe; a.w-divinylsulfont:. mol. wI. 3400. Lane 5: IAI 
rt:acted with PEG a-monoacrylatc w-monomt:thykther. mol. wI. 5()OO. Lane 6: [AI reacted with PH; 
a.w-diacrylatt:. mol. wI. 6000. 
The IOIk polyacrylamide SDS-PAGE gel shown illustrates the increase in molecular weight 
of recombinant protein pentamer [AJ due to PEGylation with a series of PEGs of increasing 
molecular weight. For instance, while presumed protein[Aj-gra{f-hexaPEG(6000)acrylate 
(mol. wt. 64.5 kDa) and its DTT -crosslinked derivatives ran in SDS-PAGE between -100 
kDa and the top of the separating gel. presumed protein[Aj-graft-hexaPEG(3400)acrylate 
(mol.wt. 4X.9 kDa) ran at about 60 kDa (lane 3, Figure 4.3.b). Even between presumed 
protein[Aj-gmft-hexaPEG(6000)acrylate and protein[AJ-graft-hexaPEG(5000)methylether 
(mol. wt. 5X kDa: lane 5) a difference in apparent molecular weight can be detected by 
SDS-PAGE. 
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Selectivity of Protein PEGylation 
One important feature of Michael-type conjugate additions of protein thiols to 
acrylate functional groups is the high selectivity of this reaction. This is a very desirable 
feature, because when proteins are modified exclusively via their thiols, primary amine-
dependent protein properties and functions may be preserved. Although primary amines of 
proteins can react with acrylate groups by Michael-type conjugate addition as well, under 
physiological conditions this reaction is very slow, on the order of hours, whereas thiols 
react very fast, on the order ofminutes.152106159 Because of this highly selective reactivity, 
Michael-type conjugate addition reactions of protein thiols to suitable conjugated reaction 
partners are very useful tools for protein modification in general. Additionally, SDS-
PAGE was employed as a suitable and straightforward method to monitor protein 
PEGylation reactions, because the grafting of PEG has a detectable effect on the mobility of 
proteins in SDS-PAGE.163 
In the model reactions involving albumin, analysis by SDS-PAGE showed that 
under physiological conditions almost no reaction was apparent between albumin and PEG-
diacrylate, mol. wt. 3400, or between albumin and PEG-dithiol, mol. wt. 3400 (Figure 
4.3.c). In particular. Figure 4.3.c.(A) shows that albumin incubated with PEG-diacrylate 
for I hr remained almost entirely unmodified and thus ran virtually identicaIJy to native 
albumin during SDS-PAGE (Figure 4.3c.(A), lane 3 vs. lane 2). 
The smaIJ smear above the albumin band in Figure 4.3.c.(A), lane 3, may indicate 
that a small percentage of the protein was modified by PEG-diacrylate. This observation 
was in stark contrast to the obvious and abundant reaction of PEG-NHS-ester with albumin 
under physiological conditions (Figure 4.3.c.(A), lane 4), or between PEG-diacrylate and 
albumin when the albumin was previously reduced and kept under denaturing conditions 
(Figure 4.3.c.(A), lane 5). 
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Figure 4.3.c: Reaction Selectivity of Michael-type Conjugate Addition 
SOS-PAGE was used to detennine the "self-selectivity" of the cross-linking reaction. (A) Lane I: mol. wI. 
markers; Lane 2: albumin + running buffer with OTT; Lane 3: albumin + PECi-diacrylate (20 mol 
PHi/mol albumin) for I hr at 37°C + running buffer with OTT; Lane 4: albumin + PEG-mono acrylate, 
mono-NHS ester (20 mol PEG/mol albumin) for I hr at 37°C + running buffer with OTT; Lane 5: 
albumin with 8M urea + reduction with TCEP + PEG-diacrylate (350 mol PEG/mol albumin) for I hr at 
37°C + running buffer with OTT; Lane 6: mol. wI. markers; Lane 9: albumin + PEG-dithiol (20 mol 
PEG/mol albumin) for I hr at 37°C + running buffer without OTT; Lane 10: alhumin + running buffer 
without DTT. It was demonstrated that PECi-diacrylate reacted with albumin only very slowly. if at all 
(Lane 3). whereas a PEG-NHS-ester reacted rapidly with albumin (Lane 4). Reduction of disulfide bonds in 
the protein. producing free thiols in the protein. led to rapid reaction of the PEG-diacrylate with the protein 
(Lane 5). PEG-dithiol initially appeared to react with albumin, presumably by disulfide exchange (Lane 9). 
Ilowever. Figure (B) shows that this was an artifact of sample preparation for gel electrophoresis. (B) Lane 
I: mol. wI. markers; Lane 2: alhumin + running buffer with OTT; Lane 3: albumin that had been released 
from a hydrogel made from PEG-tetraacrylate and PEG-dithiol + running buffer with OTT; Lane 4: albumin 
+ acrylic acid (20.000 mol acrylic acid/mol albumin) for 15 min at 37°C + running buffer with OTT; 
Lane 5: albumin + running buffer without OTT; Lane 6: alhumin + acrylic acid (20.000 mol acrylic 
acid/mol alhumin) for 15 min at 37°C + running buffer without DTT; Lane 7: albumin + PEG-dithiol (20 
mol PEG/mol albumin) for I hr at 37°C + acrylic acid (10,000 mol acrylic acid/mol albumin) for 15 min 
at 37°C + running buffer without OTT; Lane 8: albumin + PEG-dithiol for I hr at 37°C + running buffer 
without OTT: Lane 9: alhumin with 8M urea + PECi-dithiol (20 mol PEG/mol alhumin) for I hr at 37°C 
+ acrylic acid (10.000 mol acrylic acid/mol albumin) for 15 min at 37°C + nmning buffer without OTT; 
Lane 10: albumin with 8M urea + PEG-dithiol (20 mol PEG/mol alhumin) for I hr at 37°C + running 
buffer without OTT. It was demonstrated that albumin that was released from hydrogels fonned from PEG-
tetraacrylate and PEG-dithiol was unmodified (Lane 3). Reaction of reduced albumin with acrylic acid did 
not change the migration of the protein (Lane 4). PEG-dithiol did not react with alhumin under 
physiological conditions. demonstrated by quenching free thiols with acrylic acid before PAGE (Lane 7). 
which was in contrast with Lane 8 (identical to Lane 9 from Figure (A). The conclusion was that PEG-
dithiol does not react with albumin at room temperature. hut does react during the hoiling step required for 
SDS-PACiE. 
The self-selective chemistry for cross-linking polymers that is described here did 
not lead to detectable modification of the proteins that were trapped within the cross-linked 
material. The reaction of the PEG-acrylate with the PEG-dithiol is rapid, but reaction of 
PEG-acrylate with the free thiol found on bovine serum albumin was not detectable under 
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cross-linking conditions. It is unknown whether this result is general for other proteins 
since the single free thiol in albumin is probably relatively inaccessible to the PEG-acrylate 
due to steric hindrance. Regardless, the number of proteins of interest that would have a 
free thiol is rather small, and thus this potential side reaction is of little concern. 
While the reaction of the acrylate group with amine groups on the protein will occur 
over a long period of time, we found no evidence that this reaction occurs on the time scale 
required to cross-link the hydrogel. The lack of reactivity between the PEG derivatives and 
proteins is not only desirable for the formation of controlled delivery vehicles, but it also 
implies that the controlled delivery vehicle could be cross-linked in contact with living 
tissue without modifying proteins found in the tissue. 
79 
Purification of Protein-graft-PEGacrylates 
Returning to protein-gra/t-PEGacrylates, protein pentamer lArs and IBj's Ni++-
affinity was not compromised due to the PEGacrylation. Therefore, the removal of 
unreacted PEG diacrylate from PEGacrylated protein pentamers IAI or I B I was easily 
accomplished by Ni++ -affinity chromatography (Figure 4.4). 
2 3 4 5 6 7 X 
Figure 4.4: Ni++-affinity Purification of Prlltein[AI-graft-PEClacrylate 
I<1'1r polyacrylamide SDS-PA(iE was used to monitor the purification of protein[AJ-grafi-PEGacrylate hy 
N i++ -affinity chromatography. Coomassie-stained protein[ A l-grafi-PE(iacrylate is visihle in the sample 
hefore purification (lane 2). still containing unreacted excess PEG diacrylate. and in the eluate fractions 
(lanes 7 and X). 
In two independent Ni++-affinity purifications, the wash fractions (lanes 3 - 6), which had 
been freeze-dried, contained an amount of PEG diacrylate equal to the expected excess after 
full PEGylation of protein pentamers IAI or IB I. Furthermore, since large volumes of 
wash buffer had been used, and PEG is very well soluble in aqueous buffers, the eluate 
fractions (lanes 7 and X) were considered to be free of unreacted PEG diacrylate. 3 After 
dialysis and lyophilization, PEGacrylated protein pentamers IA] or I B I (containing -I09C 
(mlm) D(+)-glucose) were readily soluble up to concentrations of at least 159C (11'+1") in 
aqueous buffers as well as in serum-containing media. No spontaneous disulfide bond 
fomlation or other solubility problems were encountered with the PEGacrylated pentamers, 
in agreement with PEG's good solubility and high mobility in water.l2I! 
; Also. PHi is unlikely to have any affinity to the NiH-resin or to the column itself. 
80 
Heparin Affinity of Protein[A]-graft-PEGacrylate 
In the absence of soluble heparin, proteinrA]-f,'rajt-PEG(6000)acrylate was eluted 
from the heparin-agarose column between salt concentrations of 0.8 - 1.1 M NaCI (Figure 
4.S.a). 
a 
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Figure 4.5: Heparin-Agarose Affinity Chromatography With Protein[A]-grafr-PEGacrylate 
20'7< acrylamide SDS-PAGE gels with 16 f!L samples from eluate fractions a) without heparin. b) with the 
addition of 20 moles of heparin per mole of heparin-binding sites in proteinr A J-grafr-PEGacrylate. Lanes 
I: molecular weight marker. 2: sample before chromatography. 3: flow through after initial loading of 
column with 137 mM NaCI. 4: 137 mM NaCI. 5: 246 mM NaCI. 6: 356 mM NaCI. 7: 466 mM NaCI. 8: 
575 mM NaCI. 9: 685 mM NaCI. 10: 794 mM NaCI. II: 904 mM NaCI. 12: 1014 mM NaCI. 13: 1123 
mM NaC/. 14; 1228 mM Nae/. 15; 1342 mM NaCI. 16; 1452 mM NaCI. 17; 1562 mM NaC/. 18; 1671 
mM NaCI. 19: a) 1781 mM NaCI. b) mol. weight marker. 20: a) 1890 mM NaCI. b) 1781 mM NaCI. 
Note in a) the separation into proteinrA]-grafr-PEG acrylates of increasing molecular weight with 
increasing NaCI concentration of the eluate fractions. 
Elution at such high salt concentrations is evidence for the strong affinity of recombinant 
protein pentamer [Al for heparin, indicating that the heparin binding site was not sterically 
hindered by pendant PEG chains. The competing presence of 28.3 mg/mL soluble 
heparin, corresponding to 20 moles of heparin per mole of heparin-binding sites in the 
protein pentamer, almost completely inhibited binding of protein[A]-,l,'rajt-
PEG(6000)acrylate to the column at 137 mM NaCI (Figure 4.5.b). Protein[A]-,l,'rajt-
PEG(6000)acrylate was then eluted entirely from the heparin-agarose column with the next 
wash of 250 mM NaCI (lane 5). These results confirm the affinity of recombinant protein 
pentamer rAJ's heparin binding site for heparin. 
Confirmation of Acrylate Presence 
Fluorescently labeled thiol containing 
compounds can be used to probe and quantify 
acrylate functional groups in acrylate containing 
systems. Here, the didansyl-containing 
oligopeptide didansyl-KRDGPDGIWGDDRCG-
CONII, reacted readily with PEGacrylated and 
purified recombinant protein pentamer IA] by 
Michael-type conjugate addition, as evident from 
the fluorescence associated with the PEGylated 
protein pentamer after the 15 min reaction (Figure 
4.6). This implies that PEGacrylated protein 
pentamer IA] and, accordingly, protein pentamer 
[B] do indeed acquire and retain reactive acrylate 
termini due to their PEGacrylation. 
Figure 4.6: Acrylate Presence 
Identical Coomassie-stained (left) and UV-
exposed (right) W';'" polyacrylamide SDS-
PAGE gel confirming terminal acrylate 
viability of protein[A]-gratr-
PEG(3400)acrylate (lane I) and protein[AJ-
gratr-PEG(6000)acrylate (lane 2). 
Fluorescence associated with the PEGylated 
protein pentamers is evidence lor viable 
acrylates. which are important for 
crosslinking of the constructs. Note the 
t1uorescent acrylate probe alone. ncar the 
bottom. 
82 
Gelation by Photopolymerization and Characterization of Protein-graft-PEG 
Hydrogels 
Lyophilized protein! AJ-graft-PEG(3400)acry late and protein [A J-grajf-
PEG(6000)acrylate completely redissolved after 1 hr at 4°C and gelled upon photoinitiation 
at all concentrations between 5% and 15% (W+1') PEGacrylated protein (Figure 4.7). 
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Figure 4.7: Gelation of Protein[A]-Rratt-PEGacrylatc 
A) Schematic of light-induced gciation of protein[A]-Rratt-PEGacrylate. Note that more than two or three 
acrylate termini (as shown) call polymerize to crosslink the PEGacrylated protein pentamers. 
B) Rheological characterization of light-induced gelation of a 10% (11'+\.) protein[A]-Rratt-
PEG(6000)acrylatc solution. D Elastic modulus. G'. (pa): 0 Phase angle. O. ("). 
In contrast, at all concentrations that were tested, purified and lyophilized protein[B]-grajf-
PEG(6000)acrylate did not completely redissolve nor gel during irradiation. Recombinant 
protein [B]'s poor extent of PEGylation as well as its lower net positive charge compared 
to protein[A]-graft-PEG(6000)acrylate explain the poor solubility of protein[BJ-gr«fi-
PEG(6000)acrylate at such high concentrations as up to 15 % (11'/1'). The poor solubility of 
protein[B ]-gr«fi-PEG(6000)acrylate and, consequently, the low concentration of 
crosslinkable acrylate groups in solution explain the lack of crosslinkability. 
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The density of crosslinkable acrylate groups in solutions of protein[AJ-grt?ft-
PEG(3400)acrylate as well as -PEG(6000)acrylate were at or above the minimum con-
centration necessary for gelation. Since concentrations of protein[AJ-grajt-
PEG(6000)acrylate less than 10% (w+\') produced gels that were of poor mechanical 
strength, all subsequent experiments were done at a concentration of 10% (11'+ \') 
PEGacrylated protein. The 10% (w+\') hydrogels were homogeneous, firm to the touch 
of a pipette tip, perfectly transparent, and swelled by up to 200% of their initial mass in 
PBS, pH 7.4, over 16 h. Rheological characterization of the gelation, shown for 
protein[A]-grajf-PEG(6000)acrylate in Figure 4.7, reveals that photo initiated gelation 
occurred on the order of a few seconds. Gelation is evident from the crossover of the 
phase angle, 0, and the elastic modulus (or "storage modulus"), G', and, in particular, 
from the rapid leveling of the phase angle to nearly 0, typical for a solid. The phase change 
from liquid to solid due to gelation is also evident from the rapid increase in the elastic 
modulus to about 1.2 kPa upon photo initiation. This corresponds to a Young's modulus 
(E pEC ;6000) of approximately 3.5 kPa. (Note: E = 2(1 + !J)G', where !J is Poisson's ratio, 
assumed to be the ideal value, 0.5, a reasonable assumption for cross-linked gels). 
Surprisingly, the range of Young's Modulus EpFC;6Iloo measured for protein[Al-gr«it-
PEG(6000) gels was higher (2.9 - 3.5 kPa) than the measured range of EpECil4011 for 
protein[A]-grait-PEG(3400) gels (2.4 - 3.1 kPa), although a higher crosslink density, 
firmer consistency, and therefore larger EpECil.JOO' was expected for the latter. It may be that 
the longer tether between the reactive acrylate and the protein backbone allows for more 
effective polymerization after photoinitiation. 
The visible light-induced gelation of protein-grajf-PEGacrylate solutions occurred 
at a sufficiently rapid rate under the low intensity of visible light that was utilized, so 
gelation in sitll should be feasible in surgical contexts. Moreover, the reaction results in 
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little heat generation when the acrylate functional groups polymerize at low concentrations 
(-8.5 mM theoretical acrylates in the case of 10% (11'+1') solutions of fully PEGacrylated 
protein[Al-Rr«it-PEG(6000), and -11.3 mM theoretical acrylates in 10% (11'+1') solutions 
of fully PEGacrylated proteinlAI-gr«ft-PEG(3400)). 
Plasmin Degradability 
Protein[AI-gr«it-PEG(6000) hydrogels incubated with 2 U/ml human plasmin in 
PBS, pH 7.4. were degraded completely after 3 hrs, whereas pre-swollen hydrogels 
incubated in PBS without plasmin did not change in size even after 5 days. This shows 
that one or both of the plasmin degradation sites (i) in recombinant protein pentamer lAl 
(Chart I) are accessible and can be cleaved by human plasmin, even when they are part of a 
highly crosslinked protein-gr«it-PEG network. The particular human fibrinogen sequence 
in protein[A]-Rrajt-PEG hydrogels preserved its enzymatic degradability although it was 
fused with other protein fragments, was produced in a bacterial expression host, did not 
exist in its native three-dimensional shape and environment, and was part of a partially 
synthetic matrix with poly(ethylene glycol). 
CONCLUSION 
Initial design objectives were met by the "selective" grafting of PEG diacrylate to 
recombinant protein pentamer IAl to obtain protein[A]-gr«ft-PEG(3400)acrylate and 
-PEG(6000)acrylate. These compounds were subsequently gelled successfully by 
photopolymerization to obtain protein[AI-grajt-PEG hydrogels, which were transparent 
(allowing future microscopic analysis of three-dimensional cell cultures), had promising 
mechanical strength to support ingrowth of cells toward applications in tissue regeneration, 
and which were plasmin degradable. Especially bulk plasmin degradability was an 
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important indication that the design objective of an enzymatically degradable matrix had 
been fulfilled, in which cells might specifically degrade the material in synchrony with 
cellular migration. The results presented in Chapter 5 further illustrate the successful 
implementation of relevant biological features into these artificial matrices and the promise 
of tissue repair and wound healing that these novel materials represent. 
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CHAPTERS 
INTERACTIONS OF hFFs WITH RECOMBINANT PROTEIN 
PENTAMERS AND PROTEIN[A]-graft-PEG HYDROGELS 
INTRODUCTION 
hFF -Fibrin Clusters as a Model for Tissue Regeneration 
Cell migration from the periphery into the core of an implanted matrix and 
simultaneous resorption of the matrix are desirable features of a material intended for tissue 
repair and regeneration. To test proteinfAJ-graft-PEG hydrogels ill \'itro regarding this 
intended role, it was necessary to juxtapose the matrices to native tissue or a model of 
living tissue. The intention was to see if cellular invasion would occur from the tissue into 
the artificial hydrogels. Fibroblasts were chosen as a model cell type in light of their ease 
of handling in tissue culture as well as their important role in wound healing. In vivo, 
fibroblasts near the site of an injury are among the first cells to invade and reorganize the 
fibrin clot that initially forms in a wound. 
To avoid using tissue explants and to evaluate the behavior of a single cell type, a 
relatively easy encapsulation system was developed by Pratt et al., 200 1,126 to test 
fibroblast migration into a material of interest. hFFs were first embedded in fibrin at high 
concentration, and the resulting hFF-fibrin clusters then embedded in self-forming 
hydrogels (see details in Chapter 2). In Pratt et al.'s system, hFFs migrated out of and 
away from the region of high local cell concentration into the unpopulated and 
proteolytically degradable surrounding material, driven by fibroblasts' innate mobility and 
cell-associated protease activity. 
Inspired by the elegance and ease of this assay to model tissue regeneration, Pratt et 
al.'s "fibrin drop assay" was also used in this work to evaluate cells' interaction with 
protein-graft-PEG hydrogels under various culture conditions. 
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MA TERIALS AND METHODS 
General Notes 
Well established techniques l47 were used for cultures of neonatal human foreskin 
fibroblast (hFFs, Clonetics(Cambrex) via BioWhittaker Europe, Belgium) of passage 
numbers up to 14. Unless otherwise noted, hFFs were cultured in Dulbecco's Modified 
Eagle Medium (DMEM, with 1000 mg/L glucose, 110 mg/L sodium pyruvate, 862 mg/L 
L-alanyl-L-glutamine) supplemented with 10% (I'iV) heat-inactivated fetal bovine serum 
and 1 X antibiotic-antimycotic (all Life Technologies, Scotland). 
Nickel-Affinity Surface Coating and Cell Adhesion Experiments 
By placing 100 flL of the appropriate coating solution (PBS, pH 7.9, with 8 M 
urea) per well, protein pentamers [AI or [B I adsorbed to Ni-NTA HisSorb 96-well plates 
(Qiagen) from solutions of the following concentrations: 0, 12.4, 24.8, 31, 37.2, 43.4, 
49.6, and 62 flg/mL for protein IAl and 0, 10.8, 21.6, 27, 32.4, 37.8, 43.2, and 54 
flg/mL for protein [B I. Binding of protein to the Ni++-coated well surfaces occurred over 
night at room temperature under gentle shaking. After rinsing twice with PBS containing 8 
M urea to remove unbound protein, and twice with PBS to remove the urea, the 96-wells 
were blocked with bovine serum albumin (Fraction V, Sigma A-9418, Switzerland) (3% 
mil' albumin in PBS, 100 flL/well, 2 hrs, 37 QC). After rinsing twice with PBS to remove 
any non-adsorbed albumin, 10000 hFFs were seeded per 96-well in serum-free cell culture 
medium and incubated at 37 QC, 5% CO2, -80% relative humidity for 1 hr. Cultures were 
terminated, and cells fixed, by gradual and careful exchange of the culture medium with 
formalin solution (10%, neutral buffered, Sigma). After 15 min of fixing, adherent hFFs 
were stained with Crystal Violet Stain (4.8 mg/mL Crystal Violet (Merck, Germany) and 
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1.6 mglmL NaCI in 33% ethanol, 1.12% fonnaldehyde) for 5-10 min, thoroughly rinsed 
with deionized HcO, and air-dried prior to microscopic analysis. Microscopy and image 
processing were perfonned using a Zeiss inverted confocal light microscope (Axiovert 135, 
Zeiss, Gennany) in conjunction with a Hamamatsu Color Chilled 3CCD Camera 
(Hamamatsu, Japan) and LeicaQWin image processing software (Leica Imaging Systems 
Ltd., 1997). Matrox Inspector 3.0 software (Matrox Electronic Systems Ltd., Dorval, 
Canada) was used to count the hFFs. 
Ni-NT A HisSorb 96-wells were coated with protein pentamer fA], from a solution 
of 0.6 mglmL. for competitive inhibition studies with soluble adhesion ligand, oligopeptide 
GRGDSP (soluble RGD, Calbiochem, USA), and for inhibition studies with heparin (from 
porcine intestinal mucosa, MW 16,000 - 18,000, 181 USP units/mg, Sigma H-9399, 
Germany). Serum-containing cell culture media with soluble RGD were prepared at 
concentrations of 0, 0.3, 3, IS, 30, 58, 110, ISO, 190, 23{), 270, and 300 11M soluble 
RGD. Similarly, cell culture media with heparin were prepared at concentrations of 0, 3, 
6, 30, 60, 600, 6000, and 60000 nM heparin by consecutive dilution. 
For all sets of data, at least two independent experiments, carried out in duplicate or 
triplicate, were perfonned and analyzed. 
Embedding and Culture of hFF-Fibrin Clusters Inside Protein-grafl-PEG 
Hydrogels 
Near-confluent cultures of hFFs were trypsinized (Trypsin-EDT A: 0.5 gIL trypsin, 
0.2 gIL EDTA, Life Technologies), centrifuged (700 g, 3 min, room temp.), and 
resuspended in 2% (mh') fibrinogen from human plasma (Fluka, Switzerland) in sterile 
PBS to a concentration of 30000 hFFs/l1L. To induce gelation of the hFF-fibrinogen 
suspension, thrombin (Sigma T -6884, Switzerland) and Ca++ were added to final 
concentrations of 2 NIH units/mL and 2.5 mM, respectively, and rapidly mixed with the 
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cell suspension. Prior to gelation, 2 ~L droplets containing approximately 60000 hFFs 
each were quickly transferred to Sigmacote®-coated (Sigma, USA) microscope slides, on 
which gelation of the hFF-fibrin clusters was allowed to reach completion in a humidified 
atmosphere at 37°C for 20 min. The hFF-fibrin clusters were embedded inside 30 ~L 
protein-grafi-PEG hydrogels by placing up to four of the clusters into a 30 ~I volume of 
10% (w+v) protein-grafi-PEGacrylate solution on the bottom of a 12-well tissue culture 
plate. 14·15169 Crosslinking of the protein-graft-PEGacrylate around the hFF-fibrin 
clusters was induced in situ by exposure to the portable light source through the culture 
well lid. The hFF-fibrin clusters, thus embedded inside the protein-Rn:dt-PEG hydrogels, 
were then cultured in the 12-well tissue culture plates after covering each gel with 1.5 mL 
serum-containing DMEM. For inhibition studies wth heparin, or heparin and soluble, linear 
RGD peptide, cell culture media with heparin from porcine intestinal mucosa (MW 16,000-
18,000, 181 USP units/mg, Sigma H-9399, Germany) were prepared at concentrations of 
n, 10, 100, and 500 ~g/mL heparin by consecutive dilution. For inhibition studies with 
additional soluble, linear peptide GRGDSP (soIRGD, Novabiochem), cell culture media 
with solRGD and heparin were prepared at concentrations of 0, 10, 100, and 500 ~g/mL 
heparin and constant 500 ~M solRGD each. During inhibition studies, the respective 
inhibitor concentrations were maintained for four days by daily exchanges of the cell 
culture medium with freshly prepared medium at the original inhibitor concentrations. 
Starting on day 5, however, the culture was continued with serum-containing DMEM 
alone. For competitive inhibition studies with cyclic RGD peptide, cell culture media with 
soluble cyclo(Arg-Gly-Asp-D-Phe-Val) peptide (cyclic RGDFV, Calbiochem, USA) were 
prepared at concentrations of 0, 7.2,28.7, and 143.4 ~M peptide by consecutive dilution, 
followed by pH adjustment with I N NaOH (negligible volumes). For inhibition studies 
90 
with aprotinin, a serine-protease inhibitor, cell culture media with bovine lung aprotinin 
(Calbiochem, USA) were prepared at concentrations of 0, 5, 20, and 50 j.lg/mL aprotinin. 
During inhibition studies, the respective inhibitor concentrations were maintained by daily 
exchanges of the old cell culture medium with freshly prepared medium at the original 
inhibitor concentrations. 
To measure the cell outgrowth from hFF-fibrin clusters into the surrounding 
protein-graff-PEG hydrogels, the clusters were imaged and recorded with their center plane 
in focus. To quantify the penetration depth of the outgrowth, the area of the original hFF-
fibrin cluster was measured in the center plane, as was the area of the hFF outgrowth, 
defined by the tips of the hFF branches in the center plane of focus. These two areas were 
approximated as circular areas, and their theoretical radii subtracted from each other to give 
an average hFF outgrowth length. To quantify the number of outgrowing hFF branches 
(hFF outgrowths), the perimeter of a cell cluster was measured in its center plane, and the 
number of hFF branches emerging from this perimeter were counted. Dividing one by the 
other gave the number of hFF outgrowths per 100 j.lm perimeter length. 
For all sets of data. at least two independent experiments. carried out in duplicate or 
triplicate, were performed and analyzed. 
RESULTS AND DISCUSSION 
Cell Adhesive Properties of Recombinant Protein Pentamers [A] and [B] 
Figure 5.1 reveals that hFFs adhered to surface-immobilized protein pentamer IAJ 
in a concentration dependent manner. Microscopy (Figure 5.I.A) further revealed an 
obvious enhancement in the degree of hFF spreading with increasing coating concentration 
of protein pentamer IAl. In contrast, hFF adhesion to surface-immobilized protein 
pentamer [B 1 remained at background levels at all coating concentrations (Figure 5. 1 . B). 
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These results suggest that the RGD motifs m recombinant protein pentamer [Al have 
specific integrin-binding capability and, thus, mediate the observed cellular adhesion and 
spreading. Recombinant protein pentamer [Bl, in which the RGD motif was changed to 
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(A) hFF adhesion after I h to surface-immobilized protein pentamer IAJ on circular Ni++-patterns in serum-
containing medium. Coating concentrations: a) 0 Ilg/mL. b) :i Ilg/mL. c) 20 Ilg/mL. d) 40 Ilg/mL protein 
pentamer IAJ. (Scale bar = :i00 11m) Note the enhanced cell spreading with increasing coating 
concentration. 
(B) Human fibroblast adhesion to surface-immobilized protein pentamers. V' Number of fibroblasts adhered 
to surfaces with recombinant protein pentamer [AJ. 0 Number of fibroblasts adhered to surfaces with 
recombinant protein pentamer 1 B J. Both in serum-ti'ce cell-culture medium. 
When soluble, linear GRGDSP peptide (soluble RGD) was added to the culture medium of 
wells coated with recombinant protein pentamer [A] and blocked with BSA, hFF adhesion 
to surface-immobilized protein pentamer [AJ was competitively inhibited with a half-
inhibition concentration (IC,o) of about 85 11M soluble RGD (Figure 5.2). This 
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observation is further evidence for the specific biological activity of recombinant protein 
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Figure S.2: Competitive Inhibition of hFF Adhesion to Recombinant Rrotein Pentamer [A] 
300 
(A) Competitive inhibition of hFF adhesion to surface-immobilized protein pentamer [AJ by solRGD in 
serum-containing medium. a) () IlM. b) 75 IlM. c) 150 IlM. d) 300 IlM sol RGD. (Scale bar = 200 Ilm) 
(B) Competitive inhibition of hFF adhesion to recombinant protein pentamer IAI as a function of soluble 
RGD concentration in serum-containing medium. Number of fibroblasts attached per cm' surface area 
coated with 0.6 mg/mL recombinant protein pentamer IAJ. 
When heparin was added to the culture medium of wells coated with recombinant protein 
pentamer lAl and blocked with BSA, hFF adhesion to surface-immobilized protein 
pentamer lAJ was inhibited with an IC 511 of about 3 nM heparin, and hFF attachment was 
suppressed to background levels at 30-60 nM heparin (Figure 5.3). 
Thus it could be that, in accordance with protein pentamer [Ars strong affinity for 
heparin, which was shown by heparin-affinity chromatography as described above, 
heparin (MW 16,000 - 18,(00) bound to the surface-immobilized protein pentamers' 
heparin-binding sites, and sterically hindered access of cell-surface integrins to the protein 
pentamers' RGD adhesion sites, as integrin binding would otherwise have enabled cell 
adhesion to the surface. It could also be that, in the conformation in which the RGD in the 
protein pentamer [Al is presented, both integrin receptor binding and binding of cell-
surface heparan sulfate proteoglycans are required simultaneously for effective cell 




Figure 5.3: Adhesion Inhibition by Heparin 
Inhibition of hrr adhesion to surface-immobilized protein pentamer [AJ by heparin in serum-containing 
medium. a) 0 nM, b) 3 nM, c) 30 nM. d) 60 nM heparin, (Scale bar = 500 IJm) 
hFF Outgrowth Into Hydrogel Matrix 
Day I Day 3 Day 4 
Day 6 Day 8 
Figure 5.5: Three-Dimensional hFF Outgrowth 
Three-dimensional hFF migration and apparent proliferation in a protein[ A ]-gratr-PEG( 6(00) hydrogel. 
Culture days I. 3,4, 5, 6. R, (Scale bar = 750 IJm) 
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Figure 5.5 illustrates that hFFs embedded in fibrin on day I, started to migrate 
three-dimensionally into the surrounding protein-graff-PEG hydrogel matrix after two days 
(day 3). The hFFs assumed an extended and branched morphology as they migrated into 
the gel materials, and this outgrowth occurred in both protein[A]-gr«/t-PEG(3400) and 
-PEG(6000) hydrogels (Figure 5.6). The highly branched nature of the hFF outgrowths 
suggests a proliferative mode of matrix penetration, i.e., simultaneous migration and 
proliferation, because to account for the abundance of cells, too many cells would have had 
to follow from the fibrin bed if no proliferation had occurred along with branching and 
further outgrowth. 
Figure 5.6: hFF Morphology and Proliferative Penetration Inside Protein-Rratt-PEG I-Iydrogels 
Three-dimensional hFF morphology in protein[AI-watt-PEG(3400) and -PEG(6000) hydrogels on culture 
day 8. The highly branched nature of the hFF outgrowths suggests that the cells engaged in a proliferative 
mode of penetration. i.e .. simultaneous migration and proliferation. (Scale bar = 100 /Jm) 
When individual hFFs were separated from their fibrin bed during placement into the 
protein-grajt-PEG solution prior to gelation, these individual cells also started to migrate 
through the hydrogel matrix (Figure 5.7) and connect with neighboring cells in their 
proximity (Figure 5.8). 
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Figure 5.7: Three-Dimensional Migration of Individual Cells 
Individual hFFs migrating three-dimensionally in a protein[Aj-graft-PEG(6000) hydrogel. as seen in 
identical internal hydrogel sections shown on culture days 6 and 7. However. as can be seen. not many 
cells survived when separated from the fibrin bed. or each other. during placement into protein-graft-PEG 
hydrogels. (Scale bar = 100 /Jm) 
Figure 5.8: hFFs Forming Three-Dimensional Intercellular Connections 
hFFs initially separated from the fibrin bed re-connected with cells in the hFF-fibrin cluster or other 
individual cells (culture day .5). (Scait: bars = I mm. 200 /Jm) 
hFF outgrowth from the fibrin bed as well as apparent proliferation (Figure S. 9). 
proceeded for 5-7 days, after which the combined effects of potential bulk hydrolysis of the 
hydrogel (at the acrylate esters), proteolysis, and the increasing inward tension caused by 
the hFFs led to the concentric collapse of the cellular outgrowth (Figure 5.5, day 8). 
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Figure 5.9: Apparent Cell Divisions Inside Protein-graft-PEG Hydrogels 
Entire histological section of a hFF-fibrin cluster (left) and partial close-up (right) with surrounding protein-
grafi-PEG hydrogel showing apparent cell divisions at high magnification. Note the high density of the 
protein-graft-PEG hydrogel that hFFs were invading. (Scale bars = 500 11m. 200 11m) 
The inward tension exerted by the hFFs was so strong that in some cases sections of the 
hydrogels near edges of cellular outgrowth started to fold back upon themselves (images 
not show). Note, for instance, the folds and furrows visible on the hydrogel surface on 
day 8 (Figure 5.5) as the cell outgrowth collapses. After days 10-14, when the hydrogels 
had been completely degraded by bulk hydrolysis and/or proteolysis, the hFFs formed 
perfect spheres of cells (Figure 5.IO.a), which were larger than the original hFF-fibrin 
clusters, further supporting the conclusion that hFFs did indeed proliferate in the system. 
hFFs survived near the surface of the spherical cluster for at least ten more days, as evident 
from hFF migration from the sphere's surface to the underlying tissue culture plastic 
(Figure 5.IO.b). 
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Figure 5.10: Dense hFF Sphere Formation 
hFF-sphere (left) and partial close-up (right) after degradation of the surrounding protein-grafT-PEG hydrogel 
on c1uture day 17. hFF spheres consisted of necrotic areas ncar the center and viahle cells near the surface as 
evident from hFFs that migrated from the sphere's surface onto the underlying TCPS. (Scale bars = I mm, 
200 11m) 
Comparison of the outgrowth from hFF-fibrin clusters into surrounding protein[Al-
gr(itf-PEG(3400) and -PEG(6000) gels (Figure 
5.11) underlines the importance of mechanical 
strength for sustainable cell outgrowth. 
Protein[Al-gr(ift-PEG(3400) gels most likely 
have a higher crosslink density than 
-PEG(6000) gels (with -11.3 mM vs. -8.S 
mM theoretical acrylate groups, respectively), 
even though their Young moduli, E pEC;3c)()() = 2.4 
- 3.1 kPa and E pE(;601l1l = 2.9 - 3.5 kPa, do not 
seem to differ greatly. Nevertheless, hydrolytic 
and/or proteolytic bulk degradation led to a 
faster loss of mechanical properties and a 
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Figure 5.11: hFF Outgrowth 
in I'rotein[A]-grafi-PEG(3400) and 
-PEG(6000) lIyclrogels 
7 8 
o hFF outgrowth (in 11m) in protein[A]-
gratT-PEG(3400) hydrogels. /.) hFF 
outgrowth (in 11m) in protein[AJ-grafT-
PEG(6000) hydrogels. 
gratf-PEG(6000) hydrogels than in -PEG(3400) hydrogels. Initial outgrowth of hFFs 
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was only slightly faster in the protein[Ah,'rajt-PEG(6000) gels, possibly because their 
lower crosslink density permitted faster enzymatic degradation by advancing hFFs and, 
therefore, enabled faster cell migration. 
Inhibition of Three-Dimensional hFF Outgrowth by Heparin and solRGD (linear) 
in Protein-grait-PEG Hydrogels. 
When only heparin was added to cultures of hFFs inside protein-graft-PEG 
hydrogels, complete inhibition of three-
dimensional outgrowth occurred at a 
concentration of 500 Ilg/mL heparin, while 
virtually uninhibited outgrowth was still 
observed at 100 flg/mL heparin (Figure 
5.12 and Figure 5.13.A.c). In contrast, in 
the presence of 300 flg/mL solRGD 
peptide, significant inhibition (p ::;: 0.021) 
of hFF outgrowth by heparin already 
occurred at 10 flg/mL heparin (Figure 5.12 
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Figure 5.12: Inhibition of hFF Outgrowth 
Inhibition of three-dimensional hFF outgrowth by 
solRGD peptide Icircle]. heparin alone Isquarel. and 
heparin plus constant 300 Ilg/mL solRGD peptide 
Idiamondl. 
In cultures where complete inhibition of hFF outgrowth by heparin or heparin plus solRGD 
peptide had occurred. the hFF clusters contracted dramatically, leaving a void volume that 
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Figure 5.13: Inhibition of hPP Outgrowth by Heparin and solRGD Peptide 
Inhibition by heparin and solRGD peptide of outgrowth from hFF-fibrin clusters into surrounding protein-
grafi-PEG hydrogels. shown on day 4. 1\: a) 0 iJg/mL. b) 10 iJg/mL. c) 100 iJg/mL. d) 500 iJg/mL 
heparin alone. 
B: all with 300 iJg/mL solRCiD and a) () iJg/mL. b) 10 iJg/mL. C) 100 iJg/mL. d) 500 iJg/mL heparin. 1\ 
and 13: e) same cluster as d). after six more days of culture without inhibitors 
By day eleven, i.e., after six days of culture in the absence of inhibitors heparin and 
solRGD peptide, abundant outgrowth occurred even from hFF clusters whose outgrowth 
had been completely inhibited until day 4 (Figure 5.13, day II). This proves that 
inhibition of outgrowth and contraction of the hFF clusters was not due to toxicity and cell 
death. Instead, at 500 Ilg/mL heparin, so much heparin was binding to the heparin-binding 
sites in the hydrogel matrix that all cellular adhesion to the matrix was blocked, and cell-cell 
adhesions became so dominant for lack of adhesion to the surrounding hydrogel that the 
hFF clusters contracted so dramatically. At high concentrations, therefore, heparin alone 
not only seems to block cell-surface proteoglycan binding to the hydrogel matrix, but also 
seems to mask, or sterically hinder access by cell-surface integrins to. the RGD sites 
present in the hydrogel matrix. When 300 Ilg/ml solRGD peptide are present in the 
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system, much lower concentrations of heparin are necessary to achieve inhibition of hFF 
outgrowth, because solRGD competitively inhibits integrin-mediated cell attachment to the 
hydrogel matrix. However, solRGD alone does not completely inhibit hFF outgrowth up 
to concentrations of 500 I1g/ml (850 11M) soIRGD. The cooperative effect of heparin 
seems to be necessary to mask a sufficient number of integrin-binding sites in the matrix in 
addition to blocking proteoglycan-mediated cell adhesion. Although it was previously 
shown that only 143.4 11M of a cyclic RGD peptide (cyclo RGDFV), which blocks 
integrin-binding much more strongly 170, 171, completely inhibited three-dimensional hFF 
outgrowth in identical protein-grajt-PEG hydrogels, it is not surprizing that linear solRGD 
did not fully inhibit outgrowth even at 850 11M, considering that the concentration of RGD 
motifs in a 10% (W+1') protein-graft-PEG hydrogel is about 4000 11M (after 200% 
swelling). While the presence of solRGD evidently augmented the inhibitory effect of 
heparin on hFF outgrowth in protein-grafl-PEG hydrogels, masking or sterical hindrance 
by heparin was necessary to render solRGD sufficiently inhibitory at all. By varying the 
concentrations of, both, heparin and soIRGD, it might be possible to find concentrations of 
solRGD peptide that are competitively inhibitory to hFF outgrowth at only minimal 
concentrations of heparin. However, small concentration of heparin bound to heparin-
binding sites in the hydrogel matrix might initially promote cell attachment and outgrowth, 
as heparin can immobilize cell-secreted growth factors and extracellular matrix proteins in 
the hydrogel which might provide additional adhesion sites and trophic stimuli favorable to 
cell migration. matrix penetration and, thus, three-dimensional outgrowth. 
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Competitive Inhibition of hFF Outgrowth by Cyclic RGDFV Peptide 
When cyclic RGDFV was added to the cell culture medium, cyclic RGDFV-
concentration dependent inhibition of cell outgrowth from hFF-fibrin clusters into the 
surrounding protein-gr«ft-PEG matrix was observed (Figure 5.14). 
A 
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Figure 5.14: Inhibition of hFF Outgrowth by Cyclic RGOFY. 
a) Representative images of outgrowth from hFf<-fibrin clusters into protein[Al-gratt-PEG hydrogels on 
day:; in the presence of A) 0 /lM. B) 7.2 /lM. C) 28.7 /lM. 0) 143.4 /lM cyclic RGDFY in serum-
containing media. (Scale bar = 500 /lm) 
b) Amount of hFf< outgrowth as a function of cyclic RGDFY concentration measured in terms of cell 
outgrowths per 100 /lm perimeter length of the original hFF-fibrin cluster. 
Both the abundance of hFF outgrowth as well as hFF penetration depth into the 
surrounding protein-graft-PEG hydrogel was dramatically decreased with an IC50 of about 
20 !lM cyclic RGDFV, and outgrowth was completely suppressed at maximally 143 !lM 
cyclic RGDFV (Figure 5.14.b). Analogous to competitive inhibition of cell adhesion to 
surface-immobilized protein pentamer rAJ (Figure 5.2) with soluble RGD peptide, cyclic 
RGDFV potently blocks cell-surface expressed integrinsl70171 and thus, even in three-
dimensional culture, competitively prevented their binding to RGD sites in the protein-
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graft-PEG matrix. This suggests that in the case of uninhibited outgrowth within protein-
graji-PEG hydrogels, RGD-mediated integrin binding was indeed a relevant and, in fact, 
necessary mode of hFF attachment to the protein-graji-PEG hydrogels, as had been 
intended by the original material design by the incorporation of RGD adhesion sites into the 
protein-graft-PEG matrix. Binding of cell-surface proteoglycans to the heparin-binding 
sites in the matrix might also have contributed to hFF attachment and migration, but 
without RGD-mediated integrin binding, proteoglycan-based binding was not sufficient to 
sustain hFF outgrowth in the protein-graji-PEG hydrogels. 
Inhibition of hFF Outgrowth by Aprotinin, a Serine-Protease Inhibitor 
When bovine lung aprotinin was added to the cell culture medium, aprotinin-
concentration dependent inhibition of cell outgrowth from hFF-fibrin clusters into the 
surrounding protein-gn:{ft-PEG matrix was observed (Figure 5.15.a,b). 
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Figure 5.15: Inhibition of hFF Outgrowth by Aprotinin 
a) Representative images of outgrowth from hFF-fibrin clusters into protein[A)-graft-PEG hydrogels on 
day 6 in the presence of 1\) 0 }Jg/mL. H) ) }Jg/mL. C) 20 }Jg/mL. D) )0 }Jg/mL aprotinin in serum-
containing media. (Scale har = )00 }Jm) 
b) Amount of hFF outgrowth as a function of aprotinin concentration measured in terms of cell outgrowths 
per 100 }Jm perimeter length of the original hf<F-fihrin cluster. 
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At concentrations up to 20 f.lM aprotinin, primarily the abundance of hFF outgrowth was 
dramatically reduced, but at 50 f.lM aprotinin also the average penetration depth of the few 
existing hFF outgrowths was reduced. These results show that cell-derived serine-protease 
activity (such as activation of plasminogen and induction of fibrinolysis) is the relevant 
mode of matrix penetration of the protein-f,'raft-PEG hydrogels. 
To verify further that the plasmin degradation sites m protein[AI-f,'rajt-PEG 
hydrogels were the only cleavage sites responsible for cell-associated proteolysis during 
cell migration, it would have been useful to have protein[B J-gr(ift-PEG hydrogels 
containing the point-mutated plasmin degradation sites in the protein backbone. However, 
the relative insolubility of protein[B]-graft-PEGacrylate, designed to demonstrate this, 
illustrated that it was not possible to remove the plasmin substrate sites and alter the RGD 
sites without causing associated physicochemical changes in the protein and gel character. 
Due to the anticipated mechanical and charge differences between protein[B]- and 
protein[AJ-grafi-PEG hydrogels, a different microstructure and generally different cellular 
behavior would have to be expected. The inhibition studies with cyclic RGD and aprotinin, 
therefore, serve as alternative, and perhaps more meaningful, negative controls for cell 
adhesivity and serine-protease degradability of proteinlA I-graft-PEG hydrogels, 
respectively, without the complexities of differences in the physical properties of the gels 
due to sequence alterations. 
CONCLUSION 
Cell survival, spreading, migration, and proliferation in three dimensions require 
sufficient mechanical support as well as specific sites for cellular attachment and proteolytic 
remodeling. The present materials provide these features, based on an artificial protein 
backbone and covalent crosslinking via PEG-tethered acrylate groups for polymerization. 
104 
The fact that hFFs survived, spread, and migrated through these materials in a manner that 
depended on RGD ligation and plasminogen activation demonstrates this. The cell 
adhesion sites and plasmin substrate sites are provided within the protein backbone of the 
protein-graft-PEGacrylate precursor, as well as sites for attachment of the PEG acrylate to 
that backbone. Photoinitiated polymerization of the acrylates at the termini of the dangling 
PEG chains provides for covalent gelation. A heparin-binding domain was further 
incorporated into this construct, for use in future studies.1l99o These materials may be 
useful in wound healing and tissue regeneration, situations in which cell migration from a 
periphery into the core of an implanted matrix is desirable. In such cases, degradation 
should occur in exact temporal synchrony with cell outgrowth and be localized to the site 
and direction of cellular outgrowth. Therefore, degradation should be cell-associated and 
cell-controlled, avoiding any bulk degradation which would cause the general loss of the 
very matrix that the cells need for attachment and overall mechanical support. The hFF 
migration and apparent proliferation observed inside the protein-graff-PEG hydrogels, and 
the inhibition of these cellular functions by the serine protease inhibitor aprotinin. provides 
clear evidence that the biosynthetic matrix presented was specifically degradable in a 
localized manner by cell-associated proteolysis, as it was originally designed to be by 
incorporation of two plasmin degradation sites from human fibrinogen. It would thus 
appear that the design objectives for a biosynthetic extracellular matrix have been achieved 
by artificial protein-grcdt-PEG hydrogels: The matrix was cell adhesive, degradable by 
specific cell-derived enzymatic activity. and had sufficient mechanical strength to support 
cellular outgrowth for at least 7-9 days in "ifm, which is a relevant time scale for many 
healing processes. The immunologic properties of the matrix remain to be tested, but 
considering that human sequences were selected in construction of the hydrogels' protein 
component, and in light of the well-established immunocompatibility of PEG,128 the 
challenge of immunoacceptability may not be daunting. 
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CHAPTER 6 
EFFECT OF HEPARIN ON CHICK NEURITE OUTGROWTH ON 
PROTEIN-grafl-PEG HYDROGELS 
INTRODUCTION 
The ultimate goal of the protein-gr«ft-PEG hydrogel material described in Chapters 
4 and 5 was to be used as a matrix for nerve regeneration. The general material 
requirements that were demonstrated by the hFF-fibrin cluster model system, namely 
appropriate mechanical strength, integrin- and proteoglycan-mediated cellular adhesivity 
and cell-associated degradability in spatial and temporal synchrony with cellular outgrowth, 
also need to be fulfilled by a material that is intended to support neurite outgrowth inside a 
nerve guide tube. However, while it was possible to achieve hFF outgrowth with a 
minimal set of matrix components that enabled integrin- and cell-surface proteoglycan 
binding to the matrix, Chapter 2 illustrated that nerve cells are more complicated and require 
additional signals for outgrowth or even mere attachment. While the permanent presence of 
the RGD motif in the proteinfAJ-gr«ft-PEG gels provides binding sites for many integrin 
receptors, some of which are ubiquitously expressed, including in the peripheral nervous 
system,24 the heparin-binding site in the hydrogel's protein backbone makes it possible to 
immobilize additional adhesion- and/or trophic factors. As was briefly mentioned in 
Chapter 5, this can be achieved by taking advantage of the matrix's affinity for heparin, as 
heparin can serve as a "bridge" for the immobilization of additional biological factor(s). 
This binding scheme, involving heparin as a linker or "heparin bridge" between two 
heparin-binding sites, is illustrated in Figure 6.1. 
MGSSHHHHHHSSGLVP!""" 
t hrombil 
eel adhesion motif 
or 
growth facto r 
+ ++ 
A~KLAARLYRKA 
Figure 6.1: "lIeparin Bridge" Immobilization Scheme 
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Cell adhesion molecule or growth factor bound by a "heparin bridge" to the pentameric protcin core of 
protein-graft-PEG hydrogels (n = .'i). III1IIHHH is the protein's thrombin-cleavable hcxa-histidinc tag used 
for Ni++-affinity purification; RCiD is the fibrinogen-based integrin-binding site; and KAFAKLAARL YRKA 
is an ATIlI-based heparin-binding site. Also shown are the protein pentamer's thrombin and plasmin 
cleavage sites as well as the protein construct's thiol functional groups that were used for grafting PHG 
diacrylate. I;inally. - - - indicates the highly negatiw charge of heparin. and + marks the positive charge of 
amino acids that arc part of the protein pentamer's heparin-binding site. 
In addition to heparin's intended role as an immobilization agent for exogenous heparin-
binding factors. even without any further additions immobilized heparin is expected to have 
growth-promoting effects in an artificial matrix. as cells secrete extracellular matrix 
components and growth factors that require immobilization by heparin or other 
glycosaminoglycans in order not to diffuse away. In fact. results with the protein-grafi-
PEG system presented in this chapter indicate that matrix-bound heparin alone was 
necessary to elicit surface outgrowth of neurites on the hydrogels. while additional factors 
such as the hep.bind.-YIGSR peptide had no further beneficial effect. 
Before elaborating on the heparin-dependent two-dimensional neurite outgrowth on 
protein-grafi-PEG hydrogels. this chapter will describe and analyse the many unsuccessful 
attempts to elicit three-dimensional neurite outgrowth inside protein-graft-PEG matrices 
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using various medium formulations and additions, different neuronal cell types, and even 
different ways of embedding or juxtaposing neuronal cells to photopolymerized hydrogels. 
BACKGROUND 
DRG Assay 
In adult vertebrates, dorsal root ganglia (DGRs) lie within the vertebral column 
immediately adjacent to the spinal cord. In day 8 chick embryos, DRGs can be dissected 
easily because of their relatively large size (d ~ 500 f.lIn), incomplete nerve fiber 
development, and because all embryonic tissues, including adjacent bone, are still very soft 
and penetrable. DRG neurons relay information from skin, muscles, and joints of the 
limbs and trunk to the spinal cord. They are sensory cells that belong to the class of 
pseudo-unipolar neurons, whose axons have a central and a peripheral branch. 129 NGF 
strongly promotes neurite outgrowth from DGRs onto, or within, permissive substrates 
such as laminin, or fibrin, respectively. Such NGF-induced neurite outgrowth served as 
an assay and model system in the context of this study. In particular, the physiological 
similarities between embryonic nerve development and adult nerve regeneration after injury 
render embryonic neurons especially useful to test a material for its neuroinductive, 
neuroconductive, and degradative qualities, all essential features toward improvement of 
functional nerve regeneration. 
PC12 Cells 
The PC 12 cell line was deri ved from a transplantable rat adrenal 
pheochromocytoma. 172 PC 12 cells represent a single cell clonal line which responds 
reversibly to nerve growth factor (NGF). By one week's exposure to NGF, PC12 cells 
cease to multiply and begin to extend branching varicose processes similar to those 
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produced by sympathetic neurons in primary cell culture. By several weeks of exposure to 
NGF, the PC 12 processes reach 500-1000 11m in length under suitable culture conditions. 
Removal of NGF is followed by degeneration of processes within 24 hr and by resumption 
of cell multiplication within 72 hr.173 NGF prevents the death and stimulates the neuronal 
differentiation of PC 12 cells in serum-free medium. 174 
Because of their ease of handling and inducible neuron-like behavior, PC 12 cells 
were used to test the neuroinductive, neuroconductive, and degradative qualities of protein-
graft-PEG hydrogels. In particular, the hope was that PCl2 cells in the presence of NGF 
would attach to, degrade, and extend neuritic processes inside protein-graff-PEG 
hydrogels, thereby verifying the material's intended functions in a neuronal context. 
MA TERIALS AND METHODS 
Peptide Synthesis 
Peptides a-dansyl-LN-KAF(6A)KLAARL YRKA-N-DPGYIGSR-CONH~ (hep.bind.-
YIGSR, mol. mass 3027.5 Da) and a-dansyl-LN-KAF(6A)KLAARLYRKA-G-RGD-
SPASS-CONH, (hep.bind.-RGD, mol. mass 2882.3 Da) were made with a "Pioneer" 
peptide synthesizer (Applied Biosystems, USA) by automated solid phase peptide 
synthesis using 0.4 g peptide amide resin (NovaSyn TGR, Novabiochem-Calbiochem AG, 
Switzerland) per peptide. Synthesis occurred by standard 9-fluorenyl-methyloxycarbonyl 
(Fmoc) chemistry,1l9 using solvents from Applied Biosystems (Warrington, England) and 
all other reagents from Novabiochem-Calbiochem. After synthesis, the peptide resin was 
washed with MeOH and dried in a vacuum overnight. Peptides were cleaved from the 
resin and deprotected for 4 hrs by shaking the resin in 10 mL of a solution containing 8.8 
mL trifluoroacetic acid (TFA, Fluka, Switzerland), 0.5 mL phenol (Aldrich), 0.2 mL 
triisopropylsilane (Aldrich), and 0.5 mL water. The resin was removed by vacuum 
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filtration through fritted glass funnels and washed with 5 reSIn volumes of TFA. 
Precipitation of the peptides occurred when the filtration flow-through was added drop-
wise to chilled diethyl ether (-400 mL). The white precipitate was recovered by vacuum 
filtration (0.2 11m pore-sized PTFE membrane filters. Gelman Sciences) and washed with 
three -50 mL portions of diethyl ether. The final filtrate was dried in a vacuum chamber 
overnight and then sealed under argon for temporary storage at -20°C. 
Peptides were purified by preparative C IR chromatography (Prep Nova-Pak 19 x 
300 mm column; Waters. USA) using a BioCAD 700E chromatograph (PerSeptive 
Biosystems). Separation of peptides from impurities was achieved by applying a gradient 
of acetonitrile in 0.1 CJc TFA. The resulting eluate fractions were freeze-dried and analyzed 
by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass 
spectroscopy using the "Voyager Elite 122" spectrograph (Applied Biosystems. USA) and. 
as MALDI matrix. alpha-cyano-4-hydroxycinnamic acid (Aldrich). Before storage at -20 
0C. verified and identical peptide fractions were combined. dried in a vacuum chamber 
overnight and finally sealed under argon for storage. 
Heparin-Affinity Chromatography with Heparin-Binding Adhesion Peptide 
0.5 g heparin-agarose beads (bead size 50-150 11m. 5-7 mg heparin per milliliter 
gel; AppliChem AI4XI, Germany) were pre-swollen in PBS (0.2 gIL KCI, 0.2 gIL 
KH 2POj • 2.16 giL Na2HP04·7Hp, X gIL NaCI, pH 7.4) for I h at room temperature. 
poured into a chromatography column. and allowed to settle to yield a bed of heparin-
agarose gel of approximately I mL. 0.75 mg of hep.bind.-YIGSR in I mL PBS with and 
without 9.13 mglmL heparin from porcine intestinal mucosa (MW 16,000-1 X.OOO, I X I 
USP units/mg. Sigma H-9399. Germany) was applied to the heparin-agarose gel and 
allowed to bind for 15 min at room temperature and zero column flow. The column was 
then drained. and chromatography was performed with seventeen consecutive I mL 
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washes of PBS containing increasing amounts of NaCI, starting with the original 137 mM 
of PBS up to 2 M in steps of I 10 mM NaCI. The flow-through fractions were collected 
separately and analysed by 200C polyacrylamide SDS-PAGE for the presence of hep.bind.-
YIGSR peptide. 
Rheological Characterization of Protein-graft-PEG(6000) Hydrogels Containing 
Heparin 
A Bohlin Instruments CVO 120 High Resolution rheometer (Bohlin Instruments. 
United Kingdom) was used in combination with a portable Cermax Xenon Fiber Optic 
Light Source to obtain dynamic rheological measurements of protein-graft-PEG hydrogels 
formed ill situ in a circular parallel plate geometry. The light source was installed 
underneath a glass plate serving as the fixed bottom surface, while a circular parallel plate 
with radius 10.0 mm was rotating in oscillatory mode atop 30 !lL of a I00C (m+\') 
protein fA l-grajf-PEG(6000)acrylate solution throughout the measurement. imposing a 
target shear strain of 0.05 at a frequency of I Hz and with an initial shear stress of I Pa. 
The solutions further contained 2.X3 mg/mL heparin or no heparin. The distance between 
the bottom glass surface and the circular parallel plate was 95 !lm. After allowing the phase 
angle of the solution to stabilise for 1-2 min, the light source was switched on at designated 
time = 0 and allowed to irradiate the sample for the entire duration of the rheological 
measurement. For the two conditions (i.e .. with and without heparin) two measurements 
each were performed on two samples that were prepared identically (n=2). but due to 
material constraints the measurements have not been repeated independently. 
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Preparation of Neural Culture Medium (NCM) 
Unless otherwise stated, the composition of the medium for culture experiments 
with whole mouse or chick dorsal root ganglia (DRGs), dissociated chick DRG cells, and 










NeurobasaFM Medium 175 (Gibco 21103-031) 
N2 Supplement176 (lOOX) (Gibco 17S02-0 14) 
Albumin From Bovine Serum (Sigma A-9418) 
ABAM (Gibco IS240-(62) 
0.1 % Fibronectin Solution (Sigma F-1141) 
L-Glutamic Acid (2mg/mL) (GibeD 12419-(16) 
Glutamax I (I OOX) (Gibco 3S0S0-020) 
Nerve Growth Factor (7S-NGF) From 
Mouse Submaxillary Glands (20 f.lg/mL) (Sigma N-OS 13) 
further additions: 
(as indicated) 
Mouse Laminin (from frozen aliquots of I mg/mL, Sigma L-2020) 
Bovine Aprotinin (from 2 mg/mL in PBS; Calbiochem, USA) 
Plasmin (from frozen aliquots of 0.3 mg/mL, Sigma P-8644) 
Note: N-2 Supplement (lOOX) contains the following components: 
Bovine Insulin (SOO f.lg/mL) 
Human Transferrin (holD) (10 mg/mL) 
Progesterone (0.63 f.lg/mL) 
Putrescine (1611 f.lg/mL) 
Selenite (0.S2 f.lg/mL) 
Neither NeurobasaITM Medium nor N-2 Supplement contain any cell adhesion proteins such 
as fibronectin, laminin, collagen, or fibrinogen. 
The medium was prepared by dissolving the albumin in the NeurobasaFM Medium 
and then adding all additional components except NGF. NGF was added after sterile-
filtering the medium (0.22 f.lm pore-sized cellulose acetate sterile filter unit, Coming). 
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RPMI 1640 with GlutaMax II (Gibco 82400-(29) 
Heat-Activated Horse Serum (Gibco 26050-(88) 
Foetal Bovine Serum (Gibco 10 I 06-169) 
ABAM (I00X) (Gibco 15240-(62) 
Dissection of Chick Dorsal Root Ganglia (DRGs) 
Day 8 chick embryos (or day 9 chick embryos. when stated) were taken from 
Lewis Brown chicken eggs. DRGs were dissected according to standard protocols 
described elsewhere l47 and then kept in a small petri dish with NCM at 37°C for up to 30 
min until further processing. 
Dissection of Mouse DRGs 
Mouse DRGs were dissected from neonatal (PO) mIce (I: I hybrids of strain 
C57BL/6:FYB. kindly provided by Hasan Mohajeri of the Brain Research Institute. 
University of Zurich) and then briefly stored in NCM according to the same protocol that 
was followed for embryonic chick DRGs. 
Embedding and Culture of Whole DRGs Inside Protein-grafl-PEG Hydrogels 
Mouse or chick DRGs were embedded inside 30 !lL protein-gr~ft-PEG(3400) or 
-PEG(6000) hydrogels by placing up to four DRGs directly into a 30 !ll volume of 
initiator-containing 10% (m+l') protein-grafi-PEGacrylate solution on the bottom of a 12-
well tissue-culture plate. Photopolymerization of the protein-graJt-PEGacrylate around the 
DRGs was induced ill situ according to the same method used for hFF-fibrin clusters 
(Chapter 5). The DRGs. thus embedded inside the protein-graft-PEG hydrogels. were 
then cultured in the l2-well tissue-culture plates after covering each gel with 1.5 mL NCM. 
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Independent additions to the IOCJc (111+ I') protein-grct/t-PEG(6000)acrylate solutions 
prior to gelation included the following: 
2, 20, and 200 flg laminin per mL protein-graft-PEG hydrogel before swelling -7 with 
the intent to entrap laminin and thereby provide native neural adhesion sites within the 
matrix; this was intended as a positive control for neurite outgrowth in the protein-
gr(lft-PEG material. 
2.83 mglmL heparin (16-18 kDa) and 20 flg/mL laminin -7 with the intent to 
immobilize laminin, which has heparin-binding sites,324748 by immobilization via the 
heparin-binding scheme illustrated in Figure 6.1. 
2 flg/mL human plasminogen (Boeringer Mannheim/Roche) with and without 5 flg/mL 
bovine lung aprotinin -7 Plasminogen was added with the intent to eliminate low 
plasminogen concentrations as a limiting factor for proteolytic matrix degradation, 
Aprotinin was added to ensure that plasmin diffusion would not lead to bulk 
degradation of the matrix, 
O.5'/r (Ih') embryonic chick extract -7 to provide other (growth) factors -in addition to 
those contained in the NCM- that contribute to neurite outgrowth from embryonic chick 
DRGs, However, an undefined addition such as chick embryo extract also entailed the 
risk of introducing factors inhibitory to neurite extension, 
(i) no additions, (ii) 0.28 mglmL heparin (16-18 kDa) and 0.05 mg/mL hep,bind.-
YIGSR, (iii) 1.42 mg/mL heparin and 0,25 mglmL hep,bind.-YIGSR, (iv) 2.83 
mg/mL heparin and O.S mg/mL hep.bind.-YIGSR, (v) 28,3 mg/mL heparin and S 
mg/mL hep.bind.-YIGSR -7 with the intent to immobilize additional neuronal adhesion 
sites within the matrix using the heparin-binding scheme. Note that 2,83 mg/mL 
heparin corresponded to an amount equal to I molecule of heparin per 62 heparin-
binding sites in the unswollen protein-gr«ft-PEG(3400) hydrogels. Adhesion peptides 
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and heparin were added in equimolar amounts to ensure, in theory, binding of all 
adhesion peptides by heparin. The paired additions of heparin and hep.bind.-YIGSR 
will be referred to in terms of '"number of heparin and number of hep.bind.-YIGSR 
molecules per number of heparin-binding sites," i.e., "0, I per 500, I per 100, I per 
50, I per 5." Presumably due to the instantaneous and strong affinity of hep.bind.-
YIGSR for heparin when these two additions were present, a white precipitate became 
visible at concentrations greater than, and sometimes equal to, "1 per 50." 
Nevertheless, such suspensions were used after good mixing, and precipitates often 
disappeared after the addition of further constituents. 
(i) no additions. (ii) 0.208 mg/mL heparin (5 kDa, kindly provided by Pharmacia 
Upjohn, USA) and 0.126 mg/mL hep.bind.-YIGSR peptide. (iii) (Un3 mg/mL 
heparin (5 kDa) and 0.505 mg/mL hep.bind.-YIGSR peptide, or (iv) 1.04 mg/mL 
heparin (5 kDa) and 0.631 mg/mL hep.bind.- YIGSR peptide (corresponding to (i) 0, 
(ii) "I per 200." (iii) "I per 50," and (iv) "I per 40" heparin and hep.bind.-YIGSR 
molecules per heparin-binding sites in the gel before swelling) -7 the use of heparin 
with smaller molecular mass assured better solubility of the heparin in the presence of 
hep.bind.-YIGSR peptide. so more of both could be incorporated in the hydrogels, 
i.e .. up to I heparin and hep.bind.-YIGSR molecule per 40 heparin-binding sites in the 
gel. Also, smaller heparin molecules were less likely -should that have been a problem 
at all- to bind to the hydrogel matrix and block or mask other signals in the hydrogel 
matrix. i.e., integrin-binding RGD sites or plasmin degradation sites. 
Other variations in the attempt to elicit three-dimensional neurite outgrowth from chick 
DRGs embedded in protein-grafi-PEG(6000) hydrogels included the following: 
using day 9, instead of day 8. chick embryonic DRGs -7 Day 9 DRGs were expected 
to be more robust and to contain cells more differentiated toward their neuronal fate. 
TIle hope was that even in an unusual environment such as protein-grafi-PEG 
hydrogels. neurite extensions could be achieved from more differentiated neurons. 
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using 8% (m+l') protein-graft-PEG(6000) hydrogels -7 to test whether hydrogels that 
are less dense and less crosslinked might allow better proteolytic penetration and, 
therefore, facilitate neurite outgrowth. However, this also potentially makes possible 
non-proteolytic penetration of the matrix, i.e., if penetration was merely through 
channels and defects in the gel, which are more abundant the less dense the matrix is. 
using modified DMEM/F12 medium (Gibco 41331-026) with: 
1% (1'/1') insulin - transferrin - selenium supplement (I OOX) (Gibco 51300-(44) 
1% (1'11') ABAM (lOOX) (Gibco 15240-(62) 
OSlo (1,11') chick embryo extract, 60A ultrafiltrate (Gibco 16460-(57) 
-7 to provide an alternative to NCM so as to exclude the possibility that NCM was deficient 
or scarce in some essential component, which relatively "rich" modified DMEM/F12 was 
less likely to be. However, once again, an undefined addition such as chick embryo extract 
also entailed the risk of introducing factors inhibitory to neurite extension. 
DRGs were also embedded in 10% (m+1') protein-gr«ft-PEG(3400) gels under 
various conditions with the hope to provide DRGs with a more densely crosslinked matrix 
that would assure better mechanical support, in case the lower mechanical strength or lesser 
degree of crosslinking of protein-grqft-PEG(6000) hydrogels should have been insufficient 
in supporting three-dimensional neurite outgrowth. Independent additions to the 10% 
(m+l') protein-g]'(~ft-PEG(3400)acrylate solutions prior to gelation included the following: 
2. 20, and 200 !Jg laminin per mL protein-graft-PEG hydrogel before swelling -7 with 
the intent to entrap laminin and thereby provide native neural adhesion sites as in A. 
2.83 mg/mL heparin (16-18 kDa) and 20 !Jg/mL laminin -7 with the intent to 
immobilize laminin. which has heparin-binding sites,3247411 by immobilization via the 
heparin-binding scheme as in B. 
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2.83 mg/mL heparin (16-18 kDa) and 0.5 mg/mL hep.bind.-YIGSR -7 with the intent 
to immobilize additional binding sites within the matrix using the heparin-binding 
scheme as in E. Note that these amounts correspond to I heparin and I hep.bind.-
YIGSR molecule per 62 heparin-binding sites in the gel before swelling. 
Embedding and Culture of DRG-Fibrin Clusters Inside Protein-grafl-PEG 
Hydrogels 
2-4 ilL droplets of 2% (mh') fibrinogen from human plasma (Fluka, Switzerland) 
in sterile PBS containing 2 NIH units/mL thrombin (Sigma T-6884, Switzerland) and 2.5 
mM Ca++ were quickly placed onto Sigmacote®-coated (Sigma, USA) microscope slides. 
Using dissection tweezers, individual DRGs were rapidly transferred into these 2-4 ilL 
droplets of fibrinogen solution. Fibrinogen crosslinking occurred around the DRGs after 
incubation in a humidified atmosphere at 37°C for 20 min. The DRG-fibrin clusters were 
embedded inside 30 f.lL protein-graft-PEG(3400) and -PEG(6000) hydrogels by placing 
up to three clusters into a 30 f.ll volume of 10% (m+l') protein-gr~ft-PEGacrylate solution 
on the bottom of a 12-well tissue-culture plate. Crosslinking of the protein-graft-
PEGacrylate around the DRG-fibrin clusters was induced in situ by exposure to the 
portable light source through the culture-well lid. The DRG-fibrin clusters. thus embedded 
inside the protein-graft-PEG hydrogels, were then cultured in the 12-well tissue-culture 
plates after covering each gel with 1.5 mL NCM. 
Embedding and Culture of Dissociated DRG Cell-Fibrin Clusters Inside Protein-
graft-PEG Hydrogels 
DRGs were dissociated by incubation at 37°C with trypsin-EDTA for 5 mm 
followed by gentle trituration with a I mL plastic pipette tip. The dissociated DRG cells 
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were centrifuged (700 g, 3 mm, room temp.) and resuspended in 2% (mil') fibrinogen 
from human plasma (Fluka, Switzerland) in sterile PBS to a concentration of -6000 DRG 
cells/f.lL. To induce gelation of the DRG cell-fibrinogen suspension, thrombin (Sigma T-
6884, Switzerland) and Ca++ were added to final concentrations of 2 NIH units/mL and 2.5 
mM, respectively, and rapidly mixed with the cell suspension. Prior to gelation, 2 f.lL 
droplets containing approximately 12000 DRG cells each were quickly transferred to 
Sigmacote®-coated (Sigma, USA) microscope slides, on which gelation of the DRG cell-
fibrin clusters was allowed to reach completion in a humidified atmosphere at 37°C for 20 
mm. The DRG cell-fibrin clusters were embedded inside 30 /1L protein-Rrafi-PEG 
hydrogels by placing up to four of the clusters into a 30 /11 volume of 10% (m+l') protein-
gr«fi-PEGacrylate solution on the bottom of a 12-well tissue-culture plate. Crosslinking of 
the protein-graft-PEGacrylate around the hFF-fibrin clusters was induced in situ by 
exposure to the portable light source through the culture well lid. The dissociated DRG 
cell-fibrin clusters, thus embedded inside the protein-Rr«ft-PEG hydrogels, were then 
cultured in the 12-well tissue-culture plates after covering each gel with 1.5 mL NCM. The 
protein-grajt-PEG hydrogels contained (i) 1.42 mg/mL heparin and 0.25 mg/mL 
hep.bind.-YIGSR peptide, or (ii) 2.83 mg/mL heparin and 0.5 mg/mL hep.bind.-YIGSR 
peptide. 
Embedding and Culture of PC12 Cell-Fibrin Clusters Inside Protein-grafl-PEG 
Hydrogels 
PCI2 cells (American Type Culture collection, ATCC Number CRL-I72I, USA), 
pre-cultured in serum-containing RPMl 1640 medium. were centrifuged (700 g, 3 min, 
room temp.) and resuspended in 2% (ml\') fibrinogen from human plasma (Fluka, 
IIX 
Switzerland) in sterile PBS to a concentration of 3()()OO PC 12 cells/~L. Embedding in :2 
~L fibrin droplets was achieved according to the same method used to embed dissociated 
DRG cells. PC 12 cell-fibrin clusters were then embedded similarly inside 3() ~L protein-
graft-PEG hydrogels. Independent culture conditions for PC 12 cell-fibrin clusters in 
protein-grafr-PEG(6000) hydrogels included (A) NCM with O. 50. and 200 ng/mL NGF. 
no other additions; (B) hydrogels with 2 and 20 ~g/mL laminin. NCM with 100 ng/mL 
NCM. 
Culture of DRGs on Laminin-Coated Surfaces with Subsequent In Situ 
Formation of Protein-graft-PEG HydrogeIs in Contact with DRGs 
Tissue-culture polystyrene (TCPS) 12-well plates were coated with 20 ~g/mL 
laminin solutions in TBS by incubating 0.5-1 mL per tissue-culture well for 30 min at 37 
0c. The coating solution was removed. the wells rinsed with TBS once. and freshly 
dissected chick DRGs cultured on the lam in in-coated surfaces in NCM. After one day. 
when neuritic extensions of up to 300 ~m had grown, the NCM was removed. 10% 
(111+1') protein-graft-PEG(3400)acrylate or -PEG(6()()()acrylate solutions with the usual 
initiator system were placed around the DRGs. covering the entire bottom of the tissure-
culture well and leaving the DRGs immersed to about half its height. Crosslinking of the 
protein-graft-PEGacrylate around the DRGs was induced ill sitll by exposure to the 
portable light source through the culture well lid. The DRGs. thus half-embedded inside 
the protein-graft-PEG hydrogels. and their neuritic extensions blanketed with hydrogel. 
were then cultured in the 12-well tissue-culture plates after covering each gel with 1.5 mL 
NCM. 
119 
Culture of DRGs on Protein-grall-PEG Hydrogels 
Chick DRGs were half-embedded on the surface of 30 ilL protein-f,'r(1/t-PEG(3400) 
or -PEG(6000) hydrogels by placing up to four DRGs directly onto a 30 III volume of 
initiator-containing 10% (nl+\') protein-f,'raft-PEGacrylate solution on the bottom of a 12-
well tissue-culture plate. Photopolymerization of the protein-f,'rajt-PEGacrylate underneath 
the DRGs was induced ill situ according to the same method as for gels around hFF-fibrin 
clusters, Chapter 5. The DRGs, thus embedded on the surface of protein-f,'r(1/t-PEG 
hydrogels, were then cultured in the l2-well tissue-culture plates after covering each gel 
with 1.5 mL NCM. 
Table 6.1: Culture Conditions for DRGs Half-Embedded In Protein-grait-PEG(3400) 
Hydrogels 
BELOW: 
THEORETICAL heparin NUMBER OF THE hep.bind.- YIGSR hep.bind.-RGD 
IMMOBILIZED (16-18 kDa) ("YIG") ("RGD") 
MOLECULES, ON THE 
RIGHT, PER 
HEPARIN-BINDING 
SITES IN THE 
MATRIX 
0 0" 0'" 0" 
1 hep. + YIG per 620 0.28 mg/mL ) 0.05 mg/mU" 0 
1 hep. + YIG per 124 1.42 mg/mL (I 0.25 mg/mL (I 0 
1 hep. + YIG per 62 2.83 mg/mL'u 0.5 mg/mL'u 0 
1 hep. + RGD per 62 2.83 mg/mL ( 0 0.48 mg/mL (I 
1 hep. only per 62 2.83 mg/mL 0 0 
Independent additions to the 10% (m+\') protein-f,'ra/t-PEG(3400)acrylate solutions 
prior to gelation included (a) no additions, (b) 0.28 mg/mL heparin and 0.05 mg/mL 
hep.bind.-YIGSR, (c) 1.42 mg/mL heparin and 0.25 mg/mL hep.bind.-YIGSR (d) 2.83 
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mg/mL heparin and 0.5 mg/mL hep.bind.-YIGSR, (e) vn mg/mL heparin and (l.48 
mg/mL hep.bind.-RGD. or (f) 2.X3 mg/mL heparin only. 2.~n mg/mL heparin 
corresponded to an amount equal to I molecule of heparin per 62 heparin-binding sites in 
the unswollen protein-graft-PEG(3400) hydrogels. Adhesion peptides and heparin were 
added in equimolar amounts to ensure, in theory. binding of all adhesion peptides by 
heparin. 
Independent additions to the 10% (m+l') protein-graft-PEG(6000)acrylate solutions 
prior to gelation included (g) no additions. (h) 0.2X mg/mL heparin and 0.05 mg/mL 
hep.bind.-YIGSR (i) 2.83 mg/mL heparin and 0.5 mg/mL hep.bind.-YIGSR. Here, 2.X3 
mg/mL heparin corresponded to an amount equal to I molecule of heparin per 50 heparin-
binding sites in the unswollen protein-graft-PEG(6000) hydrogels. Again, adhesion 
peptides and heparin were always added in equimolar amounts to ensure binding of all 
adhesion peptides by heparin. 
Table 6.2: Culture Conditions of DRGs Half-Embedded In Protein-!.'ratt-PEG(6000) 
Hydrogels 
BELOW: 
THEORETICAL heparin NUMBER OF THE hep.bind.-YIGSR 
IMMOBILIZED (16·18 kDa) ("YIG") 
MOLECULES, ON THE 
RIGHT, PER HEPARIN· 
BINDING SITES IN 
THE MATRIX 
0 (F ' (P 
1 hep. + YIG per 500 o.n mg/mL'1l 0.05 mg/mL"1I 
1 hep. + YIG per 50 2K) mg/mL' 0.5 mg/mL' 
To measure the neurite outgrowth from DRGs onto the protein-graft-PEG 
hydrogels. after three days in culture the DRGs were imaged and recorded with the plane of 
neurite outgrowth in focus. Microscopy and image processing were performed using a 
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Zeiss inverted confocal light microscope (Axiovert 135, Zeiss, Gennany) in conjunction 
with a Hamamatsu Color Chilled 3CCD Camera (Hamamatsu, Japan) and LeicaQWin 
image processing software (Leica Imaging Systems Ltd., 1997). To quantify the neurite 
outgrowth, the area of the original DRG was measured, as was the area of neurite 
outgrowth, defined by the tips of neurites in the plane of outgrowth. These two areas were 
approximated as circular areas, and their theoretical radii subtracted from each other to give 
an average length of neurite outgrowth. 
For the comparison of conditions (d), (e) and (f), only one set of 4, 8, and 8 
DRGs, respectively, was analysed. For all other sets of data, at least two independent 
experiments, carried out in triplicate or higher number of DRGs, were perfonned and 
analysed. In parallel with all DRG cultures on protein-gr«{t-PEG hydrogels. DRGs were 
cultured on laminin-coated TCPS to ensure DRG viability. 
Verification of Chick Neurite Outgrowth by Immunostaining with Anti-Growth-
Associated Protein-43 (GAP-43) Monoclonal Antibody 
Outgrowth on protein-gr~ft-PEG hydrogels was stopped and DRGs fixed by 
replacement of NCM with fonnalin solution (10%. neutral buffered, Sigma). To avoid a 
fluorescent background due to antibody entrapment in the hydrogel matrix, the hydrogels 
were hydrolysed by adding I M NaOH and incubating at room temperature for 5 min. 
After removal of the hydrogel lysate, the DRGs were penneabilized with 0.1 % TritonX 
solution (Sigma) for 5 min, followed by rinsing with TBS, pH 7.4, three times. Non-
specific adsorption of antibodies to the DRGs and tissue-culture well surfaces was 
prevented by blocking with a 3% (mil') bovine serum albumin (BSA) solution (Sigma). 
and the DRGs were then incubated for I h at 37°C with a 1 X working solution of anti-
GAP-43 monoclonal antibody (Sigma, G-9264) in TBS, also containing 3% (mil') BSA. 
After three rinses with antibody-free TBS containing 3% (mil') BSA, the DRGs were 
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incubated with a I X working solution of FITC-Iabeled, Fab-specific anti-Mouse IgG 
antibody (Sigma, F-S262) in TBS with 3c/r, (m/\') BSA for I h at 37°C. Again, after three 
rinses with antibody-free TBS containing 30', (mil') BSA, the immunostained DRGs were 
visualized by observing emission between SIO-S40 nm (Zeiss, Germany) under excitation 
at 4X3 nm. As a positive control for GAP-43 staining, DRGs cultured on laminin-coated 
TCPS were similarly immunostained with anti-GAP-43 monoclonal antibody followed by 
FITC-Iabeled, Fab-specific anti-Mouse IgG antibody. 
RESULTS AND DISCUSSION 
Heparin Affinity of hep.bind.-YIGSR Peptide 
In the absence of soluble heparin, the hep.bind.-YIGSR peptide eluted from the 
heparin-agarose column between salt concentrations of 0.7-1.1 M NaCI (Figure 6.2 a,b). 
Elution at such high salt concentrations suggests a strong affinity of hep.bind.-YIGSR for 
the agarose-bound heparin. In the presence of 9.13 mg/mL soluble heparin. corresponding 
to 2 moles of heparin per mole of hep.bind.-YIGSR peptide. elution of hep.bind.-YIGSR 
occurred between salt concentrations of O.S-I.l M NaCI (Figure 6.2 c,d). This shift 
suggests that soluble heparin competitively compromised binding of the heparin-agarose to 
the hep.hind.-YIGSR peptide, causing the peptide to be eluted at a lower range of salt 
concentrations than in the absence of soluhle heparin. Together. these results confirm the 
strong and specific affinity of hep.bind.- YIGSR peptide for heparin. Hydrophobic 
interactions or other non-specific binding of hep.bind.-YIGSR to the heparin-agarose resin 
can be excluded because of the reduction in binding when soluble heparin was added. 
However. more heparin should have been added to obtain better competitive inhibition. and 
to better illustrate the specific interaction of the heparin-binding peptide with the agarose-
bound heparin in the column. 
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2OCk. acrylamide SDS-PAGE gels with 16 /lL samples from eluate fractions a.h) without heparin. c.d) with 
the addition of 2 moles of heparin per mole of hep.hind.- YIGSR peptide. Lane 1: molecular weight marker. 
2: flow through after initial loading of column with 137 mM NaCI, 3: 137 mM NaCI, 4: 246 mM NaCI. 
5: 356 mM NaCI, 6: 466 mM NaCI, 7: 575 mM NaCI. 8: 685 mM NaC!. 9: 794 mM NaCI. 10: 904 mM 
NaCI. II: 1014 mM NaCI. 12: 1123 mM NaCI. 13: 1228 mM NaCI. 14: 1342 mM NaCI. 15: 1452 
mM NaCI. 16: 1562 mM NaCI. 17: 1671 mM NaCI. 18: 1781 mM NaCI. 19: 1890 mM NaCI. 20: 
molecular weight marker. 
Together with results described in Chapter 4, which showed the strong and specific 
affinity of protein-gnift-PEGacrylate for heparin, the affinity of designed heparin-binding 
peptides. e.g.. hep.bind.-YIGSR. for heparin supported the feasibility of the 
immobilization scheme for additional adhesion sites within protein-graft-PEG hydrogels 
using heparin as a linker (see Figure 6.1). However. to show that heparin-binding 
peptides hep.bind.-YIGSR and hep.bind.-RGD really remained bound to the hydrogels 
even when peptide- and largely heparin-free medium came in contact with the gels during 
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culture, binding and release studies remam to be perfonned. This should be 
straightforward by measuring the presence and release of fluorescence from the hydrogels 
due to the heparin-binding peptides' N-terminal dansyl groups. 
Increase of the Mechanical Strength of Protein-graft-PEG Hydroge\s Due to 
Heparin 
Rheological characterization of protein-gr(lji-PEG(6000) hydrogels with and 
without 2X1 mg/mL heparin revealed that gels containing heparin have greater mechanical 
strength. After photo-crosslinking, protein-graji-PEG hydrogels that contained heparin 
reached elastic moduli (or "storage moduli"), G', up to 1.7 kPa (Figure 6.3), which 
corresponds to a Young's modulus (E~ilh hep:Il') of approximately 5.1 kPa. 
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Figure 6.]: Physical Intermolccular Crosslinking hy Heparin 
Elastic moduli. Cl'. 01 protein-gratT-PECi(60()O) hydrogels with !diamollll! and without !square! 2.R4 mg/mL 
heparin. Photo-initiation of gelation was started at lk:signated time = O. 
(Note: E = 2(1 + fl)G', where fl is Poisson's ratio, assumed to be the idea! value, 0.5, a 
reasonable assumption for cross-linked gels). The range of Young's Modulus E"ilholll hepall!\ 
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measured in parallel for protein-gr(lft-PEG(6000) gels without heparin was only 2.9 - 3.7 
kPa. in close agreement with the values reported in Chapter 4. 
The greater mechanical strength of protein-graft-PEG hydrogels can be explained by 
heparin's ability to contribute to the crosslinking by electrostatic interaction with more than 
one heparin-binding site in the hydrogel's protein backbone. Because of this physical 
crosslinking effect. even protein-gr«ft-PEGacrylate solutions containing heparin already 
exhibited appreciable elasticity (G'~llh heparin = 280 kPa; Figure 6.3). as opposed to pre-gel 
solutions without heparin (G' without hel'ann = 0). 
Fibroblast or Glial Cell Outgrowth, but Lack of Neurite Outgrowth, from Whole 
DRGs Inside Protein-graft-PEG Hydrogels 
In contrast to the human fibroblast outgrowth observed in protein-Rraft-PEG 
hydrogels (Chapter 5). no three-dimensional neurite outgrowth from embryonic chick 
DRGs could be elicited in protein-graft-PEG hydrogels under any of the conditions A - L 
described in the Materials (lnd Methods section of this chapter (Figure 6.4). Even the 
most promising conditions involving the presence of laminin in the hydrogels (conditions A 
and B) did not lead to neurite outgrowth. Apparently. even the presence of laminin and 
fibronectin (the latter usually provided in the medium) was not sufficient to promote three-
dimensional neurite extension. as these proteins may not have been sufficiently adsorbed or 
immobilized to the matrix to serve as cellular adhesion sites. In a non-immobilized state. 
laminin and fibronectin might even have inhibited neural adhesion. namely by occupying 




Figure 6.4: Lack of Three-Dimensional Neurite Outgrowth from Emhryonal Chick DRGs 
DRC; in a protein-gmti-PEG(oOOO) hydrogel with 200 IJg/mL laminin. a) day I. h) day 4. (Scale har = 
-'00 IJm) 
Nevertheless, in occasional instances, chick fibroblast or glial cell outgrowth from 
the DRGs was observed (Figures 6.5, 6.6, 6.7), but never with the same abundance as 
outgrowth from hFF-fibrin clusters in Chapter 5. Notably, this outgrowth only occurred 
when heparin was present in the hydrogels. This suggests that even for the occasionally 
observed three-dimensional chick fibroblast or glial outgrowth, and especially for chick 
neurite outgrowth, additional factors or a modification of hydrogel properties were 
necessary, namely different or beyond those of plain protein-gn!lr-PEG gels. The 
additional feature that heparin appears to have provided could either be better mechanical 
strength or a means for retaining in the hydrogel additional adhesion and/or trophic factors. 
,," .; 
a) b) '.~~~ ~.~<:: ~ ,. "''>~ 
Figure 6.5: Occasional Three-Dimensional Pihrohlast or Cilial Cell Outgrowth from Emhryonal Chick 
DRCis 
DIU, in a protein-grati-PEC,(-,400J hydrogel with 2.83 mg/mL heparin (10-18 kDa) and 0.5 mg/mL 
hep.hind.- YIClSR peptide in the gel hefore gelation. a) day I. h) day 5. c) day 5. magnified view ( I.ox). 
(Scale har = -'00 IJm) 
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a) b) 
Figure 6.6: Late Three-Dimensional Fibroblast or Glial Cell Outgrowth from Embryonal Chick DRGs 
DRC, in a protein-gratf-PEG(6000) hydrogel with 2.83 mg/mL heparin (16-IX kDa) and 0.5 mg/mL 
hep.bind.- YICiSR peptide in thL' gel before gelation. a) day I. b) day X. (Scale bar = 300 ~m) 
.< 
a) 
Figure 6.7: Three-Dimensional Fibroblast or Glial Cell Outgrowth from Embryonal Chick I)RGs at 
Low Gel Density 
DRG in a X'/' (111+\') )protein-gratr-PEC,(6000) hydrogel with 2.83 mg/mL heparin (16-IX kDa) and 
0.5 mg/mL hep.bind.- YIGSR peptide in the gel before gelation. a) day I. b) day 5. (Scale bar = 400 ~m) 
Assuming. based on the latter hypothesis, that under Condition B (gels supplemented with 
heparin and laminin) laminin was immobilized in the matrix by heparin-bridging as 
invisioned in Figure 6.1, it remains unclear why three-dimensional neurite outgrowth did 
not even occur then. Likewise. the addition of embryonic chick extract had no conducive 
effect (Condition D), nor the use of a richer growth medium than NCM (Condition 1). nor 
the use of day 9 embryonic chick DRGs (Condition G). 
Lack of Neurite Outgrowth from PO Mouse DRGs in Protein-grafl-PEG 
Hydrogels 
To exclude the possibility that non-mammalian neurons (such as those of chick 
DRGs) could not efficiently penetrate or attach to a matrix based on mammalian adhesion-
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Figure 6.8 a: Lack of Three-Dimensional Neurite Outgrowth from PO Mouse DRCis 
Mouse DIU i in a protein-gratt-PEG(3400) hydrogel with 2.X3 mg/mL heparin ( 16-1 X kDa) and 0.5 mg/mL 
hep.bind.- YIGSR peptide in the gel before gelation. a) day I. b) day 3. (Scale bar = 500 /Jm) 
However. no three-dimensional neurite extension occurred in these systems. either (Figure 
6J\), although the DRG neurons did remain viable in contact with the hydrogel material. as 
evident from nonnal neurite outgrowth on the surface of the material (Figure 6.9). Inter-
species differences with regard to chick- versus mouse plasmin's ability to digest the 
material are thus unlikely as a sole reason for the failure of neurons to extend neurites in 
protein-graft-PEG hydrogels. 
Figure 6.9: Surface Neurite Outgrowth from PO Mouse DRCis 
Mouse DRCi sun'ace-embedded on a protein-gratt-PECi(3400) hydrogel with 2.X3 mg/ml. heparin (16-18 
kDa) and 
0.5 mg/mi. hcp.hind.- Y1CiSR peptide in the gel before gelation. on culture day 2. Healthy neurite 
outgrowth proved the viability of the DRCi neurons. (Scale har = 300 /Jm) 
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Further studies would be necessary to verify that chick plasmin can specifically degrade 
protein-grajf-PEG hydrogels, but chick DRG neurites generally are capable of penetrating 
human fibrin via plasmin-mediated fibrinolysis. 177.91 Nevertheless, the lack of human 
fibrin degradation by embedded chick DRGs under conditions described in the next section 
suggests that some impairment of fibrinolysis -perhaps plasmin activation- might have 
played a role in preventing DRG neurite outgrowth. 
Lack of Outgrowth from DRG-Fibrin Clusters Inside Protein-graft-PEG 
Hydrogels 
When chick DRGs were first embedded in fibrin, and these clusters then cultured in 
protein-graft-PEG hydrogels, the hope was to elicit neurite outgrowth into the surrounding 
fibrin first, followed by a continuing outgrowth into the protein-gr~ft-PEG material. 
However, as shown in Figure 6.10, neurite outgrowth did not occur at all. Moreover, no 
fibrinolysis was observed either, suggesting that plasmin activation or activity might have 
been impaired. 
a) b) 
Figure 6.10: Lack of Three-Dimensional Neurite Outgrowth from Embryonal 
Chick DR(J-Fibrin Clusters 
DRG. partially embedded in a 0.2';( (mil') fibrin gel, in a protein-grafr-PEG(6000) hydrogel with 2.83 
mg/mL heparin (16-18 kDa) and 0.) mg/mL hep.bind.-YIGSR peptide in the protein-PEG gel before 
gelation. a) day I. b) day). (Scale bar ~ 600 !lm) 
These observations raise the possibility that diffusion of certain relevant nutrients or 
growth factors through the 10% (m+\') protein-graft-PEG material was limited due to small 
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pore sIze and absence of defects. In that case, even 8% (m+l') protein-graff-PEG 
hydrogels (Figure 6.7) must have been too densely crosslinked, as no neurite outgrowth 
was observed, either. The fact that fibroblast or glial outgrowth still occurred at a later 
point is not inconsistent with this argument. Fibroblasts and glial cells may not require the 
same growth factors and likely remain viable longer than neurons, until partial hydrogel 
degradation allows better nutrient flow and facilitated proteolytic penetration. 
Lack of Neurite Outgrowth from Dissociated DRG Cell-Fibrin Clusters Inside 
Protein-graft-PEG Hydrogels 
Not surprisingly in light of the previous section, dissociated DRG neurons also did 
not extend, nor apparently survive for long, in fibrin clusters surrounded by protein-
graft-PEG hydrogels (Figure 6.11). 
a) b) 
Figure 6.11: Lack of Three-Dimensional Neurite Outgrowth from Embryonal 
Chiek DRG Cell-Fibrin Clusters 
Dissociated DRC; Cells. embedded in a 0.2';; (ml!') fibrin get. in a protein-gratt-PEG(6000) hydrogel with 
2.83 mg/mL heparin ( 16-18 kDa) and 0.5 mg/mL hep.bind.- YIGSR peptide in the protein-PEG gel before 
gelation. a) day I. h) day 3. (Scale bar ~ 300 J.lm: both images shown at the same magnification) 
While widespread cell death was obvious inside the DRG cell-fibrin clusters, some 
fibroblasts and/or glial cells did survive and even started to spread (Figure 6.12). Also, 
proteolytic enzymes were released that lead to the total degradation of the surrounding 
protein-gr(Jft-PEG matrix by day 7, but not the fibrin bed. Degradation of the surrounding 
protein-gr(Jft-PEG matrix was already visible on day 3 (Figure 6.II.b, above). 
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Figure 6.12: Fibroblast or Glial Cell Spreading Inside Embryonal Chick DRe; Cell-Fibrin Clusters 
Dissociated DRG Cells. embedded in a O.2'7r (lI1i1') fibrin gel. surrounded by protein-gratt-PEG(6000) 
hydrogel with 2.83 mg/mL heparin (16-18 kDa) and 0.5 mg/mL hep.binLl.- YIClSR peptide in the protein-
PEG gel before gelation. on culture day 7. (Scale bars = 100 /-1m; both images shown at the same 
magnification) 
Lack of Neurite Extension by PC12 Cells Embedded in Fibrin and Placed Inside 
Protein-graft-PEG Hydrogels 
Similar to dissociated DRG cell-fibrin clusters embedded in protein-graft-PEG 
hydrogels. there was also no outgrowth of neuritic extensions from. or within. PC 12 cell-
fibrin clusters (Figure 6.13). 
a) b) 
Figure 6.13: Lack of Neurite Outgrowth from PC 12-Fibrin CI usters Inside Protein-graft-PEC, lIydrogeis 
1'(,12 cells. embedded in a 0.2';' (m/\') fibrin gel. sllITClUnded by a protein-gratt-PEC,(6000) hydrogel with 
I (lOng/mi. NCil'. a) day I. b) day 5. (Scale bar = 3(lO 11m) 
It was not tested whether PC 12 cells extend neuritic processes when embedded in fibrin 
that is not surrounded by potentially diffusion-limiting protein-graft-PEG material. but in 
most previous studies (see BACKGROUND on PCf2 Cells) PCI2 cells only extended 
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neurites when finnly attached to coated TCPS surfaces. Therefore, PC 12 cell-fibrin 
clusters might not have been a good three-dimensional model system to begin with. 
Arrest of Neurite Outgrowth after In Situ Formation of Protein-grafl-PEG 
Hydrogels 
To test whether neurites, which had already started to extend and which continued 
to be guided by an underlying laminin surface (much like nerve regeneration along a basal 
lamina or columns of Schwann cells), would penetrate a suddenly imposed protein-graft-
PEG matrix, protein-graft-PEG hydrogel was fonned on top of neurites extending on a 
laminin-coated tissue-culture surface. As shown below (Figure 6. 14), the neurite 
outgrowth was arrested after hydrogel fonnation, and cell death probably ensued soon 
after, because the entire DRG no longer remained attached to the laminin-covered surface 
(Figure 6.14 c). This observation raises the possibility that hydrogel fonnation in contact 
with DRG neurons causes neuronal cell death, which in tum triggers subsequent apoptosis, 
at least of neurons. in the entire DRG. Nutrient diffusion could not have been limiting in 
this system. 
a) 
Figure 6.14: AlTest of Neurite Outgrowth After Hydrogel Formation in Contact with 
Chick Embryonic DRGs 
DRG cultured on laminin-coated TCPS for one day, followed by protein-Rratt-PEG(3400) hydrogel 
formation (n() additions) around the DRe;, thus covering the neurites that had extended on the TCPS. a) On 
the day of gel formation. b) after I day (slightly magnified). and after:; days of culture in NCM. (Scale 
bars = 300 /.lm and 600 /.lm) 
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Surface Neurite Outgrowth upon Protein-grafl-PEG Hydrogels 
Neurite-like extensions grew from surface-embedded embryonic chick DRGs on 
protein-graft-PEG hydrogels under various culture conditions (Figure 6.15.a,b). To verify 
that these extensions were axonal extensions expected of pseudo-unipolar sensory neurons 
present in DRGs,129 immunohistochemistry was performed. The extensions immuno-
stained positive for growth-associated protein-43, GAP-43, a neural-specific, intracellular 
phosphoprotein, also known as B-50, F I. pp46, p57 and neuromodulin, that is found 
exclusively in the peripheral and central nervous systems.l7!! GAP-43 is a major protein of 
axonal growth cones 179 and in certain presynaptic terminals, but it is absent from dendritic 
growth cones. ISO 
'* 
a) ··;.;'-...... P'-- b) 
c) t·---- d) 
Figure 6.15: Anti-(jAI'-43 Immunostaining of Axonal (a and h) and Non-Axonal (c and d) Outgrowth 
a) DRCi. surface-emhedded on a protein-graft-PHi hydrogel. with 2.X3 mg/mL heparin (16-1 X kDa) and 0.5 
Illg/mL hep.hind.- Y l(iSR peptide in the gd hcfore gelation. on culture day 4. c) DRG fully emhcdded. hut 
ncar the gel's top surface. in a protein-graft-PEG hydrogel with 2.X3 Illg/mL heparin ( 16-1 X kDa) and 0.5 
Illg/mL hep.hind.- YI(iSR peptide in the gel heforc gelation. on culture day 4. (Scale hal's = .,00 /Jill) 
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The positive stain for GAP-43 associated with the neurite-like extensions from 
chick DRGs (Figure 6.1 S.b) indicates that these extensions were indeed axonal extension 
from pseudo-unipolar sensory neurons present in DRGs.129 When monoclonal anti-GAP-
43 and secondary antibody were used to stain cellular outgrowth from DRGs under 
conditions that did not produce neurite-like extensions (Figure 6.1 S.c), only a weak 
fluorescent signal resulted that was associated with the body of the original DRG (Figure 
6.1 S.d), indicating that, indeed, no axonal outgrowth had occurred. (In this case, the DRG 
had sunk too deeply into the protein-graft-PEGacrylate solution before gelation, so 
apparently only fibroblasts managed to emerge from the DRG onto the hydrogel surface.) 
Immunostains of chick DRGs cultured on laminin-coated TCPS served as positive controls 
for the presence and staining of GAP-43. As expected, only the neuritic extensions from 
the DRG stained positive (Figure 6.16.b), while neuronal support cells that had also 
migrated along with the neuritic extensions (Figure 6.16.a) did not stain positive for GAP-
43 (Figure 6.16.b). 
,.:" 
a) If 
Figure 6.16: I\nti-GI\P-43 Immunostaining of Axonal Outgrowth Upon Laminin-Coated TCPS 
DRC; cultured on a lam in in-coated surface for six days; fixed with formalin and immunostained against 
(;AP-43. Note neuronal support cells in a) that did not stain positive for (;1\1'-43. 
Heparin-Dependence of Neurite Outgrowth upon Protein-graft-PEG Hydrogels 
Based on Figure 6.17.a, surface neurite outgrowth seemingly required both heparin 
and hep.bind.-YIGSR to be bound to 10% (m+l') protein-graft-PEG(3400) hydrogel 
matrices. However, when incorporating heparin alone, surprisingly the same levels of 
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surface neurite outgrowth occurred as with hep.bind.-YIGSR. This clearly suggests that in 
this system the necessary factor in promoting neurite outgrowth was heparin, not the 
laminin-based hep.bind.-YIGSR peptide. The hep.bind.-YIGSR peptide, if biofunctional 
at all, even seemed to have a mildly inhibitory effect on neurite extension. This inhibitory 
effect could be due to competitive inhibition of neural adhesion by soluble YIGSR peptide 
that was not properly immobilized in the matrix via heparin. Alternatively, the inhibitory 
effect on neurite outgrowth could be due to an excessIve concentration of hep.bind.-
YIGSR peptide in the matrix. At excessive ligand concentrations, cell migration and 
neurite outgrowth can be inhibited, because cells and growth cones actually bind too 
strongly to their substrate. 181 182 
a) 
400 ..,-------------, 
Moles of Heparin and hep.bind.-YIGSR 























Addition to Hydrogel 
Figure 6.17: Heparin-Dependence of Axonal Outgrowth On the Surface of Protein-graft-PEG Hydrogels 
a) Neurite outgrowth. after three days of culture. on protein-graft-PECJ(3400) hydrogcls as a function of 
heparin and hep.bind.- YIGSR concentration expressed in terms of heparin and hep.bind.- YIGSR molecules 
per number of heparin-binding sites in the hy drogels. The relevant factor in promoting the observed 
neurite outgrowth was heparin. not the hep.bind.- YIGSR peptide. b) Length of neurite outgrowth after 
three days with different additions to protein-graft-PEG(3400) hydrogels prior to gelation. Addition of 
heparin alone apears to be the relevant factor that enabled axonal outgrowth on hydrogels. (Added were 2.83 
mg/mL heparin and equimolar amounts of hep.bind.-peptides. as indicated.) 
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Resolution of this issue hinges upon the results of anticipated release studies of 
hep.bind.-YIGSR peptide from protein-graft-PEG hydrogels. A combination of factors 
could explain why the addition of heparin to the protein-grajt-PEG hydrogels promoted 
neurite extension. Bare protein-gn:~ft-PEG hydrogels only allow minimal or no protein 
adsorption due to their high PEG content, which is a constituent known to prevent protein 
adhesion in hydrogels and in surface-tethered forms.12l! (Recall the PEG-based, and 
therefore cell- and protein-adhesion resistant surfaces of Chapter 2.) Therefore, a protein-
graft-PEG hydrogel constitutes a matrix containing only RGD adhesion sites, unless 
additional adhesion molecules and neuronal growth factors are actively immobilized by 
design, or are directly deposited by outgrowing neurons themselves. The addition and 
binding of heparin to the protein-grqft-PEG matrix (see Chapter 4) provided binding sites 
for the exogenous hep.bind.-YIGSR adhesion peptide and, perhaps more importantly, for 
extracellular matrix components and growth factors secreted by cells present in DRGs. 
Although the hep.bind.-YIGSR peptide was either not successfully, or excessively, 
immobilized to matrix-bound heparin or was not functional for structural and/or 
accessibility reasons, matrix-bound heparin likely bound cell-secreted molecules to the 
hydrogel matrix, thus enabling outgrowth on a material that is otherwise non-adhesive, 
deficient. or for other reasons not supportive of axonal outgrowth. 
In addition to heparin's role in immobilizing adhesion and growth factors in the 
hydrogel matrix, the rheological results with protein-grajt-PEG(60()() hydrogels showed 
that heparin enhances the mechanical strength of the matrix presumably by virtue of its 
physical interactions with more than one heparin-binding site in the hydrogel. Hydrogels 
that exhibit better mechanical integrity are also likely to better support neurite extension, as 
cell attachment and deposition of extracellular matrix on a weak and flexible substrate are 
difficult. 
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Dependence of Neurite Outgrowth on Crosslink Density of Protein-grafl-PEG 
Hydrogels 
Although the mechanical properties of 10% (m+\') protein-gr«ft-PEG(3400) and -
PEG(6000) hydrogels did not seem to differ significantly (Chapter 4). Figure 7 shows a 
pronounced difference in the length of neurite outgrowth on protein-graft-PEG(3400) 
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Heparin Concentration in Hydrogels 
Prior to Ge lation 
Figure 6.17: Effect of Hydrogel Crosslink Density on DRG Neurite Outgrowth 
Difference in length of DR(; neurite outgrowth on protein·grati-PEG(3400) [diamond! versus -PHl(60()O) 
!sljuare! hydrogels after three days of culture. 
A likely explanation for the effect of PEG chain length on neurite outgrowth is that protein-
graft-PEG(3400) hydrogels are expected to be more highly crosslinked. considering a 
theoretical acrylate concentration of ~ I 1.3 mM at the time of crosslinking compared to only 
~X.5 mM theoretical acrylates in the case of 107(1 (m+\') protein-gr«fr-PEG(6000) gels. It 
appears that the difference in crosslink density and, therefore. subtle differences in network 
architecture facilitated better cell adhesion and/or extracellular matrix deposition on protein-
graft-PEG(3400) gels than on protein-grafr-PEG(6000) gels. Better and more abundant 
matrix deposition onto protein-grajt-PEG(3400) gels may also have resulted from the 
higher overall concentration of heparin binding sites, i.e., theoretically -9.4 mM in 
PEG(3400) gels versus -7.1 mM in PEG(6000) gels. 
CONCLUSION 
Three-dimensional neurite outgrowth could not be elicited within protein-gn:dl-PEG 
hydrogels under the culture conditions and with the neural cell types that were tested. 
However, surface neurite outgrowth upon protein-grajt-PEG matrices occurred under 
certain conditions. 
When small amounts of heparin were added to protein-graff-PEG hydrogels (up to 
molecule of heparin per SO heparin-binding sites in the hydrogel), surprisingly the 
heparin promoted neurite outgrowth from chick DRGs and. thus. served as a tissue 
engineering tool toward better implant materials. In particular. the results in this chapter 
suggest that heparin bound to the hydrogel matrix by virtue of the ATIII-based heparin-
binding site that the hydrogels contain. Heparin molecules that are thus immobilized in the 
matrix affected the physical properties and. arguably, the molecular structure of the protein-
graft-PEG hydrogels. Furthermore. while other glycosaminoglycans (e.g .. chondroitin 
sulfate)5554 directly inhibit neurite outgrowth. heparin can facilitate neurite outgrowth by 
binding relevant neuronal adhesion molecules. including laminin and fibronectinHIJI1I4 as 
well as a number of heparin-binding growth factors. Therefore. when protein-gr({/l-PEG 
hydrogels bind heparin. heparin in tum can serve as an anchor for such extracellular matrix 
proteins and/or growth factors which might otherwise diffuse away from the hydrogel. 
In summary. on protein-grafl-PEG hydrogels. surface outgrowth ofaxons from 
DRG neurons depended on heparin-content in the hydrogels. While further examination of 
the effect of heparin is under way. apparently heparin not only improves the mechanical 
properties of protein-grajt-PEG hydrogeJs and thereby enables better neurite outgrowth. 
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but heparin may also serve as an anchor for neural adhesion and trophic factors relevant in 
neuronal attachment, survival, and outgrowth. 
FUTURE WORK 
In order to effect three-dimensional neurite outgrowth, it is necessary to know what 
exact conditions in two dimensions enable surface neurite outgrowth, while processes do 
not extend three-dimensionally. The possibility that enclosure in a gel and the resulting 
spatial arrest prevent outgrowth is one possible circumstance. A way to identify active 
inhibitory factors or mere limitations on outgrowth due to poor neuron-associated 
plasminolytic activity. and to lift possible diffusional limits on essential neuroactive 
molecules. is to assess neurite outgrowth inside porous protein-gu4t-PEG gels. For this, 
methods would have to be designed to pattem protein-graff-PEG gels three-dimensionally. 
Furthennore. cellular staining techniques should be employed to assess the survival 
of neurons inside versus on protein-graft-PEG gels; and the presence. survival. and role of 
supporting cells in fully embedded versus surface-embedded DRGs should be further 
characterized. Supporting cells should be identified and their possible role at the front of 
two-dimensional neurite outgrowth be analysed, keeping in mind that supporting cells 




SUMMARY, CONCLUSIONS, AND OUTLOOK 
MATERIAL DEVELOPMENT 
The key achievement in the work presented in this doctoral thesis was the creation 
of a novel and versatile class of biosynthetic materials: protein-graft-PEG hydrogels. 
During the development of this material, future variants of which can contain virtually 
unlimited biological functionality based on its protein component, several challenges had to 
be addressed that arose from the processing of proteins toward the goal of rendering them 
within a hydrogel matrix. 
Protein Solubility and Oxidation State 
For in situ applications in tissue repair, the protein-based precursor of protein-graft-
PEG hydrogels had to exist in a water-soluble form. However, due to electrostatic, 
hydrophobic and covalent interactions proteins -including small oligopeptides- often 
coalesce and precipitate, making chemical modification of proteins difficult. In contrast to 
some native water-soluble proteins, this problem is even more pronounced in recombinant 
proteins that are not optimized for solubility or folded appropriately after recovery from 
their expression host. Even more problematic are cysteine-rich proteins, which may exist 
in a reduced form inside bacterial expression hosts, but are very prone to disulfide bonding 
during downstream processing. 
These difficulties were solved in the case of protein-graff-PEG hydrogels by 
synthesizing PEGylated protein precursors whose thiols were used. and thus prevented 
from intermolecular disulfide bonding, as designated PEGylation sites. PEGylation, in 
tum, ensured good water solubility based on high-molecular-weight PEG's excellent 
solubility. high mobility, and large exclusion volume in water. 128 Transforming proteins 
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by PEGylation into hydrogel precursors is a powerful and necessary tool especially when 
incorporating hydrophobic protein constructs in a hydrogel matrix. 
Before the PEGylation of protein pentamers, a crucial step toward obtaining 
protein-graft-PEG hydrogels was the reduction of protein thiols by TCEP, avoiding the use 
of thiol-containing reducing agents such as ~-mercaptoethanol or DTT, which engage in 
mere thiol exchange and require repeated dialysed for -often incomplete- removal. The 
invaluable advantage of choosing TCEP as a reducing agent was that it liberates thiols, but 
is irreversibly consumed itself without introducing unwanted additional thiols into the 
system. The thiols that were reduced by TCEP are thus available instantly for further 
reaction without interference by the reducing agent itself. 
Modification of Proteins by Michael-Type Conjugate Addition 
Many protein modification schemes have either directly targeted, or inadvertently 
involved, protein primary amines (i.e., a protein's amine-terminus or amines found in 
lysine residues)}6s.J8S As elaborated in Chapter 4, this was successfully avoided in the 
PEGylation of protein pentamers [A] and [B], and their amine-related functions thus 
retained, by PEGylating via a Michael-type conjugate addition that consisted in the selective 
addition of protein thiols to PEG acrylate groups. To employ this Michael-type conjugate 
addition in order to PEGylate .i!!!)!. protein or protein fragment of interest, protein thiols can 
be added by recombinant incorporation of cysteine residues in the protein. 
Purification by NiH -Affinity Chromatography 
Separation of protein-graft-PEGacrylate product from unreacted PEGdiacrylate 
after Michael-Type conjugate addition was necessary, because an excess of PEGdiacrylate 
was used during the PEGacrylation of protein pentamers to ensure complete 
PEGacrylation. Usually, separations of PEG from PEGylated product represent 
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fonnidab1e difficulties, but in the case of protein-graji-PEGacrylate the hexa-histidine tag, 
which had already served in the purification of protein pentamers from bacterial lysate and 
in their immobilization on Nickel-coated tissue culture wells, also enabled purification of 
the PEGacrylated protein. The hexa-histidine tag, therefore, proved to be an extremely 
fortunate addition to protein pentamers [A] and fBl. 
In situ Photogelation 
The photochemistry used for the crosslinking of protein-graft-PEGacrylate 
involved non-toxic initiators, generated little heat, and -even when perfonned in direct 
contact with actual or model tissue- caused no apparent cell death, e.g., by radical transfer 
to cellular membrane proteins. Furthennore, crosslinking only required initiation with 
visible light at low intensity, and complete gelation of protein-gr«fi-PEGacrylate solutions 
occurred at a sufficiently rapid rate. Therefore, crosslinking in situ should be feasible in 
surgical contexts even when time limitations are of major concern. 
In summary, this research has defined and optimized a set of tools for designing and 
expressing recombinant proteins with intennittent, thiol-containing cysteines; for selective 
PEGacrylation of these thiols via Michael-type conjugate addition; for purification of the 
PEGacrylated proteins by Ni++-affinity chromatography; and for the rapid. in situ fonnation 
of protein-grafi-PEG hydrogels by photocrosslinking. 
The successful creation of prototypic protein[Al-grafi-PEG hydrogels promises that 
many other protein domains can be combined and rendered in a similar hydrogel fonn 
toward the repair of specific target tissues or toward applications beyond tissue repair such 





Protein-grajt-PEG hydrogels fulfill the majority of physical requirements postulated 
in Chapter 2 for a matrix intended for implantation and tissue repair: 
5. Protein-gr~ft-PEG hydrogels represent a homogeneous, highly crosslinked matrix 
whose mechanical strength was sufficient to support cell attachment and migration. 
While non-covalent crosslinking schemes are conceivable (e.g., based on hydrophobic 
interactions or IOmc linkers), In protein-grl.{ft-PEG hydrogels covalent 
photocrosslinking was the key feature that enabled rapid formation and ensured 
sufficient mechanical strength of this highly hydrated system containing flexible PEG 
chains grafted onto a protein core. 
6. Aqueous solutions of protein-grajt-PEGacrylate can be coated or injected into a medical 
device (such as a nerve guidance channel) or pasted directly onto the site of an injury 
(such as the severed nerve endings after peripheral nerve transection) and then be 
transformed to a solid state under physiological conditions. Liquid-to-solid 
transformation of a material in situ is desirable in applications of the material as a 
scaffold for tissue regeneration, because the matrix will conform perfectly to the 
micromorphology of adjacent tissues, avoiding spaces and gaps that might fill with 
unwanted ECM molecules or scar tissue. Also, liquid-to-solid transformation and 
perfect morphological conformity of the matrix enable its use as a resorbable sealant 
(e.g., for the nerve guide openings). 
7. Protein-gr~ft-PEG hydrogels were transparent and, therefore, allowed microscopic 
analysis of three-dimensional cell cultures. The high water content of PEG matrices 
and their homogeneous sub-micron architecture may account for this feature. 
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Biofunctional Features 
Even more important in a material intended for implantation and tissue repair are its 
biological characteristics and functions: 
8. To impart biological function to the protein-;?raft-PEG hydrogels, minimal functional 
protein elements were assembled by recombinant DNA techniques and the target protein 
bacterially expressed. Thus, the protein constituent of the matrix as well as PEG, the 
synthetic polymer precursor, are artificial. By avoiding animal- and human donor-
derived materials, the complexities and risks associated with non-autologous tissue 
products were avoided. 
9. Protein-;?raft-PEG hydrogels' principal constituent, protein-;?raft-hexaPEGacrylate, as 
well as the hydrogels' degradation products appeared to be non-toxic in contact with 
model tissue, hFF-fibrin clusters, as well as embryonic chick DRGs. However, it 
remains to be tested whether the matrices' degradation products are systemically non-
toxic and non-immunogenic ill vi\'O. To minimize the potential for immunogenicity, the 
core protein sequence was based on human protein sequences, and poly(ethylene 
glycol) was chosen as the bulk constituent because of its well-established 
immunocompatibility.l28 
10. lntegrin-mediated hFF attachment and three-dimensional cell migration inside the 
protein-graft-PEG matrices was achieved by incorporating the RGD motif as a 
permanent element of the matrix. Immobilization of heparin led to surface neurite 
outgrowth on protein-;?raft-PEG matrices. Most likely, neuroactive adhesion- and/or 
trophic factors from the culture medium, or substances secreted by cells, bound to the 
heparin and, thus, stimulated neurite extension onto the otherwise non-permissive 
matrix. 
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II. Protein-gr~ft-PEG matrices were degradable by plasmin ill vitro, and by cell-
associated enzymatic activity ill l'ivo, both by virtue of plasmin-degradation sites that 
were part of the matrices by design. 
MA TERIAL IMPROVEMENTS AND FUTURE APPLICATIONS 
Material Improvements 
To avoid photochemical crosslinking of protein-gr~ft-PEGacrylate, which involves 
light-induced radical polymerization, a small dithiol-containing crosslinking agent such as 
PEG dithiol, HS-PEG-SH, might prove feasible to form a hydrogel network with protein-
gr~ft-PEGacrylate ill situ. The hope is that both thiols react with terminal acrylates of 
different protein-graft-PEGacrylate molecules and thus link them. Many such Michael-type 
conjugate additions would lead to a crosslinked network under the same benign conditions 
under which photocrosslinking was performed, albeit probably slower, but without the 
occurrence of any radical species. 
Another potential material deficiency of the protein-graft-PEG hydrogels might be 
bulk hydrolytic degradation (at the acrylate esters), although relative to enzymatic 
degradation, hydrolysis is probably insignificant under physiological conditions. Should it 
nevertheless be desirable to preclude potential bulk hydrolysis of the protein-gr~ft-PEG 
hydrogels, core proteins could be PEGylated by Michael-type conjugate addition to PEG 
divinylsulfone. 159 whose functional end groups are much less prone to hydrolysis, so that 
the resulting hydrogels would be degradable by enzymatic processes only. However, 
photocrosslinking as described in Chapter 4 does not work with vinylsulfone-terminated 
protein-graft-PEG. Therefore, possible alternative photochemical schemes would have to 
be identified. or protein-graft-PEGvinylsulfones would have to be crosslinked by HS-
PEG-SH. for example, at the expense of crosslinking speed. PEG divinylsulfone-based 
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hydrogels, crosslinked by multithiol-containing oligopeptides, are currently under 
investigation by Hubbell ct al. 
Arguably the most serious deficiency of protein-/?raft-PEG hydrogels is the 
difficulty of micropatterning, which is desirable in some scaffolds for the engineering of 
artificial organs, and which some researchers consider necessary for better and faster 
functional regeneration of severed peripheral nerves.4 Proposing ways to produce 
patterned protein-/?raft-PEG hydrogels is beyond the scope of this doctoral thesis. 
Likewise, in the context of nerve regeneration, it was not one of the design goals for 
protein-/?raji-PEG matrices to contain inherent structural clues that facilitate proper path 
finding and correct nerve cable connections when the regenerating axons reach the distal 
nerve stump. The hope is that even unguided distal stump invasion and eventual target re-
innervation, combined with axonal plasticity in the periphery and in the brain, will 
eventually lead to satisfactory functional recovery. 
Biological Considerations 
Although no three-dimensional neurite outgrowth was observed in protein[A]-/?raff-
PEG hydrogels, the fact that hFFs invaded this biosynthetic material was still promising of 
its potential as a matrix to promote nerve regeneration. If hFFs infiltrated the material, the 
right combinantion of adhesive and neuroinductive signals might enable neurite ingrowth 
into future variants of protein[A]-/?/"(4f-PEG hydrogels. One way of modifying present 
protein[A]-/?ratf-PEG hydrogels is by using the heparin-bridging scheme to present 
additional adhesion- and/or growth factors. Studies are in progress to get a clearer 
understanding and better control over heparin-mediated immobilization of additional factors 
in the material. 
Another way of creating an environment conducive to nerve regeneration is to pre-
seed protein-/?ri1tf-PEG hydrogels with suitable autologous support cells, in particular 
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Schwann cells, that secrete relevant ECM adhesion molecules and growth factors, and that 
promote neurite extension directly by engaging neurites in intercellular adhesions. 
Alternatively, stem cells that develop into such support cells should be considered as a way 
to avoid sacrificing a patient's functional and mature nervous tissue. Protein-grajt-PEG 
hydrogels might prove to be useful matrices for the delivery of stem cells that differentiate 
in response to local stimuli at the site of implantation. 
As far as the material design is concerned, as long as uncertainty remains about the 
usefulness (and choice) of minimal neuroactive oligopeptides (Figure 6.17) which might or 
might not actually be immobilized in the hydrogels via heparin, additional neuroactive 
domains could however be incorporated into the protein backbone of protein-gr({jt-PEG 
hydrogels in hopes of promoting neurite outgrowth three-dimensionally. 
As an alternative to immobilization of neuroactive signals via a "heparin bridge," 
neuroadhesive domains could be coupled to a heparin analogue. Such a heparin analogue-
coupled neuroactil'e factor would in theory bind directly to the heparin-binding sites of 
protein-graft-PEG hydrogels, and could thus be immobilized inside the hydrogels without 
the need for a "heparin bridge." This would constitute a more direct immobilization scheme 
than the one chosen in this study (Figure 6.1), and it would avoid the need for one of the 
original design's two binding interactions. In fact, if a proven immobilization scheme can 
be established, adhesion sites in the backbone become dispensable, as any signal of choice 
could be delivered by coupling it to a heparin analogue followed by direct binding to 
exclusively heparin-binding protein-graft-PEG hydrogels. Future studies will show 
whether incorporation of adhesion signals into the backbone or whether the more flexible 
scheme of immobilizing biological factors via binding to the gels' heparin-binding sites will 
be more successful in promoting neurite extension. 
148 
In summary, since the protein-grafi-PEG material described in this doctoral thesis fulfilled 
some essential requirements toward functioning as a matrix for nerve regeneration, such as 
suitable physical properties, apparent lack of local toxicity, cell adhesivity, proteolytic 
degradability, and ease of handling, the hope is that possible future experiments will prove 
the material's successful performance in supporting improved nerve repair ill vivo. 
Toward this end, it might prove conducive to incorporate or immobilize additional adhesion 
and/or growth factors, and it might be helpful or even necessary to pre-seed the matrix with 
suitable supporting cells, such as autologous Schwann cells or neural stem cells. 
Versatility of Protein-grafl-PEG Hydrogels 
In closing, it is worth to re-emphasize protein-gnlfi-PEG hydrogels' very versatile 
nature that stems from the exchangeable protein elements that lie at the matrices' core. Any 
protein fragment, provided that it remains or becomes water soluble after PEGacrylation, 
can be rendered in a hydrogel form and thus impart its function to the matrix of which it has 
become a part. Different protein components with different adhesive or degradative 
specificities can be incorporated in hydrogels to promote regeneration of specific target 
tissues, the difference to oligopeptide-based hydro gels being that much more complex and 
complete biological functionality can potentially be harnessed. Given the possibility to 
incorporate an amount and variety of biological information only limited by Nature's own 
repertoire, perhaps future protein-graji-PEG hydrogels -possibly patterned- even hold 
promise as three-dimensional scaffolds for the manufacture of entire artificial organs grown 
from differentiated donor cells or stem cells. This was foreshadowed when fibroblasts -as 
a model cell type for ingrowth into protein-gr~fi-PEG hydrogels- attached to, migrated 
within, apparently proliferated in, and eventually completely colonized the matrix (Figure 
5.10, Chapter 5). 
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